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Abstract 
Fluorinated heterocyclic compounds have drug like properties and possess a valuable 
biological activity due to their rigid chemical structures and the high solubility profile. 
Novel fluorinated heteroarenes have been synthesised by SNAr reaction of a range of 
fluorinated arenes including pentafluoropyridine, hexafluorobenzene and 
pentafluorotoluene to introduce a range of groups specially nitriles, benzimidazole, 
carbazole and benzimidazole. A number of cyclization reactions have been 
investigated with the aim of forming polycyclic structures that could act as DNA 
intercalators. 
The synthesised compounds have been characterized by elemental analysis, IR, 1H 
and 19F NMR spectroscopy and single crystal analysis. These compounds have been 
screened for their biological activities including DNA thermal denaturation assay, 
UV-Visible spectroscopy, fluorescence spectroscopy, X-ray co-crystallization and 
antimicrobial activity study. Some of the compounds showed potential DNA bonding 
activity in particular the carbazole derivatives.                              
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Chapter 1 
Introduction
 2 
1. Introduction 
Heterocyclic chemistry is very important during lead optimization in drug discovery and 
development in the pharmaceutical industry, and the majority of the therapeutic agents 
contain at least one heterocyclic sub-unit within their chemical structure. Many functional 
heterocyclic compounds have drug like properties and possess valuable biological activity 
due to their rigid chemical structures and high solubility profile. Increasingly studies have 
focused on discovery and synthesis of a variety of heterocyclic derivatives via the 
chemistry of highly fluorinated heteroaromatic schemes.1,2 The presence of fluorine in 
drug molecules has been found to have many beneficial effects. 
Henri Moissan established the field of fluorine chemistry in the late 19th century with the 
first isolation of elemental fluorine in 1886. At that time the extreme reactivity of fluorine 
narrowed the spreading of fluorinated compounds. This situation changed in the 1960s 
and 1970s with the introduction of selective and safe fluorinated reagents that were 
compatible with regular laboratory procedures and instruments and therefore agreeable to 
elaboration of novel fluorinated lead substances.3,4 The fluorinated heterocyclic 
compounds are critical in various technological developments and have become important 
intermediate products in the synthesis of various pharmaceuticals, agrochemicals, 
fluoropolymers and in material science in what can be named “the modern age of fluorine 
chemistry”.3,4,5  The development of synthetic organofluorine chemistry and the proper 
understanding of the role of fluorine in biological behavior of the compounds have been 
facilitated to synthesise more effective and leading fluorine containing  pharmaceutical 
candidates.6,7,8 Moreover, it has been estimated that around 20-25% of medicines consist 
of fluorinated substances4,9,10,11 and among the various drugs in the world, more than 150 
pharmaceutical candidates are fluorinated compounds which is comparatively a large 
number compared to other halogen containing drugs.12 Gakh and Burnet (2011) indicated 
that the use of fluorinated biologically active substances in medicinal chemistry increased 
steadily between 1957-2006 from about 7% to about 15% according to the food drug 
administration (FDA).13 
1.1. Fluorine physical characteristics 
Fluorine is the most reactive electronegative element with very low polarizability 4,14,15 
and a very low bond dissociation energy F-F (155 kJ/mol).16 In contrast the bond 
dissociation energy for C-H and C-F are 411 kJ/mol and 485 kJ/mol respectively.16 
Fluorine atom has the second smallest van der Waals radius (1.47 Å), which is sited 
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between hydrogen (1.20 Å)17 and oxygen (1.52 Å)17 and allows fluorine to behave like a 
hydroxyl group and contribute in hydrogen bonding interactions.3 The low polarizability 
affecting the fluorine and the three non bonding electron pairs are important physical 
characteristics of biological activity of fluorinated compounds.3,10,14,15 In addition, the 
high reactivity of fluorine is referred to the strong bond between fluorine and other 
elements and a very weak F-F bond. Also the greater strength of the C-F bond over the C-
H bond results in high chemical stability of fluorinated compounds.3,18 The physical and 
chemical properties of the molecule can be changed significantly by introducing a 
fluorine atom to the molecule. As a consequence of these characteristics, a group 
containing fluorine could be used to substitute a non-fluorinated one in a biologically 
active molecule, which could change the activity of the compound, lipophilicity, 
bioavailability and metabolic stability dramatically. This ability to modify the 
pharmaceutical behavior of a compound by adding fluorine atoms clarifies why medicinal 
and bioorganic chemistry of fluorine has become an active area of research, and why a 
large number of pharmaceutical candidates contain fluorine atoms.2,12,19 
1.2. Biological impact of fluorination 
1.2.1. Absorption 
The xenobiotic molecule has to be absorbed and penetrate several barriers without being 
changed or eliminated before reaching the macromolecule target. The absorption 
properties of the molecule can be modified by fluorination, as it is known ionisable drug 
absorption depends on the lipophilicity of charged and neutral species. Fluorine 
substitution can modify the ionisation of the substance at pH 7.4, consequently the 
lowering of the pKa of nitrogen containing heterocyclic compounds or amines by 
fluorination enhance the absorption particularly for the oral administrated drugs.12  
1.2.2. Lipophilicity 
The blood brain barrier permeability of a lead molecule can be increased by introducing a 
fluorine atom in a specific position resulting in enhanced affinity of the compound to the 
target molecule. In addition, lipophilicity is usually increased when a fluorine atom is 
introduced to an aromatic ring or if a fluorine atom is located in the vicinity of a basic 
nitrogen atom.9 Some fluorinated groups are isosteric with several functional groups and 
they can mimic them in the interaction with the target biological macromolecules such as 
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receptors, nucleic acids and enzymes and this is a very critical strategy in the design and 
synthesis of receptor ligands, enzyme inhibitors and mechanism-based inhibitors.12  
1.2.3. Metabolism 
The stability of molecules against metabolic oxidation can be increased by exchanging a 
proton with fluorine atom due to the higher dissociation energy of C-F bond versus C-H 
bond (the dissociation energy of a C-F and C-H bonds are 485 kJ/mol and 411 kcal/mol 
respectively).9,16 Furthermore, because the fluorine atom is rare in nature, it is less likely 
to be degraded by naturally occurring enzymes, thus it can help to enhance the drug 
metabolic stability.7 The fluorinated analogue of a biologically active compound is 
normally recognized by the same enzyme, receptor or nucleic acid target. The specific 
physicochemical properties of fluorine modify the interactions between the compound 
and the constituents of the biological medium. Because of the size difference between the 
hydrogen atom and the fluorine atom, the replacement of hydrogen with one or more 
fluorine atoms can adjust the conformation of the molecule, consequently altering enzyme 
or receptor binding affinity, or changing the main metabolic process of the therapeutic 
agents.3,10,14,20 
1.3. SNAr reactions of perfluoroarenes 
There is now a substantial body of literature on organofluorine chemistry.21,22 A vast 
range of nucleophiles have been shown to react with perfluoroarenes in SNAr reactions 
with nucleophiles based on C, O, N, S and P. Examples of reactions involving 
hexafluorobenzene 1 are shown in scheme 1. The anion of diethyl phosphonate reacts 
with hexafluorobenzene 1 through the phosphorus atom to give phosphonate 2.23 
Hexafluorobenzene 1 also reacts readily with alkyllithiums such as methyllithium and 
forms pentafluorotoluene 3.24 The sodium salt of benzyl alcohol reacts with 
hexafluorobenzene 1 to give ether 4.24 Hexafluorobenzene 1 reacts with amines such as 
morpholine to give tertiary amine 5.25 Sulfur nucleophiles are particular effective and 
hexafluorobenzene 1 reacts with sodium hydrogensulfide to give pentafluorobenzenethiol 
6.26 
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In each case the nucleophile adds to the electron deficient fluorinated ring to form an 
anionic tetrahedral intermediate 7, with the charge delocalized across the five remaining 
sp2 hybridised carbons, and stabilized by the inductive effect of the fluorine atoms as 
shown in Scheme 2. Only the most important resonance structure 7, with the charge on 
the central carbon with the maximum orbital coefficient, is shown. Rearomatisation then 
occurs with loss of a fluoride ion to form the product.22 
 
 
 
 
 
 
Scheme 1. Various SNAr reactions of hexafluorobenzene 
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Addition of a further nucleophile is possible and the same, or a different, nucleophile can 
add to mono-substituted perfluorobenzene derivatives (Scheme 3).         
 
For example normal butyllithium (n-BuLi) reacts twice with hexafluorobenzene 1 
forming initially 10, and then addition of a second molecule affords                                
1,4-dibutyl tetrafluorobenzene 11 (Scheme 4).27                  
Scheme 4. Reaction of hexafluorobenzene with butyllithium27 
                                                  
Scheme 2. Mechanism of SNAr reaction 
Scheme 3. 1,4-Disubstitution of hexafluorobenzene 
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When two molecules of the same nucleophile attack, predominantly the 1,4-disubstituted 
product is obtained, due to the destabilizing effect of para-fluorine if the nucleophile 
attacks at any other position, as shown in Scheme 5. 
    
                              
Attack at the 4-position is promoted by the strongly inductive effect of one ipso, and two 
ortho, fluorines.  A para-fluorine however destabilizes the intermediate due to repulsion 
by the small lone pairs on the fluorine atom of the electrons accumulating in the p-orbital 
on C-1 (largest orbital coefficient in the delocalized π-system). The meta fluorines have a 
slight activating effect which has been ascribed to a dipole effect.28, 29 Similarly if a 
different nucleophile adds to a mono-substituted perfluorobenzene derivative, 1,4-
addition is also preferred, although minor amounts of the ortho substituted compound is 
sometimes observed. Reaction of ethyl pentafluorobenzoate 12, for example, with sodium 
ethoxide gives the 1,4-disubstituted product 13 in 96 % with only a trace amount of the 
1,2-disubstituted compound 14 (Scheme 6).30  
            
Scheme 5. Mechanistic basis of orientation in di-substitution of 
hexafluorobenzene 
Scheme 6. Reaction of ethyl pentafluorobenzoate with sodium 
ethoxide30 
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Even when the first group added is an electron donating group, 1,4 addition is still 
observed to avoid the repulsive effect of a para-fluorine atom. For example addition of a 
phenol such as 2-bromophenol 15 to hexafluorobenzene 1 gives the 1,4-bis ether 17 via 
the mono-substituted complex 16.31 In fact it is often found that the 1,4-disubstitution 
product is formed predominantly during attempts to effect mono-substitution. The second 
nucleophile often reacts more readily with the first-formed product e.g. 16 than with the 
starting material due to the presence of a destabilising para-fluorine. Any other atom in 
the para-position generally makes that compound more reactive. From a synthetic point 
of view a large excess of the starting perfluoroarene is often required in order to obtain 
useful yields of mono-substituted compounds (Scheme 7).   
 
          
The vast majority of disubstitution reactions lead to the 1,4-disubstituted product, but 
there are a few exceptions where 1,2-disubstitution can occur. This usually arises where 
the first substituent can coordinate to the incoming nucleophile. For example reaction of 
the sulfone 18 with ethylmagnesium bromide forms the product 20 where the ethyl group 
has added ortho to the sulfone group (Scheme 8).32      
Scheme 7. Reaction of hexafluorobenzene with 2-bromophenol31 
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1.3.1. Perfluorinated pyridine 
Sandford et al., in 2010 have established that perfluoroheteroaromatic systems such as 
pentafluoropyridine are excellent core scaffolds for the synthesis of various highly 
functionalized heteroaromatic and ring fused polycyclic compounds.1 Pentafluoropyridine 
is highly reactive toward nucleophilic attack due to the presence of five highly 
electronegative fluorine atoms attached to the heterocycle and the ring nitrogen, and all 
five fluorines atoms can be replaced by nucleophiles in SNAr reactions.33 Scheme 9 
outlines the possible principle of the order of the nucleophilic substitution in 
pentafluoropyridine 21 and this order of the nucleophilic attack can depend on the effect 
of each substituent once attached to the heterocyclic ring as well as to the nature of the 
attacking nucleophile.1,33,34,6 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 9. General approach to the synthesis of pentasubstituted 
pyridine systems 
Scheme 8. 1,2-Disubstitution occurs in the case of a coordinating sulfone 
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The first nucleophile again adds at the 4-position, para to the stabilizing nitrogen, and 
avoiding the repulsion of a para-fluorine atom. Subsequent nucleophiles then attack at C-
2 and C-6 which are adjacent to the ring nitrogen. The final nucleophiles tend to add to C-
3 and C-5. Scheme 10 shows some examples of the general strategy of the nucleophilic 
substitution of pentafluoropyridine 21. Reaction of ethyl acetoacetate with 
pentafluoropyridine 21 in the presence of sodium hydride (NaH) under reflux in 
tetrahydrofuran (THF) for 70 h provided enol ester 22 that arose from the replacement of 
fluorine by the anion of ethyl acetoacetate.1 Phenyllithium reacted with 
pentafluoropyridine 21 and formed biaryl 23.35 Reaction of the highly nucleophilic 
hydrazine with pentafluoropyridine 21 afforded compound 24.36 In all three examples the 
addition of the nucleophile occurs at C-4 (Scheme 10).                     
 
 
  
Di- and tri-substitution is possible as shown by the examples in Scheme 11.33,37 The 
sodium salt of benzenesulfinic acid reacted with pentafluoropyridine 21 to form sulfone 
25 in high yield. Treatment of this compound with diethylamine led to formation of 26 in 
moderate yield, and the amine group was shown by 19F NMR spectroscopy to have added 
Scheme 10. SNAr reactions of pentafluoropyridine 
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at the 2-position. On the other hand reaction of 25 with ethylenediamine led to the tri-
substitution product 27 in 92 % yield. In this case addition is most likely to have occurred 
firstly at the more reactive C-2 position, with the other amino group then attacking C-3 to 
form the piperazine ring. This reaction shows the possibility of forming an additional 
fused ring and this approach is a key theme of the Weaver group research.         
 
 
                   
 
 
A further example of ring formation is shown in Scheme 12 and involved the reaction of 
pentafluoropyridine 21 with 2-iminopiperidine 28 which provided the tricyclic compound 
29 after heating with NaHCO3 at 180 °C for 30 minutes under microwave irradiation. 
Initial attack at C-4 is most likely to have occurred, followed by a second SNAr reaction at 
C-3 to close the imidazole ring.37  
Scheme 11. Di-and tri-substitution reactions of 
pentafluoropyridine37 
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In contrast, the reaction of pentafluoropyridine 21 with acetamidine 30 in the presence of 
NaHCO3 under reflux in acetonitrile for 17 h gave the uncyclized amidine derivative 31 
(Scheme 13).37 It is not clear why compound 31 failed to cyclize under these conditions, 
although the temperature employed was lower than in the case of 29.   
                         
One aim of the research in the group is to effect ring formation of fluorinated aryl ethers 
such as 32 (Scheme 14). Lithiation of compound 32 was investigated by treatment with 
two equivalents of n-BuLi in THF at −78 °C followed by warming to room temperature 
(RT) and provided the benzo-bis-benzofuran 33 (Scheme 14).31  
Bromine-lithium exchange in 32 was believed to have generated a highly nucleophilic 
aryllithium which then effected on SNAr reaction on the ortho-position of the central 
perfluorobenzene ring forming the fused benzofuran structure; the reaction occurring at 
both ends of the molecule. The regioisomer formed can be accounted for by consideration 
of the site of attack by the second to react aryllithium group. This would attack para to 
the carbon of the first-formed benzofuran ring rather than para to fluorine.31 
Scheme 12. Reaction of pentafluoropyridine with                              
2-iminopiperidine37 
Scheme 13. Reaction of pentafluoropyridine with acetamidine37 
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Lithium-bromine exchange in ether 34 was expected to generate an aryllithium which 
would lead to intramolecular substitution of the fluorine at C-3 of the pyridine ring to 
close the furan ring forming 35. However treatment of the tetrafluoropyridyl ether 34 with 
n-BuLi in THF at low temperature afforded a compound which was not the expected 
tricyclic furan 35. Spectroscopic analysis indicated that the tetrafluoropyridine ring was 
intact. The product was shown to be the 2-(tetrafluoropyrid-4-yl)phenol 36 indicating that 
the reaction had proceeded by a Smiles type rearrangement. It appears that the aryllithium 
formed prefers to attack at C-4 rather than at C-3 to avoid the destabilizing effect of a 
para-fluorine, even though this means the reaction has to proceed via a strained four-
membered ring intermediate. Treatment of the phenol 36 with sodium hydride in DMF 
did then give the fused benzofuran 37 quantitatively with the phenoxide oxygen effecting 
nucleophilic substitution of the fluorine atom at 3-position of the pyridine ring (Scheme 
15).31 
 
 
 
 
 
 
 
 
 
 
Scheme 14. Cyclization of bis-ether (32) to benzo[1,2-b:4,5-b']bis[b]benzofuran (33)31 
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When the corresponding thioether 38 was treated with n-BuLi, direct cyclization occurred 
by SNAr reaction at C-3 and no rearrangement was observed. The anion stabilizing effect 
of the sulfur is believed to lower the activation energy for attack at C-3 overriding the 
repulsive effect of the para-fluorine (Scheme 16).31  
               
 
Scheme 15. Smiles reaction was observed in lithiation of                                                 
4-(2-bromophenoxy)tetrafluoropyridine31 
Scheme 16. Normal cyclization occurred in the case of       
4-(2-bromophenylsulfanyl) tetrafluoropyridine31 
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It was planned to focus on the chemistry of fluorinated arenes relevant to heterocyclic 
drug synthesis.  
1.4. Fluorinated pharmaceutical agents 
1.4.1. Thymidylate synthase inhibitors 
Wide ranges of fluorinated cancer treatment drugs are now available for curing tumors. 
The most common drugs broadly used are 5-fluoropyrimidines, for example                     
5-fluorouracil (5-FU) and 5-fluoro-2'-deoxyuridine (FdUrd) (Figure 1). The key strategy 
of 5-FU is inhibition of cell division in cancerous tissue, while 5-FU and its derivatives 
play a critical role in mechanism-based inhibition of the enzyme thymidylate synthase 
(TS), since the TS enzyme is responsible for the synthesis of the compounds that act as 
the building block for DNA repair and synthesis in particular thymine.11  
 
 
 
 
 
 
Figure 1. Examples of TS inhibitors  
1.5. DNA binding studies of organic fluorinated compounds 
1.5.1. DNA-drug interactions 
Deoxyribonucleic acid (DNA) is a nucleic acid that holds the genetic information which is 
required to identify the biological progress of cell life.38,39 A highly dynamic natural 
molecule, it consists of two tightly intertwined strands forming a double helix.40,41 The 
double strand is held together by hydrogen bond interactions between complementary 
base pairs units (Figure 2).41,42 Each strand is made of subunits called nucleotides. Each 
nucleotide is made of a sugar (deoxyribose), a phosphate group, and a nitrogenous base, 
which is Adenine (A), Guanine (G), Cytosine (C), or Thymine (T). The bases form 
complementary A–T and G–C pairs across the helix. 
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The integrity of DNA is a vital feature of cell life, since the molecule carries hereditary 
information and instructs important biological processes of living cells such as 
transcription (gene expression and protein synthesis) and replication (a key step in cell 
division and growth).43,44,45 It is important to understand the mechanism of genetic 
processes of differentiation and cell growth; moreover it is one of the most promising 
biological targets for developing anti cancer agents that aim to limit tumor cell growth. 
38,40,45,46,47,48 Targeting DNA to control cell functions by interfering with replication or by 
modulating transcription appears logical.47 When a small molecule binds to DNA and 
affects, alters or inhibits DNA functions, these compounds act as drugs when alteration or 
inhibition of DNA functions is necessary to treat or control certain diseases.47 This theory 
is significant in biology and medicinal chemistry to design and synthesis novel DNA 
targeted compounds for treating genetic origin diseases such as cancer.49  
 
 
 
Figure 2. DNA double helix 
(http://bio3400.nicerweb.com/Locked/media/ch01/01_08-DNA_double_helix.jpg) (Date: 1-1-2014) 43 
  
1.5.2. Types of DNA-drug interaction 
The pharmaceutical compounds interact with DNA in different ways:  
(i) Through control of transcription factors and polymerases. In this interaction the 
drugs interact with proteins that bind to DNA.  
(ii) Through binding of small ligand molecules to DNA double helix.47  
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The small organic molecules that interact with DNA can be classified into three different 
groups, alkylating agents, groove binding agents and intercalating agents.   
1.5.2.1. Alkylating agents 
Alkylating agents can cause DNA damage by formation of cross-links, bonds between 
atoms in the DNA. In this process, the alkylating agent that has two DNA binding sites 
will bind covalently with two bases of DNA. This cross-linking of the two strands of 
DNA prevents the use of that DNA as a template for further Ribonucleic acid (RNA) and 
DNA synthesis. Consequently, the replication and transcription of DNA will be inhibited 
and will lead to cell death. An example of cross linking agent is cisplatin that makes intra- 
and inter-strand cross-links through replacement of chloride ligands by the nitrogen atoms 
on the purine bases (Figure 3).44,47,50,51  An example of an alkylating agent is chlorambucil 
which forms cross links by alkylation of the N-7 position of guanine or adenine (Figure 
4).52 
 
 
Figure 3. Cisplatin covalently bound to DNA interastrand [structure a and b], interstrand 
[structure c]  
 
Figure 4. The structure of chlorambucil   
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1.5.2.2. Groove binding agents 
Groove binding compounds are crescent-shape or narrow curved shaped molecules, which 
are isohelical to the curves of the DNA. These compounds are able to bind with the major 
or minor grooves of DNA without causing large changes to the DNA. The major groove 
is wide and relatively small and shallow, and approximately 22 Å in width. The minor 
groove is deeper and narrower, and only about 12 Å in width (Figure 5).53 Some small 
compounds such as netropsin bind to the minor groove of DNA by hydrogen bonding, 
electrostatic and van der Waals interactions.47,54 Netropsin is a naturally occurring basic 
oligopeptide that display good antibiotic activities against viruses, fungi and bacteria 
(Figure 6).55,56   
 
 
Figure 5. Representation of minor and major grooves of B-DNA structure                  
 19 
  
 
 
 
 
 
Figure 6. Groove binding agent netropsin  
1.5.2.3. Intercalating agents 
Intercalating agents are flat aromatic or hetero-aromatic molecules, which slide and stack 
at proper sites between adjacent DNA base pairs leading to significant π-electron overlap 
and double helix distortion.40,46,47,54,57,58,49  These compounds stack perpendicular to DNA 
backbone and bind to DNA non-covalently in a reversible manner without breaking up the 
hydrogen bonds between the DNA base pairs. The stability of the DNA-intercalator 
complex is sustained with van der Waals, hydrophobic, hydrogen bonding and charge 
transfer forces. When an intercalating agent is inserted between DNA base pairs, a 
decrease in the DNA helical twist and lengthening of the DNA occurs, consequently 
delaying or preventing cell replication and growth. Therefore, DNA intercalating 
compounds are widely used in chemotherapeutic treatment to inhibit DNA replication in 
rapidly growing cancer cells.47,48    
DNA- intercalating agents which impair the stability of DNA double helix can be either 
mono or bis-intercalators.  
Monointercalating agents 
Monointercalating compounds are able to intercalate between double stranded DNA but 
can also bind single-stranded DNA with high affinity. An example of well known 
monointercalating agent is acridine orange (Figure 7).44 
Bis-Intercalating agents 
Bis-intercalating agents have two potential intercalating rings systems connected by 
linkers, which can differ in rigidity and length.48 An example of cyclo-bis-intercalator that 
exhibited DNA unwinding properties is bis-acridine A (Figure 7).44  
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Figure 7. Mono and bis intercalating compounds  
1.5.3. Techniques used to study drug–DNA interactions 
Experimentally there are a variety of techniques, which can be performed to study drug-
DNA interaction; in the present study five different techniques were used, which are DNA 
thermal denaturation studies, DNA-drug complex co-crystallization, UV-Visible 
spectroscopy, fluorescence spectroscopy and antimicrobial activity also investigated 
against a gram positive strain (Escherichia coli) and a gram negative strain 
(Staphylococcus aureus). 
1.5.3.1. DNA thermal denaturation assay 
The term DNA denaturation means the melting of a DNA double strand to generate two 
single strands by breaking the hydrogen bonds between the base pairs in the double helix. 
DNA thermal denaturation refers to the heat treatment over a critical temperature leading 
to denaturation of DNA double helix into single strand components in the presence or 
absence of a drug.54,59,60 The most common method to study the DNA melting transition is 
investigating the alteration in ultraviolet (UV) absorbance of a dilute DNA solution with 
gradual increase in the temperature.41,61 DNA absorbs the UV light strongly at 260 nm 
and by increasing the temperature the melting of DNA increases as well as the absorbance 
until the complete denaturation of the DNA happens and the absorbance remains constant 
in any further heating after DNA melting.59 The temperature at which half of the DNA is 
denatured is called the melting temperature (Tm). Also it means the half of DNA bases of 
a single strand do not interact with their complementary bases on the other strand and Tm 
values normally fall between 50 °C and 100 °C.22,46 When the DNA is monitored by UV 
spectroscopy and the temperature elevated gradually, a sigmoidal curve is obtained from 
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absorption data, which determines the Tm value and represents DNA denaturation. When 
the same DNA is complexed with an intercalator or other DNA binding molecule and 
monitored by UV spectroscopy under the same thermal conditions, another sigmoidal 
curve is obtained but this time the curve is shifted to higher temperature compared to the 
curve that obtained from DNA without any intercalator. The Tm value of                    
DNA-intercalator complex is always higher than the Tm value of the DNA alone due to 
the high stability of the DNA-drug complex  (Figure 8).46 
 
 
Figure 8. Curve of temperature vs. DNA denaturation in the presence or absence of      
DNA-intercalating agent 
 
1.5.3.2. DNA crystallization method 
Macromolecular X-ray crystallography is an important method for determining the three-
dimensional structure of DNA-drug complexes. DNA crystallography has the same 
experimental and basic theoretical foundations as protein crystallography. The main steps 
in DNA and protein crystallography are crystal growth and X-ray diffraction data 
collection. However, there are some variations in the methods of crystal growth and, data 
collection between DNA and protein crystallography. In DNA crystallography the quality 
and the quantity of the required materials is critical and the complications in crystal 
growth can be affected by the source or nature of the biological material.  
There are several procedures to crystallize biological macromolecules and all of which 
aim to bring the biological macromolecules solution to a supersaturation state and many 
parameters affect the crystallization of macromolecules. While stabilization, purification, 
storage and handling of macromolecules are also critical steps prior crystallization 
process.37 In addition, intrinsic physico-chemical parameters such as, supersaturation 
(concentration of macromolecules and precipitants), temperature, pH, purity and ionic 
strength of the buffer, pressure, magnetic and electric field, viscosity effects and the 
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difference in concentration between DNA/drug solution and the crystallizing 
(dehydrating) solution are important factors. The biochemical and biophysical parameters 
including binding of ligands (cofactors, substrates), purity of the macromolecules and 
possible bacterial contamination are very significant in crystallization of the DNA. 
Moreover, nucleation and crystal growth can be affected by the method used. Thus it 
advisable to try a range of crystallization methods to achieve the best crystallization.62 
Crystallization by vapour diffusion methods 
The most common method in macromolecules crystallization is the vapour diffusion 
technique, first used for tRNA (transfer ribonucleic acid) crystallization. It is suitable for 
very small volumes less than 2 µL. The principle of this technique is based on 
crystallization of a biological macromolecule in a droplet with buffer, crystallizing agent 
and additives, which is equilibrated against a reservoir containing a solution of 
crystallizing agent more concentrated than the droplet. Equilibration occurs by diffusion 
of the volatile substances such as organic solvent or water molecules, until the vapour 
pressure of the reservoir and the vapour pressure in the droplet become the same. The 
droplet volume changes when the equilibration happens by water exchange from the 
droplet to the reservoir leading to changes in the concentrations of all droplet components. 
This principle relates for three crystallization methods, hanging drop, sitting drop and 
sandwich drop (Figure 9).62 If crystallization is successful the drop containing the crystals 
can be taken up in a capillary for transfer to the X-ray diffractometer. 
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Figure 9. Schematic representation of crystallization by vapour diffusion methods  
1.5.3.3. UV-visible absorption spectroscopy 
UV-visible absorption spectroscopy is one of the most common and the simplest 
technique that is used to study both the stability of DNA and their interactions with small 
molecules. UV-visible absorption spectroscopy can be used to study and investigate the 
DNA-Drug interactions by monitoring the alterations in the absorption properties of the 
DNA molecule or drug molecule. Normally, the molecules used as ligands display an 
absorption band, which can be easily distinguished in the visible region. To identify 
whether there is any interaction between the DNA and the molecule the simplest way is 
study the shifting of the position of the maximum of this band from when the drug is free 
in solution to when the drug is bound to DNA. It has been assumed that the strength of the 
interaction between the DNA and the ligand could be indicated with the magnitude of this 
shift.47,63 DNA UV-visible absorption spectra show a broad band (200-350 nm) in the UV 
region with a maximum absorption at 260 nm and the absorbance ratios (A260 / A280 and 
A260 / A230) can indicte the purity of DNA. This ratio should be in the range of 1.8-1.9 to 
ensure that DNA is sufficiently free of protein.47    
1.5.3.4. Fluorescence spectroscopy 
Fluorescence spectroscopy is another important technique that used to investigate the 
interactions between DNA and small ligands molecules. The high sensitivity and the 
selectivity are the main advantages of molecular fluorescence over other techniques. The 
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data of the fluorescence spectra are normally obtainable as emission spectra, which is a 
plot of the fluorescence intensity versus wavelength (nm) or wavenumber (cm-1). 
Emission spectra differ significantly and are related to the chemical structure of the 
compounds and the solvent that used to dissolve it. Compounds containing aromatic 
functional groups with low-energy π-π transition levels have a large number of transitions 
and more intense and useful fluorescence compared to compounds containing aliphatic 
and alicyclic carbonyl structures or highly conjugated double-bond structures.47,64 In this 
technique and in the various analytical tools based on fluorescence emission the mode of 
DNA-drug binding can be determined. The fluorescence intensity normally increases with 
the effective interaction between the molecule and DNA. Hence, in case of intercalating 
compounds, the molecules are inserted between DNA base pairs of the double helix. The 
rotation of the unbound molecules favors the radiationless deactivation of the excited 
state, but a significant increase in the fluorescence emission is observed if the molecules 
are bound rigidly in the DNA. The opposite is the case for groove binding compounds and 
a decrease in the fluorescence intensity will observed in the presence of DNA because the 
molecules are exposed on the outer surface of the helix where they can interact with 
external fluorescence quenchers in the surrounding solution.47,65,66    
1.5.3.5. Antimicrobial activity 
In medicinal chemistry a considerable and critical part of the preclinical evaluation of any 
novel compound involves characterisation and judging its influence on bacteria in vitro. 
The antibacterial activity of the compound is determined by its ability to selectively 
interfere with bacterial growth and survival. In drug development these important stages 
are sometimes difficult as they are between the highly challenging antibacterial discovery 
process and difficult task of demonstrating safety and efficacy in vivo.67 Disk diffusion 
method is one of the oldest methodologies for antimicrobial susceptibility assay, and still 
one of the most widely used antimicrobial susceptibility investigation methods in routine 
clinical laboratories.68 The protocol of disk diffusion method is based on saturated small 
disks 6 mm in diameter with different concentrations of test compound, which are stacked 
in solidified inoculated agar with the examined bacterial strain in petri dishes. The plate is 
allowed to incubate at 37 °C for 24 h or 48 h. If the compound has antimicrobial activity it 
will show a clear zone around the disk and the zone edge should be judged with the naked 
eye with the plate held about 30 cm from the eye.69 Criteria for activity is based on 
inhibition zones (mm); an inhibition zone of more than 20 mm indicates significant 
 25 
activity, for 18-20 mm inhibition is good, 15-17 mm is low, and below 11-14 mm is non-
significant activity.70      
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Chapter 2 
Results and Discussion 
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2. Results and discussion 
2.1. Aim of the project 
The aim of this study was to synthesise novel heteroarene and fluorinated heteroarene 
compounds with potential bioactivity. In particular for the synthesis of new heterocycles, 
it was planned to exploit the easy SNAr reaction of fluorinated arenes such as 
hexafluorobenzene and pentafluoropyridine to introduce a range of groups, specifically 
nitriles, benzimidazoles, carbazoles and benzamides which will allow subsequent ring 
fusion processes to be carried to generate polycyclic structures, which could act as DNA 
intercalators or allow biaryl type links to be set up to generate conformationally flexible 
polyaryl systems with potential activity for DNA groove binding (Scheme 17). 
 
 
 
 
 
 
 
 
 
 
                 
 
In addition consideration and investigation of the biological activity of the synthesised 
compounds as DNA binding molecules or antimicrobial agents was to be carried out using 
DNA thermal denaturation assay, UV absorption, ethidium bromide fluorescence 
displacement experiments, DNA-compound co-crystallization and antimicrobial activity 
assays. 
The main key to this work was to study possible interactions between the synthesised 
compounds as possible groove binding, or intercalating agents, with DNA base pairs by 
different binding mechanisms including hydrogen bonding and electrostatic forces. 
Scheme 17. General approach to ring forming reactions 
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2.2. Organic synthesis 
In medicinal chemistry N-heterocycles are very important compounds because of their 
biological and technological significance. Nitrogen plays an important role in the 
interaction of small molecules and drug targets, and the large percentage of presently used 
drugs contain N-heterocyclic moieties.71 These compounds have a remarkable synthetic 
importance and their utilization in organic synthesis is useful. Moreover, organic 
scientists have studied the preparation of N-heterocycles from useful starting materials 
intensively. For example N-heterocycles can be synthesise from nitro compounds, nitrile 
compounds or amino compounds or their derivatives containing a nitrogen atom.72  
Research in the group involves using perfluoroarenes, many of which are now 
commercially available, as convenient starting materials for heterocyclic synthesis where 
new rings can be readily formed by SNAr reaction using appropriate bis-nucleophilic 
precursors. 
2.2.1. Synthesis of fluorinated benzonaphthyridine derivatives  
Naphthyridine and their benzonaphthyridine derivatives are compounds of current interest 
in medicinal chemistry due to their wide spectrum of biological activities such as 
antibacterial, antiviral and anticancer activity.73,74  This class of compounds have been 
studied intensively and it has been reported by Ferraris and co-workers75 that compound 
5H-5,6-dihydrobenzo[c][1,8]naphthyridine (Figure 10) is an active benzonaphthyridine 
derivative which used in treatment the ischemic injuries.75 
 
 
Figure 10. Example of an active benzonaphthyridine derivative 
 
As mentioned before the fluorine atom can change the biological properties of organic 
compounds by influencing its metabolism. That because of the specific physicochemical 
characteristics of fluorine atom which increase the lipophilicity of the compound, its small 
van der Waals radius and high electronegativity, which make it very similar to hydroxyl 
group and allow the fluorine atom to be a valuable resource for enhancing the therapeutic 
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efficacy of biologically active compounds.76 Based on the above interest it was decided to 
design and synthesise fluorinated benzonaphthyridine derivatives using 
pentafluoropyridine as readily available starting material. Reaction of pentafluoropyridine 
21 with ethyl 2-nitrophenylacetate 41 was expected to give tetrafluoropyridine derivative 
42 (Scheme 19), the precursor to a benzonaphthyridine 43a or 43b (Scheme 20).  
The first step of the reaction was the esterification of 2-nitrophenylacetic acid 40 using 
ethanol and H2SO4 (Scheme 18). The target product 2-nitro-phenyl-acetic acid ethyl ester 
41 was afforded after recrystallization as pale yellow crystals with 37 % yield. 1H NMR 
spectroscopy proved the successful synthesis of the target product by showing the 
expected signals of the aromatic and the aliphatic protons, δH (400 MHz, CDCl3) 8.13 
(1H, dd, J 8.4 and 1.2 Hz), 7.60 (1H, td, J 7.2 and 1.2 Hz), 7.48 (1H, td, J 8.4 and 1.6 Hz), 
7.36 (1H, dd, J 7.6 and 0.8 Hz), 4.18 (2H, q, J 6.8 Hz), 4.02 (2H, s), 1.26 (3H, t, J 6.8 
Hz). Moreover mass spectrometry showed the correct mass of compound 41, HRMS 
(ESI) m/z found 232.0576, C10H11NO4Na+ requires 232.0580. 
 
Scheme 18. Esterification of 2-nitrophenyl acetic acid           
 
 
The second step for the synthesis of the fluorinated benzonaphthyridine derivative was the 
reaction of ethyl ester 41 with one equivalent of pentafluoropyridine in the presence of 
NaH as base and dimethylformamide (DMF) as a solvent to form tetrafluoropyridine 
derivative 42 (Scheme 19). By adding ethyl ester 41 to a stirred suspension of NaH in 
DMF fizzing was observed in the mixture indicating that ethyl ester 41 deprotonated and 
then reacted with pentafluoropyridine by SNAr reaction. The reaction was successful but 
due to the low yield (13 %) of product 42 and detection of the starting material and some 
impurities with 1H NMR spectroscopy, the number of moles of pentafluoropyridine 
increased to enhance the chance of the combination between pentafluoropyridine and 
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ethyl ester 41 to give larger yield of fluorinated ethyl ester 42. Moreover the reaction 
condition was modified by using THF instead of DMF as this was easier to remove. 
Stirring under a N2 atmosphere at RT for 24 h then improved the yield to 93 %. 19F NMR 
spectroscopy proved the successful synthesis of the target product 42 and showed two 
multiplet signals for two pairs of fluorine atoms in the range 72.91-72.73 (2F, m) and 
21.17-20.99 (2F, m). Mass spectrometry found the expected mass for the 
tetrafluoropyridine derivative 42, HRMS (ESI) m/z found 357.0512 (M−H)
-
 C15H9F4N2O4 
requires 357.0504. IR spectroscopy showed the expected signals for the main functional 
groups in the compound 42 with the following signals vmax/cm-1 (film) 1737 (C=O), 1531 
(NO2), 1348 (NO2).  
 
Scheme 19. Reaction of pentafluoropyridine with 2-nitrophenyl acetic acid ethyl ester (41)              
It has been reported that nitro compounds could be successfully cyclized to nitrogen 
heteroaromatic structures by heating them with reducing agents such as metallic iron.77 It 
was hoped that heating compound 42 in the presence of metallic iron and HCl (aq) would 
allow the reduction of nitro group to an amino group which consequently could substitute 
one fluorine atom and form tricyclic structure by SNAr reaction (Scheme 20). The data 
analysis suggested that the fluorinated ethyl ester 42 had reacted and orange crystals were 
afforded. Mass spectrometry found the expected mass ion for the cyclized compound 43a, 
HRMS (ESI) m/z found 307.0705 (M−H)
-
, C15H10F3N2O2 requires 307.0700. 
Unfortunately 19F NMR spectrum was quite complicated and displayed a number of 
signals, which could not be fully interpreted. Some signals could have been due to nitroso 
or hydroxylamine intermediates which had not cyclized to the fluorinated dihydro 
benzonaphthyridine 43a or 43b. The spectroscopic data suggests some of the product 43a 
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had formed but the material could not be obtained completely pure.  
Scheme 20. Cyclization of fluorinated ethyl ester (42)   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.2. Synthesis of fluorinated indole heterocycles using pentafluorotoluene    
In drug discovery the indole scaffold is one of the most important subunits for developing 
and synthesizing new drug candidates. Extensive research on indole chemistry has 
increased the number of biologically active synthetic compounds and natural products. A 
variety of indole containing compounds demonstrate a good therapeutic effect as anti-
inflammatories.78 Synthesis of fluorinated indole organic compounds will affect 
significantly the biological activity of the compounds and should lead to an improvement 
in the pharmacodynamic and pharmacokinetic characteristics of the compound.76 
Although several approaches have been developed in the field of indole synthesis, 
fluorinated analogues indole based biologically active compounds are not well known.76 
Because of that we designed some fluorinated indole based compounds using 
pentafluorotoluene as a core scaffold and as a source of fluorine atoms and reacted it with 
a range of different nitrile compounds. The reaction was based on deprotonation of the 
methyl group in pentafluorotoluene with NaH, and addition of the anion to a nitrile group, 
followed by nucleophilic substitution of the neighboring fluorine atom by the resulting 
imine anion, to generate novel fluorinated indole derivatives (Scheme 21). The proposed 
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compounds could then be further elaborated into intercalators or groove binders, or tested 
directly for anti-microbial activity.  
Scheme 21. Proposed mechanism of the reaction of pentafluorotoluene with nitrile groups 
    
 
 
 
 
 
  
2.2.2.1. Reaction of pentafluorotoluene with benzonitrile   
Reaction of pentafluorotoluene 44 with benzonitrile 45 in the presence of NaH as base 
and THF as solvent worked well at RT and compound 46 was formed successfully 
(Scheme 22). 19F NMR spectroscopy showed four different signals corresponding to four 
fluorine atoms, δF (376 MHz, CDCl3) 17.21-17.18 (1F, m), 17.15-17.11 (1F, m), 2.99-
2.96 (1F, m), 2.93-2.90 (1F, m). The 1H NMR spectrum showed a singlet at 7.28 for the 
indole H-3 proton and signals for the phenyl group. The NH signal could not be observed. 
In addition, mass spectrometry found the expected mass of the target compound 46, 
HRMS (ESI) m/z found 264.0446 (M−H)
-
, C14H6F4N requires 264.0442, and IR analysis 
detected a broad signal at 3066 vmax/cm-1 for the N-H group. Different nitrile groups have 
been studied to synthesise a series of fluorinated indole novel compounds using 
pentafluorotoluene as core scaffold (Table 1). 
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Scheme 22. Reaction of pentafluorotoluene with benzonitrile                
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Table 1. Reaction of different nitriles with pentafluorotoluene 
R Results Conditions Expected product  Yield %   
 
 
acetonitrile 
47  
Indole 
formed Acetonitrile used as a solvent, RT  
(24 h), NaH 
      
48 
52 % 
  
 
 
2-thiophenecarbonitrile 
49  
Two un 
identified 
products 
formed 
1) DMF, NaH, 
RT (24 h). 
2) THF, NaH, 
66 °C (24 h).  
       
50 
- 
  
 
 
 
4-methoxybenzonitrile 
51 
No indole 
1) DMF, NaH, 
RT (24 h). 
2) THF, NaH, 
RT (24 h). 
3) DMF, NaH,  
at 80 °C. 
4) THF, NaH, 
reflux at 66 °C. 
         
52 
- 
   
 
 
 
 
3-methoxybenzonitrile 
53 
No indole 
 
1) DMF, NaH, 
RT (24 h). 
2) THF, NaH, 
RT (24 h). 
        
54 
- 
    
 
2-pyridinecarbonitrile 
55   
Un 
expected 
triazine 
57 
(Scheme 
23) 
THF, NaH, RT  
(24 h). 
        
56 
- 
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Reaction of acetonitrile 47 with pentafluorotoluene 44 was studied under different 
conditions. In the presence of a mixture of DMF and THF as solvents at RT, or heated at 
60 °C, unfortunately the reaction did not work well, and the 1H and 19F NMR spectra were 
complicated. Moreover IR analysis detected a signal at 2222 vmax/cm-1, which suggested 
the presence of the starting nitrile group in the sample. Because of that it was then decided 
to do the reaction in concentrated solution using acetonitrile as solvent. Interestingly the 
reaction worked well and the target fluorinated indole derivative 48 was afforded in 52 % 
yield (Table 1). 19F NMR spectroscopy proved the presence of four fluorine atoms in the 
product by detecting four multiplet signals, δF (376 MHz, CDCl3) 20.63-20.59 (1F, m), 
20.08-19.99 (1F, m), 17.23-17.14 (1F, m), 2.99-2.91 (1F, m). Mass spectrometry found 
the expected mass for the target product 48, HRMS (ESI) m/z found 202.0289 (M−H)
-
, 
C9H4F4N, requires 202.0285. Unfortunately all attempts to crystallize the oily product 
failed.  
2-Thiophenecarbonitrile 49 was reacted with pentafluorotoluene 44 under different 
conditions and the results were quite different. In the presence of DMF as solvent IR 
spectrum showed a signal for the starting nitrile, vmax/cm-1 (film) 2226 but 19F NMR 
spectroscopy suggested the formation of the target compound 50 (Table 1) as a major 
product by detecting four different fluorine signals. Mass spectrometry found the exact 
mass for the target product 50, HRMS (ESI) m/z found 270.0011 (M−H)
-
, C12H4F4NS 
requires 270.0006. 1H NMR spectroscopy showed the expected signals for the thiophene 
ring protons of the target product but the proton in the indole ring was not observed, as it 
is expected to be around 7.1-7.3 ppm but it could be masked with chloroform signal. 
Unfortunately, the product was afforded as yellow oil and TLC showed tailing because of 
that it was not possible to purify the product and it was decided to change the reaction 
conditions to get better results. Using boiling THF as solvent rather than DMF the results 
also changed, interestingly the starting nitrile signal was not detected in the IR spectrum 
and mass spectrometry found the expected mass for the target product 50, However, 19F 
NMR spectroscopy was unexpected and showed two different patterns of multiplet signals 
in the range 17.20-17.10 (m) and 3.00-2.90 (m). Moreover, the 1H NMR spectrum also 
could not show the indole ring proton expected at 7.1-7.3 ppm. The product was 
crystallized but sadly the crystals were powder like and not suitable for X-ray 
crystallography because of that it was not possible to identify the product that formed.        
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Reaction of 4-methoxybenzonitrile 51 with pentafluorotoluene 44 was studied in various 
conditions to synthesise compound 52 (Table 1). Different solvents were used at RT such 
as DMF and THF and NaH as base, unfortunately the reactions did not work well and 1H 
NMR spectroscopy detected the expected signals of the starting material and IR 
spectroscopy showed a sharp signal for starting nitrile group at 2218 vmax/cm-1.  Because 
of that the reaction was heated for 24 h at 80 °C in DMF as solvent, or at 66 °C in THF as 
solvent. Unfortunately the reactions did not work and the starting material was identified 
with spectroscopic analysis. The failure of the 4-methoxybenzonitrile 51 to react may 
have been due to the lower electrophilicity of the nitrile group, which is conjugated to the 
electron donating methoxy group. Because of that it was decided to try                                  
3-methoxybenzonitrile 53 which could be more electrophilic as methoxy group not in the 
para position and that might prevent the easy donation of electrons from methoxy group. 
Again the reaction did not work by using THF or DMF as solvents at RT and the target 
compound 54 was not afforded and starting material was detected with 1H NMR 
spectroscopy. Also mass spectrometry could not find the target product as well as the 
TLC, which showed only one spot corresponding to the starting material.  
In the reaction of 2-pyridinecarbonitrile 55 with pentafluorotoluene 44 interestingly an 
unexpected complex compound formed rather than the target compound 56 (Table 1), in 
the presence of NaH as base and THF as solvent at RT. Pentafluorotoluene 44 did not 
react with 2-pyridinecarbonitrile 55 but the latter reacted with two further                         
2-pyridinecarbonitrile 55 molecules forming the triazine compound 57 (Scheme 23). In 
addition the triazine then co-crystallized with a molecule of pyridine-2-carboxamide, 
which must have formed by reaction of the nitrile 55 with traces of water present in the 
reaction mixture. 1H NMR spectroscopy confirmed the product had been formed by 
detecting several doublet and triplet signals for aromatic rings between 7-9 ppm. 
Moreover, 19F NMR spectroscopy suggested the absence of fluorine atoms in the sample 
and the final evidence of the synthesis of the unexpected product was obtained with X-ray 
crystallography (Figure 11). The X-ray structure showing how the amide group forms 
hydrogen bonds to two of the pyridine substituents of the triazine.       
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Scheme 23. Attempted reaction of pentafluorotoluene with 2-pyridinecarbonitrile    
 
 
 
 
 
 
 
 
 
   
 
Figure 11. X-ray crystal structure of complex (57)  
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2.2.3. Synthesis of thiazole and pyrazole heterocycles  
Thiazole derivatives are becoming increasingly important in the pharmaceutical industry 
and they have a variety of applications in the field of medicinal chemistry. Dawood et al., 
2013 reported that thiazole derivatives showed strong anticancer activity on a human lung 
cancer cell line. Moreover, thiazole derivatives act as anti-inflammatory agents and 
showed their anti-cancer activity by reporting their inhibitory profile against human 
hepatocellular carcinoma cell line.79 It is considered several thiazole scaffolds have an 
excellent anti-cancer activity by inhibiting the epidermal growth factor receptor-tyrosine 
kinase enzyme such as the pyrazolyl thiazole derivative (Figure 12) which plays a critical 
role in cell growth regulation.79 
               
Figure 12. Pyrazolyl thiazole derivative 
 
Pyrazole and N-substituted pyrazoles derivatives have several chemical and 
pharmaceutical applications due to their versatile biological activities. It has been reported 
that pyrazoles involved in several active compounds, can act as antimicrobial, antitumor, 
antileukemia, antidepressant and antifungal agents. Interestingly a typical model of 
pyrazole containing a diaryl-heterocyclic template celecoxib (Figure 13) proved its 
activity as safe gastrointestinal anti-inflammatory agent by selective inhibition of 
cyclooxygenase enzyme.80    
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Figure 13. The structure of celecoxib 
 
As a result of a remarkable pharmacological efficiency of thiazole and pyrazole 
derivatives, and in continuation of the authors’ efforts to synthesise new anticancer 
agents, it was planned to design a series of novel fluorinated thiazole and pyrazole 
compounds using pentafluoropyridine, hexafluorobenzene and pentafluorobenzaldehyde 
as starting materials in order to evaluate their biological activity, while also studying the 
synthetic and mechanistic aspects of the reactions.    
2.2.3.1. Synthesis of fluorinated thiazole derivatives using pentafluoropyridine and 
thiobenzamide 
Pentafluoropyridine 21 was reacted with thiobenzamide 58 with the hope of forming 
thiazole 60 (Scheme 24). However in practice, reaction of pentafluoropyridine 21 and 
thiobenzamide 58 did not work well in the presence of NaH as base and DMF as solvent 
and the target product 60 was not afforded. The data analysis suggested the unstable 
compound 59 was formed but it broke down to benzonitrile 61 and tetrafluoropyridine-4-
thiol 62 which is reversibly converted to tetrafluoro1H-pyridine-4-thione 63 and that was 
proved with IR spectrum which detected the nitrile group of benzonitrile, vmax / cm-1 (film) 
2222. 19F NMR spectroscopy detected two multiplet peaks in the range 74.16-73.94 (2F, 
m) and 26.88-26.72 (2F, m) which could correspond to either the tetrafluopyridine-4-thiol 
62 or tetrafluoro-1H-pyridine-4-thione 63. In addition mass spectrometry found the 
expected mass for tetrafluoro-pyridine-4-thiol 62 or tetrafluoro-1H-pyridine-4-thione 63, 
HRMS (ESI) m/z found 181.9692 (M−H)
-
, C5F4NS, requires 181.9693 and IR spectrum 
detected N-H signal, vmax / cm-1 (film) 3460 (N-H). Interestingly by changing the solvent 
from DMF to THF this was not the case, and the compound 59 was afforded after column 
chromatography purification as a yellow oil (0.914 g, 80 %). 1H NMR spectroscopy 
showed the expected signals for the aromatic protons of the benzene ring, δH (400 MHz 
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CDCl3) 7.68-7.48 (5H, m), 7.29 (1H, bs, NH) and mass spectrometry displayed the exact 
mass for the compound 59, HRMS (ESI) m/z found 286.0273, C12H6F4N2S requires 
286.0182. Nitrile signal did not appear in the IR spectrum and that proved the compound 
59 did not break down to benzonitrile 61 and tetrafluoropyridinethiol 62, moreover 19F 
NMR spectroscopy exhibited two multiplet peaks for two pairs of fluorine atoms in the 
range 74.27-74.03 (2F, m) and 27.01-26.83 (2F, m). 
To avoid the breakdown of compound 59 which may be catalyzed by base it was 
attempted to cyclize the compound 59 by heating in THF at 66 °C without any base, but 
unfortunately the cyclization reaction did not work, and the starting compound was 
detected by 19F NMR spectroscopy, which showed the same two multiplet signals of the 
starting compound.  
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Scheme 24. Reaction of pentafluoropyridine with thiobenzamide 
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2.2.3.2. Synthesis of fluorinated thiazole derivatives using pentafluoropyridine and 
naphthalene-1-thiocarboxamide 
Reaction of pentafluoropyridine 21 with naphthalene-1-thiocarboxamide 64 aimed to 
synthesise the heterocyclic compound 66 (Scheme 25) which could show potential DNA 
binding activity. Compound 65 was formed and it was again shown to be unstable with 
break down to naphthalene-1-carbonitrile 67 and tetrafluoropyridine-4-thiol 62 which is 
reversibly converted to tetrafluoro-1H-pyridinethione 63 as was observed previously. The 
occurrence of naphthalene-1-carbonitrile 67 was proved with mass spectrometry and the 
expected mass was displayed, HRMS (ESI) m/z found 153.0584, C11H7N requires 
153.0584, and IR detected the nitrile group signal, vmax / cm-1 (film) 2224 (C≡N). In 
addition 1H NMR spectrum showed the aromatic rings signals between 7-8 ppm for 
naphthaline-1-carbonitrile 67, δH (400 MHz, DMSO-d6) 8.33 (1H, d, J 8.4 Hz), 8.18 (1H, 
dd, J 7.2 and 0.8 Hz), 8.13 (2H, t, J 8.0 Hz), 7.82(1H, td, J 7.2 and 1.2 Hz), 7.74 (1H, td, J 
7.2 and 1.2 Hz), 7.69 (1H, dd, J 8.4 and 7.2 Hz). The 19F NMR spectroscopy showed 
multiplet signals for two pairs of fluorine atoms in the range 74.16-73.94 (2F, m) and 
26.88-26.72 (2F, m), which suggested the presence of compound 62 or compound 63. In 
addition mass spectrometry found the exact mass for compound 62 or compound 63, 
HRMS (ESI) m/z found 181.9692 (M−H)
-
, C5F4NS, requires 181.9693.  
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Scheme 25. Reaction of pentafluoropyridine with naphthalene-1-thiocarboxamide 
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2.2.3.3. Synthesis of fluorinated thiazole derivatives using hexafluorobenzene and 
naphthalene-1-thiocarboxamide    
Hexafluorobenzene 1 was reacted with naphthalene-1-thiocarboxamide 64 and the 
reaction aimed to synthesise fluorinated heterocyclic thiazole derivative 68, which could 
possess a good DNA binding activity (Scheme 26). In contrast to the previous reactions 
involving pentafluoropyridine, the reaction worked well at RT in the presence of NaH as 
base and THF as solvent and the product was formed a semi-crystalline solid. 
Recrystallization from ethanol and chloroform gave shiny creamy crystals but 
unfortunately only in 16 % yield with m.p 165-168 °C. 19F NMR spectroscopy indicated 
the presence of the target compound 68 by demonstrating four fluorine signals, δF (376 
MHz, CDCl3) 23.80 (1F, dd, J 20 and 15 Hz), 14.79 (1F, dd, J 19 and 14 Hz), 3.96 (1F, t, 
J 19 Hz), 3.24 (1F, t, J 20 Hz). The expected mass of the target molecule was displayed 
by GC-MS with m/z at 333. However it was unable to obtain an accurate mass 
measurement by electrospray ionisation due to the non-polar nature of the fluorinated 
molecule. This problem has been observed a number of times in the group with 
polyfluorinated compounds failing to ionize by ESI, but the nominal low resolution 
molecular ion signal was detected by GC-MS which employs electron impact ionization. 
The difference in reactivity between the pentafluoropyridine and hexafluorobenzene is not 
clear, and it cannot account for the failure of the pyridine derivatives to cyclize when 
closure of the thiazole occurred in the case of the hexafluorobenzene.  
Scheme 26. Reaction of hexafluorobenzene and naphthalene-1-thiocarboxamide           
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2.2.3.4. Synthesis of fluorinated fused thiazole derivatives using pentafluoropyridine 
and 2-mercaptobenzimidazole 
Reaction of pentafluoropyridine 21 with 2-mercaptobenzimidazole 69 was investigated 
with the aim of synthesising polycyclic compound 72 by sequential SNAr reaction 
(Scheme 27). The reaction was studied in different solvents and conditions but a product 
only was formed in the presence of NaH as base and a mixture of THF and DMF as 
solvents. The properties of the solid product isolated were not consistent with the 
tetracyclic structure 72, and it was first believed the product to be the mono-adduct 70, 
since a signal at 298 was observed in the mass spectrum, HRMS (ESI) m/z found 
298.0071 (M−H)
-
, C12H4F4N3S requires 298.0068. The 19F NMR spectrum showed four 
signals that were also not consistent with structure 70, although it was thought the four 
signals observed, rather than the expected two, could have explained by hindered rotation. 
It was then decided to see if further treatment of this compound would lead to formation 
of the tetracycle 72. However the material was recovered unchanged after treatment with 
sodium hydride in boiling dioxane. Then a good crystal of the new compound was 
obtained and the structure was shown by X-ray crystallography (Figure 14). Surprisingly 
the structure was shown to be compound 71 in which a tetrafluoropyridine ring had added 
both to the sulfur atom and one of the nitrogens of the benzimidazole ring. The 
identification of this structure then explained the 19F NMR spectrum and the four signals 
observed matched correctly with the two pairs of fluorine atoms on two pyridine rings. 
Further analysis of the mass spectrum showed a signal at 446, HRMS (ESI) m/z found 
446.9962 (M−H)
-
, C17H3F8N4S requires 446.9956 agreeing with the new structure. The 
signal first observed at 298 must have due to a trace amount of product 70. Elemental 
analysis fitted with the expected composition for a molecular formula of C17H4F8N4S 
(448) calculated C, 45.55; H, 0.90; N, 12.50. Found C, 45.41; H, 0.92; N, 12.00.    
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Scheme 27. Reaction of pentafluoropyridine with 2-mercaptobenzimidazole 
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Figure 14. X-ray crystal structure of compound (71)  
2.2.3.5. Synthesis of fluorinated fused thiazole derivatives using pentafluoropyridine 
and 2-mercapto-4(3H)-quinazolinone   
Reaction of pentafluoropyridine 21 with 2-mercapto-4(3H)-quinazolinone 73 was aimed 
at synthesising tetracyclic fluorinated thiazole derivative 74 and 75 which could possess 
good DNA binding activity. In the presence of a mixture of solvents THF and DMF at RT 
the reaction worked and the data suggested the presence of the cyclized thiazole 
derivative 74 or 75 (Scheme 28). 19F NMR spectroscopy showed three signals for three 
different fluorine atoms, δF (376 MHz, CDCl3) 106.50 (1F, dd, J 30 and 10 Hz), 74.44 
(1F, dd, J 22 and 10 Hz), 16.26 (1F, dd, J 29 and 22 Hz), as well as the GC mass 
spectrometry which showed the expected mass of the cyclized compound 74 or 75, GC-
MS (EI) m/z 307 but unfortunately the yield was very low (4 %). Due to the small 
quantity of 74 or 75 obtained it was not possible to determine which of the two possible 
regioisomers 74 or 75 had been formed.  
 Unfortunately, by repeating the reaction on larger scales to get a higher yield, under the 
same conditions, the uncyclized compound 76 was obtained and that was suggested by 19F 
NMR spectroscopy which demonstrated two signals, δF (376 MHz, DMSO-d6) 70.60-
70.43 (2F, m) and 28.73-28.54 (2F, m). 
The possible cyclization of compound 76 to 74 or 75 (Scheme 29) was studied under 
different conditions. Firstly NaH was used as base in the presence of dioxane as solvent 
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under reflux at 101 °C for 24 h to deprotonate the N-H group and allow the cyclization of 
the compound by nucleophilic aromatic substitution SNAr reaction. According to 
spectroscopic data the cyclization reaction did not work and the uncyclized starting 
compound was recovered. Because of that a stronger base was used to allow cyclization 
of the compound 76, which was potassium bis(trimethylsilyl)amide solution in the 
presence of THF as solvent at  −78 °C, but still the cyclization reaction did not work and 
only the uncyclized compound 76 was detected by spectroscopic analysis.  
 
Scheme 28. Reaction of pentafluoropyridine with 2-mercapto-4(3H)-quinazolinone 
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Scheme 29. Attempted cyclization of tetrafluoro-pyridine quinazoline derivative (76) 
 
2.2.3.6. Synthesis of fluorinated thiazole derivatives using pentafluorobenzaldehyde and 
2-mercapto-4(3H)-quinazolinone 
Due to the successful addition of the mercaptoquinazolinone to pentafluoropyridine it was 
decided to investigate the behavior of this compound towards other fluorinated arenes. 
Reaction of pentafluorobenzaldehyde 77 with 2-mercapto-4(3H)-quinazolinone 73 
worked well in the presence of a mixture of THF and DMF as solvents and NaH as base 
at RT and compound 78 was afforded (Scheme 30). 19F NMR spectroscopy proved the 
presence of the uncyclized compound 78 with two multiplet signals for two pair of 
fluorine atoms, δF (376 MHz, DMSO-d6) 30.19-30.10 (2F, m) 16.27-16.17 (2F, m). In 
addition the mass spectrometry showed the expected mass of the uncyclized compound, 
HRMS (ESI) m/z found 353.0018 (M−H)
-
, C15H5F4N2O2S requires 353.0013.  
In order to try and cyclize compound 78 and get either of the possible tetracyclic 
fluorinated thiazole derivatives 79 or 80 (Scheme 30) NaH base was used in the presence 
of dioxane as solvent under reflux at 101 °C for 24 h. The reaction aimed to deprotonate 
(N-H) group and allow cyclization of the compound by nucleophilic aromatic substitution 
SNAr reaction, but the cyclization did not work and according to the spectroscopic data, 
the starting material, uncyclized compound 78 was afforded.  
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Scheme 30. Reaction of pentafluorobenzaldehyde with 2-mercapto-4(3H)-quinazolinone 
 
2.2.4. Synthesis of fluorinated benzothieno derivatives 
Thienopyridines derivatives have attracted much attention in medicinal chemistry due to 
their isosterism with indolopyridine and showed potential biological activity. They have 
been reported in the literature as antifungal, antibacterial and anticancer agents.81,82 
Benzothienopyridines possess a π-electron rich thiophene ring and π-electron deficient 
pyridine ring. These annelated aromatic heterocycles are attracting the attention of organic 
chemists.82 It has been reported by Weaver et al., 2011 that ring closing reactions of 
substituted polyfluoroarenes is a quick way to generate polycyclic compounds. Using 
lithium-bromine exchange 2-bromophenyl perfluoroaryl sulfides or ethers formed 
fluorinated benzofurans or benzothiophenes by SNAr substitution reaction of the adjacent 
fluorine atom in the perfluoroaryl subunit.31 As part of our investigations in this area it 
was planned to study ring closure by lithiation of bromoaryl ethers and sulfides containing 
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a perfluoroarene ring and it was wished now to further explore the chemistry of these ring 
systems both from a mechanistic point of view and synthetically to make potentially 
biologically active compounds. 
2.2.4.1. Synthesis of fluorinated benzothiophene using 2-bromothiophenol and 
pentafluoropyridine31  
Fused thiophenes had been prepared previously in the group and it was hoped to explore 
further the chemistry of these new fluorinated compounds. For example it was planned to 
study displacement of the fluorines in 83 and 85 to build up potential intercalator 
compounds, which will be discussed later. 
The same fluorinated precursor that was investigated by Weaver et al., 2011 was 
resynthesised and cyclized with the same procedure in order to obtain the fluorinated 
benzothiophene subunit. The plan was to displace the remaining fluorine atoms that may, 
in principle, be displaced by nucleophiles to create biologically active molecules.  Thus 
reaction of pentafluoropyridine 21 with 2-bromothiophenol 81 worked well at RT in the 
presence of NaH as base and DMF as solvent and the target compound 82 (Scheme 31) 
was successfully synthesised with 21 % yield. The target compound was fully 
characterized with 1H NMR spectroscopy which detected the benzene ring protons, δH 
(400 MHz, CDCl3) 7.47 (1H, dd, J 7.6 and 1.2 Hz) 7.38 (1H, d, J 7.6 Hz) 7.17 (1H, td, J 
7.6 and 1.6 Hz) 7.11 (1H, td, J 7.6 and 2.0 Hz). Moreover, the 19F NMR spectrum showed 
two multiplet signals for two pair of fluorine atoms, δF (376 MHz, CDCl3) 70.81-70.76 
(2F, m), 25.38-25.28 (2F, m)  
Lithiation of 4-(2-bromo-phenylsulfanyl)-2,3,5,6-tetrafluoro-pyridine 82 was expected to 
result in lithium-bromine exchange and then intramolecular substitution of the fluorine at 
C-3 of the pyridine ring to close the thiophene ring. The reaction worked well and the 
cyclized compound 1,3,4-trifluoro-benzo[4,5]thieno[3,2-c]pyridine 83 (Scheme 31) was 
afforded in 66 % yield. The data was in good agreement with that reported previously by 
Weaver et al., 2011.31  
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Scheme 31. Reaction of pentafluoropyridine with 2-bromothiophenol31                       
2.2.4.2. Synthesis of fluorinated benzothiophene using 2-bromothiophenol and 
hexafluorobenzene31 
Hexafluorobenzene 1 was reacted with 2-bromothiophenol 81 in 1:2 equivalents in order 
to synthesise bis-bromophenylsulfanyl tetrafluorobenzene derivative 84 (Scheme 32). The 
reaction worked well in DMF and the 1,4-disubstitution product 84 was afforded after 
crystallization. 19F NMR spectroscopy displayed one single peak for four identical 
fluorine atoms, δF (376 MHz, DMSO-d6) 31.18 (4F, s). When the bis-sulfide 84 was 
treated with two equivalents of n-BuLi in THF (Scheme 32) cyclization occurred between 
both bromophenyl groups and the central fluorinated benzene ring and the known 
pentacyclic compound 85 was afforded in 85 % yield.31 Investigations into the 
displacement of the fluorines in this compound are discussed in section 2.2.8.10.  
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Scheme 32. Reaction of hexafluorobenzene with 2-bromothiophenol31                         
 
2.2.5. Synthesis of fluorinated benzofuran derivatives 
One of the most important sources of antiproliferative products is benzofuran derivatives. 
It has been reported that benzofuran derivatives showed a selective and potent cytotoxic 
activity and antiproliferative effect against cancer cell line.83 Thus as a part of our project 
in synthesis of bioactive DNA binding compounds, it was thought that benzofuran-based 
fluorinated analogs could display DNA binding activity. It was also of interest to extend 
the lithiation studies developed by Weaver et al., 2011. Lithiation of 2-bromophenyl 
perfluoroaryl ethers had led to either cyclization to benzofurans or Smiles-type 
rearrangement to phenols. The plan was to study this reaction further with                         
1-bromo-2-naphthol to see if compound 88 or 90 would form on lithiation (Scheme 34). 
2.2.5.1. Synthesis of 4-(3-bromonaphthalen-2-yloxy)-2,3,5,6-tetrafluoro-pyridine (87) 
Reaction of pentafluoropyridine 21 with 1-bromo-2-naphthol 86 worked well in the 
presence of DMF at RT and the target compound 87 (Scheme 33) was afforded in 100 % 
yield. 19F NMR spectroscopy showed two multiplet peaks for two pairs of fluorine atoms, 
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δF (376 MHz, CDCl3) 73.29-73.12 (2F, m), 6.10-5.94 (2F, m). In addition, the mass 
spectrometry showed the expected mass of compound 87, HRMS (ESI) m/z found 
369.9528 (M−H)
-
, C15H579BrF4NO requires 369.9496 and the elemental analysis proved 
the purity of the product, analysis (%) calculated for C15H6BrF4NO (370): C, 48.64; H, 
1.62; N, 3.80. Found C, 48.52; H, 1.56; N, 3.80. X-ray crystallography proved the 
synthesis of the target compound 87 (Figure 15) again confirming addition had occurred 
at C-4.  
 
Scheme 33. Reaction of pentafluoropyridine with 1-bromo-2-naphthol 
 
 
 
 
 
      
 
 
 
 
      
 
 
Figure 15. X-ray crystal structure of compound (87)   
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2.2.5.2. Ring closing of 4-(3-bromonaphthalen-2-yloxy)-2,3,5,6-tetrafluoropyridine (87) 
Lithiation of the easily prepared 4-(3-bromonaphthalen-2-yloxy)tetrafluoropyridine 87 
was expected to form the trifluoro-aza-benzo-furan derivative 90 by lithium-bromine 
exchange, and then intramolecular substitution of the fluorine at C-3 of the pyridine ring 
to close the furan ring (Scheme 34). However treatment of the tetrafluoropyridine 
derivative 87 with n-BuLi in THF at low temperature afforded a product, which was not 
the expected tetracyclic furan 90, but it was a mixture of compounds consisting mainly of 
88 and with a trace amount of 89. IR and 1H NMR spectroscopy indicated the presence of 
an alcohol group, vmax / cm-1 (film) 3411 (O-H), δH 7.77-7.69 (1H, bs, OH). Mass 
spectrometry also suggested the presence of a mixture of two compounds 88 and 89, GC-
MS (EI) m/z 293 major and 273 minor. Thus, the reaction had proceeded by Smiles type 
rearrangement 84 rather than SNAr reaction at the 3-position of the pyridine ring as had 
been observed by Weaver et al., 2011 in the case of 2-bromophenyl tetrafluoropyrid-4-yl 
ether.31 The two compounds 88 and 89 unfortunately could not be separated by column 
chromatography. This minor by-product was proposed to be the tetracyclic structure 89, 
likely to have formed by cyclization of the first-formed Smiles rearrangement product 88 
under the basic conditions of the reaction. However it could not be ruled out that the 
minor compound might be structure 90, if cyclization had occurred without 
rearrangement. The low amount of material formed did not allow further analysis in the 
time available. Interestingly, a different outcome was observed when the lithiation was 
conducted in the presence of N,N,N,N-tetramethylethylenediamine (TMEDA) in THF at  
-78 °C. In this experiment a trifluoro cyclized compound, 90, was afforded in 16 % yield 
after column chromatography. 19F NMR spectroscopy proved the presence of a cyclized 
compound by exhibiting three signals for three fluorine atoms, δF (376 MHz, CDCl3) 8.03 
(1F, d, J 26 Hz), 1.76 (1F, d, J 21 Hz), 72.81 (1F, dd, J 26 and 21 Hz), and the mass 
spectrum gave the expected mass of the cyclized compound 90, GC-MS (EI) m/z 273. 
The 19F NMR spectrum showed the presence of a clean (in terms of fluorine) single 
compound containing three fluorine atoms. The 1H NMR spectrum however showed a 
complex series of multiplets in the aromatic region consistent, but not fully in accord (in 
terms of integration), with the proposed structure 90. Some aromatic impurities may still 
have been present. The product formed in this reaction could potentially be the alternative 
ring fused product 89, but in the absence of any sign of Smiles rearrangement product, 
this seems unlikely, and it is believed that direct cyclization occurred in the presence of 
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TMEDA as an additive. Further work would be required to verify the structures of the two 
fused tetracyclic products. The proposed mechanism is shown in the following scheme 
(Scheme 34). 
 
Scheme 34. Cyclization of 4-(3-bromo-naphthalen-2-yloxy)-2,3,5,6-tetrafluoro-pyridine (87)                    
 
 
2.2.5.3. Synthesis of 2-bromo-3-pentafluorophenyloxynaphthalene (91) 
 In order to extend this chemistry it was planned to turn to the corresponding reaction with 
hexafluorobenzene. Reaction of hexafluorobenzene 1 with 1-bromo-2-naphthol 86 at RT 
in DMF worked well and the target compound 91 (Scheme 35) was afforded after column 
chromatography as white crystals in 11 % yield with m.p. 112-114 °C. 19F NMR spectrum 
showed the expected signals for the target compound 91, δF (376 MHz, CDCl3) 7.86 (2F, 
d, J 17 Hz), 2.41 (1F, t, J 23 Hz), 0.21-0.13 (2F, m).          
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Scheme 35. Reaction of hexafluorobenzene with 1-bromo-2-naphthol   
 
 
 
 
 
  
2.2.5.4. Synthesis of bromo 3-[2,3,5,6-tetrafluoro-4-(naphthalene-2-yloxy)-phenoxy]-
naphthalene (92) 
Reaction of hexafluorobenzene 1 with two equivalents of 1-bromo-2-naphthol 86 was 
studied in DMF but it did not go to completion and only substitution by one 1-bromo-2-
naphthol occurred. However in the presence of THF and using the syringe pump to add 
hexafluorobenzene 1 very slowly the reaction worked and di-substitution of 
hexafluorobenzene occurred and the target compound 92 (Scheme 36) was formed 
although in a low 11 % yield. 19F NMR spectroscopy proved the formation of the target 
compound 92 by showing one singlet peak for four identical fluorines due to the 
symmetry of the compound, δF (376 MHz, CDCl3) 61.81 (4F, s). Due to the low amount 
of compound 92 it was not possible to study the lithiation reactions. 
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Scheme 36. Reaction of hexafluorobenzene with 2 equivalents of 1-bromo-2-naphthol 
                 
2.2.6. Synthesis of fluorinated 4-methylbenzenesulfonamide derivatives   
To further extend the lithiation cyclization strategy to nitrogen containing compounds it 
was planned to investigate the synthesis of N-(2-bromophenyl)-                                          
4-methylbenzenesulfonamide. It has been reported that benzenesulfonamide derivatives 
have important applications in medicinal, analytical, catalytic and pharmaceutical 
chemistry.85,86 These compounds are widely used in treatment of Streptococci infections 
and some benzenesulfonamide derivatives are used as an effective inhibitors in cancer 
treatment and other diseases treatment such as heart failure and cystic fibrosis.86 In the 
interest of these applications the present study investigated the synthesis of fluorinated 
benzenesulfonamide derivatives using pentafluoropyridine and hexafluorobenzene to 
achieve novel, more effective, pharmaceutical fluorinated benzenesulfonamide 
derivatives, which might show a potential DNA binding activity. It was hoped that the 
toluenesulfonyl group would increase the acidity of the N-H allowing easy deprotonation, 
and readily reaction of the anion with perfluoroarenes. Once added, for example in 
compound 96 (Scheme 38), the bromobenzene ring could be lithiated to see if the 
resulting aryllithium would cyclize onto the fluorinated ring by SNAr reaction, or induce 
Smiles-type rearrangement as had been observed in the case of tetrafluoropyridyl ethers. 
This would extend this approach and allow nitrogen containing heterocycles to be formed. 
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2.2.6.1. Synthesis of N-(2-bromophenyl)-4-methylbenzenesulfonamide (95) 
The title compound was synthesised by reaction of 2-bromoaniline 93 with                       
p-toluenesulfonyl chloride 94 in pyridine (Scheme 37). When the reaction was heated 
over night at 80 °C the target compound did not form and a complex dark coloured 
mixture was afforded with a complicated NMR spectrum. However by leaving the 
reaction to stir at RT for 72 h the target product N-(2-bromophenyl)-                                  
4-methylbenzenesulfonamide 95 was afforded in 87 % yield. 1H NMR spectroscopy 
displayed the expected signals of the target compound and X-ray crystallography showed 
the structure of the target product (Figure 16). Mass spectrometry found the exact mass of 
compound 95, HRMS (ESI) m/z found 323.9702 (M−H)
-
, C13H1179BrNO2S requires 
323.9699 In addition elemental analysis demonstrated the presence of pure product, 
analysis (%) calculated for C13H12BrNO2S (324): C, 47.86; H, 3.71; N, 4.29. Found C, 
47.83; H, 3.71; N, 4.29.   
Scheme 37. Reaction of 2-bromoaniline with p-toluenesulfonylchloride 
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Figure 16. X-ray crystal structure of N-(2-bromophenyl)-4-methylbenzenesulfonamide (95)  
2.2.6.2. Synthesis of N-(2-bromophenyl)-4-methyl-N-(2,3,5,6-tetrafluoropyridine-4-yl)-
benzenesulfonamide (96)  
Reaction of pentafluoropyridine 21 with compound 95 was one of the most difficult 
reactions in the project and the target compound 96 (Scheme 38) was not afforded directly 
and several conditions had to be investigated to successfully synthesise the target 
fluorinated compound 96. In the presence of NaH as base to deprotonate the N-H group of 
compound 95 in THF at RT, the target compound 96 was not formed and only the starting 
material was detected with GC-MS. By increasing the equivalents of pentafluoropyridine 
21 in THF at RT again only the starting material was detected in the GC-MS and the 
target compound 96 was still not formed. By changing the reaction conditions, and 
leaving the reaction mixture to stir in boiling THF for 24 h, a complicated material was 
afforded according to TLC and 1H NMR spectrum. By using a mixture of THF and DMF 
as solvents under reflux at 66 °C for 2 h and then allowing the reaction mixture to stir at 
RT for 24 h, interestingly the target compound 96 was afforded after column 
chromatography purification as white crystals in 23 % yield. 19F NMR spectroscopy 
proved the presence of the target fluorinated compound 96 by displaying two multiplet 
signals for two pairs of fluorine atoms, as well as mass spectrometry found the exact mass 
of the target compound, δF (376 MHz, CDCl3) 72.82-72.65 (2F, m), 8.53-8.37 (2F, m); 
HRMS (ESI) m/z found 472.9588 (M−H)
-
, C18H1079BrF4N2O2S  requires 472.9588. 
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Scheme 38. Reaction of pentafluoropyridine with compound (95) 
  
2.2.6.3. Synthesis of N-(2-bromophenyl)-4-methyl-N-(2,3,4,5,6-pentafluorophenyl)-
benzenesulfonamide (97)  
After the successful synthesis of compound 96 in the previous reaction it was hoped to 
extend the reaction using hexafluorobenzene.    
The reaction of hexafluorobenzene 1 with benzenesulfonamide derivative 95 (Scheme 39) 
in a mixture of THF and DMF as solvents did not work even in the same reaction 
conditions of the case of pentafluoropyridine reaction. The mass spectrometry and TLC 
analysis detected the starting compound 95.     
Scheme 39. Attempted reaction of hexafluorobenzene with compound (95) 
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2.2.6.4. Cyclization of N-(2-bromophenyl)-4-methyl-N-(2,3,5,6-tetrafluoropyridine-4-
yl)-benzenesulfonamide (96)  
Reductive debromination reaction was investigated for compound 96 in order to cyclize 
the compound by an intramolecular SNAr process (Scheme 40). The first cyclization 
reaction was studied with n-BuLi in THF; unfortunately the reaction did not work well. 
The second cyclization reaction was investigated with iron powder in ethanol and under 
reflux at 78 °C for 24 h, again still the reaction did not work and the starting material was 
detected with spectroscopic analysis. Due to the low yields of the starting uncyclized 
compound 96, the difficulty of preparing it in larger yield, and the lack of time we 
stopped this investigation. 
 
Scheme 40. Attempted cyclization of N-(2-bromophenyl)-4-methyl-N-(2,3,5,6,-
tetrafluoropyridine-4-yl)-benzenesulfonamide (96)       
     
2.2.7. Synthesis of fluorinated aryl carbazole derivatives 
Nitrogen containing heterocyclic aromatic compounds such as carbazole and its 
derivatives are important substances in drug design and synthesis, and have a significant 
attention of medicinal chemists because of their biological activity. The tricyclic 
carbazole nucleus exists in many natural alkaloids and synthetic derivatives, and 
possesses desirable electronic and charge transport characteristics, as well as a large π-
conjugated system for organoelectronic applications. Moreover, several functional groups 
are easily introduced into the structurally rigid carbazole ring to alter the biological 
activities of the compound.87,88,89 These characteristics result in the extensive potential 
applications of carbazole based derivatives in the field of medicinal chemistry as 
antitumor agents, anti-inflammatory agents, antimicrobial and antioxidative  
substances.87,90 For example, the carbazomycins are an extraordinary class of carbazole 
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scaffold antibiotics.91 Carbazomycin A and carbazomycins B (Figure 17) showed a high 
activity growth inhibition of phytopathogenic fungi and have antibacterial and anti-yeast 
activities.89 
                         
 
Figure 17. The structure of carbazomycins  
In the interest of the above suggestions, it was planned to design and synthesise systems 
that combined more than one bio labile component, namely carbazole and a fluorinated 
aromatic substrate to provide a potentially biologically active DNA binding structure. It 
was hoped the large π surface of the carbazole ring would be desirable for intercalation 
into duplex DNA and allow effective π−π stacking. The N-H group in carbazole 
derivatives can be easily deprotonated, for example with sodium hydride, and it was 
expected that such anions would add readily to perfluoroarenes by SNAr reaction to allow 
rapid assembly of polycyclic aromatic structures with potential for elaboration into DNA 
binding molecules.   
2.2.7.1. Synthesis of 9-[1-(9H-fluorene-9-yl)-2,3,5,6-tetrafluoro-pyridine-4-yl]-9H-
carbazole (100) 
Reaction of hexafluorobenzene 1 with carbazole 99 in ratio 1:2 equivalents afforded the 
target compound 100 (Scheme 41), after recrystallization from hot toluene, as yellow 
crystals with m.p. 344-350 °C. 1H and 19F NMR spectroscopy demonstrated the presence 
of the target compound 100, δH (400 MHz, CDCl3) 8.22 (4H, d, J 7.6 Hz), 7.56 (4H, t, J 
7.2 Hz), 7.43 (4H, t, J 7.2 Hz), 7.35 (4H, d, J 8.0 Hz); δF (376 MHz, CDCl3) 21.00 (4F, s); 
as well as the mass spectrum which showed the expected mass of the target molecule, 
GC-MS (EI) with a peak at m/z 480. The final evidence for the presence of the target 
compound 100 was the X-ray crystal diffraction analysis, which confirmed the structure 
of the title compound (Figure 18). Interestingly X-ray analysis also detected the presence 
of unexpected product 101 (Figure 19) since four carbazole rings were attached to one 
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hexafluorobenzene ring. Unfortunately TLC analysis showed only one spot and mass 
spectroscopy could not observe the expected mass for the unexpected compound 101 as 
well as 19F NMR spectrum detected only one signal, which means compound 101 must be 
present as a very minor component and the major compound is the expected dicarbazole 
compound 100.          
 
Scheme 41. Reaction of hexafluorobenzene with carbazole                   
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Figure 18. X-ray crystal structure of compound (100)  
 
Figure 19. X-ray crystal structure of unexpected minor compound (101)  
2.2.7.2. Synthesis of 9-pentafluorophenyl-9H-carbazole (102) 
This reaction aimed to synthesise monocarbazole derivative 102 (Scheme 42), using a 
ratio 1:1 of carbazole:hexafluorobenzene. In this case only dicarbazole derivative 100 was 
afforded. Because of that it was decided to increase the ratio of hexafluorobenzene in the 
reaction mixture. Carbazole:hexafluorobenzene 1:10 equivalents was used and carbazole 
was added very slowly to the reaction mixture using a syringe pump to increase the 
chance of monocarbazole 102 formation. Spectroscopic data and TLC suggested the 
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presence of a mixture of mono and dicarbazole derivatives, and column chromatography 
allowed us to separate the mixture. The monocarbazole derivative 102 was afforded as 
white crystals in 11 % yield and the dicarbazole derivative 100 was afforded as yellow 
crystals in 22 % yield. The first formed product 102 appears to be more reactive than the 
starting hexafluorobenzene 1, and addition of a second molecule of the nucleophile occurs 
readily. This phenomenon has been observed previously in the group and may be due to 
the repulsive effect of a para-fluorine atom in the starting hexafluorobenzene 1.  
 
Scheme 42. Reaction of hexafluorobenzene with carbazole 
  
2.2.7.3. Synthesis of 9-(2,3,5,6-tetrafluoropyridine-4-yl)-9H-carbazole (103) 
The synthesis of 9-(2,3,5,6-tetrafluoropyridine-4-yl)-9H-carbazole 103 was investigated 
by reaction of pentafluoropyridine 21 with carbazole 99 at RT in the presence of NaH as 
base and a mixture of THF and DMF as solvents (Scheme 43). TLC analysis showed the 
presence of the starting carbazole 99, and column chromatography purification allowed us 
to get the target product 103 as yellow crystals in 51 % yield. 1H NMR and 19F NMR 
spectroscopy proved the presence of the compound 103 and mass spectrometry found the 
expected mass of the compound, GC-MS (EI) m/z 316.    
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Scheme 43. Reaction of pentafluoropyridine with carbazole                         
Interestingly by repeating the experiment in the same conditions to collect more material 
of the target product 103 to do further reactions, the spectroscopic data suggested the 
presence of unexpected tricarbazole derivative 104 (Scheme 44) with m.p. 217-221 °C.19F 
NMR spectroscopy displayed one signal for two fluorine atoms due to the symmetry of 
the compound, δF (376 MHz, CDCl3) 39.65 (2F, s). 1H NMR spectroscopy showed 
multiplet peaks for carbazole rings suggesting the formation of tricarbazole derivative 
104, δH (400 MHz, CDCl3) 8.19-8.09 (m), 7.63-7.56 (m), 7.48-7.38 (m), 7.36-7.30 (m). 
Unfortunately neither orbitrap nor GC-MS found the exact mass of the target tricarbazole 
derivative 104. Even addition of silver ions to try to form a charged complex failed to 
allow characterisation by mass spectrometry.   
Scheme 44. Tricarbazole compound (104) afforded by reaction of hexafluorobenzene with 
carbazole 
  
 68 
2.2.7.4. Synthesis of 9-(2,3,5,6-tetrafluoro-4-methylphenyl)-9H-carbazole (105) 
The compound 9-(2,3,5,6-tetrafluoro-4-methylphenyl)-9H-carbazole 105 (Scheme 45) 
was successfully synthesised by reaction of carbazole 99 with pentafluorotoluene 44 in 
the presence of NaH as base and a mixture of THF and DMF as solvents under reflux at 
66 °C for 48 h. The product was afforded as white crystals in 37 % yield and m.p. 153-
155 °C. Mass spectrometry found the expected mass of the target compound 105, GC-MS 
(EI) m/z 329 and 19F NMR spectroscopy showed two signals for two pairs of fluorine 
atoms, δF (376 MHz, CDCl3) 19.80-19.72 (2F, m), 17.14-17.05 (2F, m). The final 
evidence was the X-ray crystal diffraction analysis, which confirmed the structure of the 
title compound 105 (Figure 20). 
 
Scheme 45. Reaction of pentafluorotoluene with carbazole             
 
Figure 20. X-ray crystal structure of compound (105) 
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2.2.7.5. Synthesis of 4-carbazol-9-yl-2,3,5,6-tetrafluorobenzaldehyde (107) 
With the success of the reaction of carbazole and pentafluorotoluene it was hoped to study 
if the process could be extended to pentafluorobenzaldehyde 106. Different conditions 
were investigated to synthesise the target compound 107 (Scheme 46), but unfortunately it 
was not possible to synthesise the desired aldehyde. The product material in all conditions 
showed complicated TLC analysis and 1H NMR and 19F NMR spectroscopy. After 
carrying out column chromatography on the sample, 19F NMR spectroscopy showed two 
multiplet signals with minor impurities which suggested the formation of the target 
compound 107, but GC mass spectrometry detected only the starting carbazole and did 
not find the target compound 107. 1H NMR spectroscopy showed the expected signals for 
the starting carbazole but did not reveal the carbonyl group proton, which expected to be 
around 10-11 ppm.      
Scheme 46. Attempted reaction of pentafluorobenzaldehyde with carbazole           
              
2.2.7.6. Synthesis of tetrafluoro di-carbazole derivative (109) 
Because the reaction of carbazole 99 with pentafluorobenzaldehyde 106 did not work 
(section 2.2.7.5) it was decided to use more reactive perfluorinated compound 
pentafluorobenzoyl chloride 108 (Scheme 47). Interestingly in the ratio 1:1 equivalents of 
pentafluorobenzoyl chloride:carbazole in a mixture of THF and DMF at RT addition of 
carbazole 99 had occurred at both the acid chloride and at the 4-position of the 
perfluorophenyl ring. The acid chloride 108 had acylated the nitrogen of one carbazole 
and then undergone SNAr reaction at the 4-position with a second carbazole anion. 19F 
NMR spectroscopy showed two signals for compound 109, δF (376 MHz, CDCl3) 22.95-
22.86 (2F, m), 22.54-22.43 (2F, m). Two smaller signals at 43.89 and 42.40 indicated the 
presence of a minor fluorine-containing by-product, but this could not be identified. Mass 
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spectrometry found the exact mass of di-carbazole compound 109, HRMS (ESI) m/z 
found 509.1269 (M+H)
+
, C31H17F4N2O requires 509.1272.                      
Scheme 47. Reaction of pentafluorobenzoyl chloride with carbazole 
 
2.2.7.7. Synthesis of 4-carbazol-9-yl-2,3,5,6-tetrafluorobenzamide (111) 
Then it was planned to investigate addition of carbazole to a more stable carboxylic acid 
derivative, namely pentafluorobenzamide 110 to see if clear addition to the 4-position 
would occur. Reaction of carbazole 99 with pentafluorobenzamide 110 worked well at RT 
in the presence of a mixture of THF and DMF as solvents and NaH as base and the target 
compound 111 was successfully synthesised, (Scheme 48). 4-Carbazol-9-yl-2,3,5,6-
tetrafluorobenzamide 111 was afforded as yellow crystals with  m.p. 203-206 °C, as pure 
product as proved with elemental analysis, analysis (%) calculated for C19H10F4N2O 
(358): C, 63.68; H, 2.79; N, 7.82. Found C, 63.22; H, 2.72; N, 7.87. Mass spectrometry 
exhibited the expected mass of the title compound, GC-MS (EI) m/z 358, and the 19F 
NMR spectrum revealed two signals for two pairs of fluorine atoms, δF (376 MHz, 
CDCl3) 23.18-23.09 (2F, m), 21.64-21.55 (2F, m). In addition X-ray crystallography 
proved the structure of the target carbazole derivative 111 (Figure 21). The X-ray 
structure showed the carbazole ring to be twisted out of the plane of the 
tetrafluorobenzamide ring. 
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Scheme 48. Reaction of pentafluorobenzamide with carbazole 
   
 
 
 
 
 
 
 
 
 
 
 
Figure 21. X-ray crystal structure of compound (111)  
2.2.7.8. Synthesis of 3,4-dihydro-7-carbazol-9-yl-5,6,8-trifluoro-1H-quinolin-2-one 
(114) 
In order to improve water solubility of the new derivatives to allow study of their 
interaction with DNA it was decided to investigate addition to the 3-(pentafluorophenyl) 
propionamide 112 which has a flexible polar side chain. The target carbazole derivative 
113 (Scheme 49) was not formed but the cyclized compound 114 was produced and 
showed carbazole had successfully added to C-4 of 3-(pentafluorophenyl)-propionamide 
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112 as well the amide side chain cyclizing to form a dihydroquinolin-2-one. The base 
NaH was used in slightly excess to deprotonate NH group of starting carbazole, but also 
affected deprotonation of the NH2 group in amide and consequently the tricyclic carbazole 
derivative was formed by nucleophilic substitution reaction of a further fluorine atom. 
The spectroscopic data suggested the presence of the carbazole derivative 114 in 63 % 
yield. Mass spectrometry found the exact mass of the compound 114, HRMS (ESI) m/z 
found 365.0912 (M−H)
-
, C21H12F3N2O requires 365.0907. 19F NMR spectroscopy showed 
three fluorine signals rather than the two expected for uncyclized 113.         
Scheme 49. Attempted reaction of 3-(pentafluorophenyl)propionamide with carbazole     
 
 
 
 
 
 
 
 
  
2.2.7.9. Study the reaction of carbazole with methyl pentafluorobenzoate (115) 
A useful substituent for further functionalization of potential drug molecules would be an 
ester group. Therefore it was decided to investigate whether the carbazole anion would 
also add to the 4-position of methyl pentafluorobenzoate 115 (Scheme 50). The mono 
carbazole compound 116 was formed in 16 % yield at RT in the presence of NaH as base 
and THF as solvent and the product was isolated as white crystals with m.p. 148-152 °C. 
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19F NMR spectroscopy showed two signals for two pairs of fluorine atoms, δF (376 MHz, 
CDCl3) 24.46-24.37 (2F, m), 21.17-21.08 (2F, m). The expected mass of the target 
molecule was displayed by GC-MS (EI) with a peak at m/z 373, as well as the IR analysis 
which displayed the expected signals for the functional groups in the structure,             
vmax /cm-1(film) 1736 (C=O), 1296 (C-O). The successful synthesis of mono carbazole 
compound 116 was confirmed by X-ray crystallography (Figure 22). 
In a further experiment to try to improve the yield the reaction of methyl 
pentafluorobenzoate 115 and carbazole 99 was repeated but the reaction condition was 
changed and in this case the mixture was refluxed at 66 °C in THF (Scheme 50). The 
work-up procedure afforded yellow oil but after recrystallization processes with hot 
ethanol the white crystals isolated had a higher m.p. 179-181 °C. The desired compound 
116 was not formed, and the bis-substituted product 117 was formed instead in low yield 
15 % only. 19F NMR spectroscopy showed three signals which suggest the bis-carbazole 
compound formed, δF (376 MHz, CDCl3) 40.64 (1F, d, J 13 Hz), 29.01 (1F, d, J 22 Hz), 
24.57 (1F, dd, J 22 and 13 Hz). Moreover mass spectrometry found the exact mass of the 
compound 117, HRMS (ESI) m/z found 520.1387, C32H19F3N2O2 requires 520.1393. The 
higher reaction temperature may have encouraged formation of the di-substitution product 
117, although its production is surprising since two equivalents of the 
pentafluorobenzoate were employed. Possibly the mono-substitution product 116 was 
formed but it could not be isolated. 
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Scheme 50. Reaction of methyl pentafluorobenzoate with carbazole  
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Figure 22. X-ray crystal structure of compound (116)  
2.2.7.10. Synthesis of di-carbazole derivatives from decafluorobiphenyl 
To extend the range of fluorinated heterocycles it was hoped to explore SNAr reaction of 
the commercially available decafluorobiphenyl 118. It was planned to study carbazole as 
a nucleophile due to its success in reacting with other fluoroarenes.   
Carbazole derivative 119 was successfully synthesised at RT in ratio of starting materials 
carbazole:decafluorobiphenyl in 2:1 equivalents in the presence of a mixture of THF and 
DMF as solvents (Scheme 51). Recrystallization with hot ethanol afforded the title 
compound as white crystals with m.p. 296-298 °C in 76 % yield.19F NMR spectroscopy 
demonstrated the expected signals for the target compound 119, δF (376 MHz, CDCl3) 
25.69 (4F, s), 20.90 (4F, s). Unfortunately as discussed earlier, the exact mass could not 
be observed with orbitrap mass spectrometry or with GC mass spectrometry, but 
elemental analysis suggested the presence of the target compound as pure product, 
analysis (%) calculated for C36H16F8N2 (628): C, 68.78; H, 2.54; N, 4.45. Found C, 68.06; 
H, 2.43; N, 4.33. 
  
 76 
Scheme 51. Synthesis of di-carbazole derivative (119) from decafluorobiphenyl 
 
2.2.7.11. Synthesis of mono-carbazole derivatives from decafluorobiphenyl  
Then it was planned to prepare the mono-carbazole adduct 120 (Scheme 52) which would 
allow addition of other nucleophiles at the 4`-position of the unsubstituted 
pentafluorophenyl ring. The reaction of carbazole:decafluorobiphenyl in a 1:1 ratio at RT 
was therefore studied, using a mixture of THF and DMF as solvents. Decafluorobiphenyl 
was added to a stirred suspension of NaH and carbazole was added very slowly using a 
syringe pump to increase the chance of formation of mono-carbazole derivative 120 than 
di-carbazole derivative 119. Interestingly the final product was a mixture of three 
compounds, which were separated by column chromatography. The major compound was 
dicarbazole derivative 119 with 22 % yield, monocarbazole derivative 120 was afforded 
in 29 % yield and the minor compound was alcohol 121, which was obtained in 7 % yield. 
The spectroscopic analysis showed the evidence of formation of these compounds and 
highlighted in the experimental section in more details. The formation of the phenol 
derivative 121 may have been due to traces of sodium hydroxide in the reaction mixture 
generated from sodium hydride and moisture.   
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Scheme 52. Study the reaction of carbazole with decafluorobiphenyl 
 
2.2.7.12. Study the reaction of 9-(2,3,5,6-tetrafluoro-4-methylphenyl)-9H-carbazole 
(105) with nitriles 
Because of the limited success of the previous investigation of indole heterocyclic 
derivatives using pentafluorotoluene 44 and nitriles (Section 2.2.2), it was hoped to study 
the reaction of carbazole derivative 105 with nitriles (Scheme 53) with the aim of 
deprotonating the methyl group and adding resulting anion to the nitrile with the 
expectation that the imine anion formed might cyclize onto the tetrafluorobenzene ring as 
discussed previously (Section 2.2.2). It was hoped that the bulky carbazole ring would 
block the lower half of the molecule preventing side reactions at the 3,4 or 5 positions that 
might have hampered the reaction in the previous examples. It was also expected the 
carbazole derivative would be crystalline allowing easier isolation and characterization. 
Three different nitriles were studied 4-methoxybenzonitrile, benzonitrile and acetonitrile. 
Again treating compound 105 with NaH and any of the three nitriles unfortunately failed 
to give the desired indoles (122 - 123 – 124) and the starting compound 105 was detected 
by the spectroscopic analysis. The continued lack of success in forming indoles then 
prompted us to investigate other areas and the study of reaction with nitriles was 
discontinued.   
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Scheme 53. Investigation the reaction of compound (105) with nitriles 
 
2.2.8. Synthesis of bis-intercalating agents 
Organic intercalating agents are the compounds that interact with the DNA double strand 
reversibly. Bis intercalating organic compounds involve two potential intercalating ring 
systems connected together by a linker, which can be of different length and different 
rigidity. Due to more than one intercalating unit bis-intercalating agents possess higher 
DNA binding constants and sequence selectivity and exhibit slower dissociation than 
mono intercalating compounds.48  
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In the interest of the above suggestion it was hoped to design and synthesise a series of 
potentially bis-intercalating compounds using the novel fluorinated compounds that had 
been synthesised in this study. In addition it was planned to exploit the reactivity of the 
aldehyde group in derivatives of perfluorobenzaldehyde towards imine formation, or of 
the remaining ring fluorines on the aromatic nucleus to SNAr reaction. It was hoped 
diamine compounds would act as bis-nucleophiles and allow two potential intercalating 
compounds to be linked together to increase their DNA binding potency. It was planned 
to study if improved binding would occur through thermal melting and UV and 
fluorescence assays.        
2.2.8.1. Study the reductive amination of pentafluorobenzaldehyde and                      
2,2-(ethylenedioxy)bis(ethylamine)    
In order to synthesise bis-intercalating compounds it was hoped to investigate the reaction 
of pentafluorobenzaldehyde 106 and aliphatic amine 2,2-(ethylenedioxy)bis(ethylamine) 
125 (Scheme 54) in 2:1 ratio to synthesise compound 127 as a core scaffold for 
fluorinated-bis intercalators which will be involved in further studies later. The reaction 
worked well at RT in DCM as solvent, NaBH4 was used to reduce the intermediate imine 
126 and the target compound 127 was afforded in 77 % yield. 19F NMR spectroscopy 
detected the expected fluorine signals for the target compound, δF (376 MHz, CDCl3) 
17.68-17.52 (4F, m), 5.80 (2F, t, J 20 Hz), -0.52 to -0.73 (4F, m) and mass spectrometry 
displayed the expected mass of the title compound, HRMS (ESI) m/z found 509.1272 
(M+H)
+
, C20H19F10N2O2 requires 509.1281. 
 Pentafluorobenzaldehyde 106 and aliphatic amine 2,2-(ethylenedioxy)bis(ethylamine) 
125 also studied in the ratio of 1:1 equivalents to synthesise the target compound 129 
(Scheme 55) to be involved in further studies in the project to synthesise water soluble 
mono-intercalating compounds. Mass spectrometry suggested the presence of the target 
compound 129 and found the expected molecular formula of the compound, HRMS (ESI) 
m/z found 329.1277 (M+H)
+
, C13H18F5N2O2 requires 329.1283. Unfortunately 19F NMR 
and 1H NMR spectroscopy and elemental analysis showed some impurities and TLC 
analysis showed tailing, because of that the sample could not be purified and it was not 
studied further.  
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Scheme 54. Synthesis of a potential bis-intercalating scaffold (127)                                                
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Scheme 55. Synthesis of a potential bis-interlacing scaffold (129)                                                            
2.2.8.2. Investigation of the reaction of carbazole with bis-intercalator scaffold (127)  
After successful formation of compound 127 it was planned to investigate the possibility 
of interacting it with carbazole to synthesise bis-intercalating compound 130 (Scheme 
56). Carbazole 99 was reacted with compound 127 in the ratio 2:1 equivalents at RT in 
the presence of NaH as base and THF as solvent. The work-up procedure afforded sticky 
yellow material and column chromatography purification yielded yellow crystals with 
m.p. 238-241 °C. Mass spectrometry gave the exact molecular formula of the target 
compound 130, HRMS (ESI) m/z found 803.2627 (M+H)
+
, C44H35F8N4O2 requires 
803.2627. 1H NMR spectrum showed some signals consistent with the predicted structure 
although they were weak, and signals possibly due to starting carbazole were also 
observed. The 19F NMR spectrum also did not show the expected two signals of two pairs 
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of fluorine atoms but exhibited three signals, different from the signals of the starting 
compound 127, which might suggest the formation of some of the target compound. The 
elemental analysis was far from the calculated values, which could also suggest 
fluorinated impurities in the sample that could not be removed with column 
chromatography. Unfortunately, the crystals were not suitable for X-ray crystallography 
and further investigations are still required to fully characterize the compound.  
  
Scheme 56. Study reaction of carbazole with compound (127)                        
2.2.8.3. Study the reaction of 1-bromo-2-naphthol with bis-intercalator scaffold (127)  
The reaction of 1-bromo-2-naphthol 86 with compound 127 was carried out in THF at RT 
in the presence of NaH as base to deprotonate bromonaphthol 86 hoping to displace the  
4-position fluorine atom in compound 127 by nucleophilic substitution reaction (Scheme 
57). If formed compound 131 would represent a useful substrate for cyclization using the 
lithiation strategy already developed. Work-up procedure gave a yellow oil and column 
chromatography purification yielded yellow oil as well. Again 19F NMR spectroscopy 
showed three signals very close to signals of the starting compound 127. Mass 
spectrometry could not find the expected mass of the target compound 131. It appears the 
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reaction was unsuccessful and the target compound 131 was not formed despite the 
success of related reactions with phenolic nucleophiles.     
                  
Scheme 57. Attempted reaction of 1-bromo-2-naphthol with compound (127)                          
2.2.8.4. Study the reaction of di-carbazole (100) with 2,2-(ethylenedioxy)bis(ethylamine) 
(125) to form a potential bis-intercalator 
Two equivalents of di-carbazole derivative 100 were reacted with one equivalent of 
aliphatic amine 125 in order to form compound 132 that might possess potential DNA 
intercalating activity (Scheme 58). The reaction was carried out at RT in a mixture of 
THF and DMF as solvents in the presence of two equivalents of Et3N to neutralise the HF 
by-product. Unfortunately the reaction did not work and only the starting material was 
recovered according to 19F NMR spectroscopy, which showed a singlet peak at 20.72 
ppm. Mass spectrometry could not find the expected mass of the target compound. 
Further studies on this reaction to incorporate one or two amine chains onto carbazole 
derivative 100 are discussed in section 2.2.9.2.   
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Scheme 58. Attempted synthesis of a potential bis-intercalator from bis-carbazole derivative 
(100)                                                       
2.2.8.5. Investigation of the synthesis of a potential bis-intercalator from mono 
carbazole derivative (103)  
After the failed attempt to synthesise a potential bis intercalator using di-carbazole 
derivative 100 it was planned to use the mono carbazole derivative 103 hoping it to be 
more reactive than the di-carbazole one. It was expected that the amine linker be add at 
the 2-position of the pyridine ring. The starting amine chain and mono carbazole 
derivative were used in the ratio 1:2 equivalents to allow addition of two mono carbazole 
derivatives to one amine chain. Interestingly the reaction worked well in boiling THF for 
24 h and the target compound 133 was successfully synthesised (Scheme 59). Work up 
procedure gave creamy crystals and TLC analysis suggested the presence of the starting 
mono carbazole. Column chromatography purification yielded 133 as white crystals 
(0.332 g, 64 %) with m.p. 66-73 °C. 19F NMR spectroscopy showed three multiplet 
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signals in the range, 70.95-70.78 (m), 15.36-15.24 (m), 1.71-1.63 (m), confirming 
addition at C-2. Mass spectrometry found the expected mass of the target compound 133, 
HRMS (ESI) m/z found 741.2407 (M+H)
+
, C40H31F6N6O2 requires 741.2407. Elemental 
analysis was close to the calculated values although the value for the percentage of carbon 
was high, analysis (%) calculated for C40H30F6N6O2 (740): C, 64.86; H, 4.08; N, 11.35. 
Found C, 67.52; H, 3.73; N, 11.97. 
 
Scheme 59. Synthesis of a potential bis-intercalator from mono carbazole derivative (103) 
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2.2.8.6. Investigation of the synthesis of a potential bis-intercalator from biphenyl 
carbazole derivative (119) 
After an unsuccessful attempt to synthesise a potential bis-intercalator compound 132 
from di-carbazole derivative 100 in the previous reaction (Section 2.2.8.4) it was decided 
to use di-carbazole derivative 119, hoping in this case the reaction could work well with 
the aim of synthesising a potential bis-intercalating compound 134 (Scheme 60). The 
reaction mixture was heated at 101 °C in dioxane for 24 h in the presence of two 
equivalents of Et3N to neutralize HF by-product in the reaction mixture. The starting 
material di-carbazole derivative 119 and the amine chain was in ratio 2:1 equivalents to 
allow di-nucleophilic substitution of the amine chain with two fluorine atoms to form 
compound 134. 1H NMR spectroscopy did not show the expected signals of the target 
compound 134 and displayed only carbazole ring signals, which suggest just the starting 
compound 119 was present and no signals for the amine chain. 19F NMR spectroscopy 
also showed two signals characteristic of the starting material.   
Then it was planned to study the possibility of formation a potential DNA bis-intercalator 
using mono carbazole adduct to decafluorobiphenyl compound 120 (Scheme 61). The 
starting mono carbazole derivative 120 and the amine chain 125 was in ratio 2:1 
equivalents and fortunately the reaction worked well in boiling dioxane for 24 h and the 
target compound 135 was successfully isolated in 93 % yield. 1H NMR spectroscopy 
showed the expected signals for the target compound 135, δH (400 MHz, CDCl3) 8.18 
(4H, d, J 7.6 Hz), 7.49 (4H, td, J 7.2 and 1.2 Hz), 7.38 (4H, td, J 8.0 and 0.8 Hz), 7.26 
(4H, d, J 8.0 Hz), 4.73- 4.65 (2H, bs, NH), 3.80-3.72 (8H, m), 3.76 (4H, s). The 19F NMR 
spectrum showed four signals in accord with the four pairs of fluorine atoms in the 
differentially di-substituted biphenyl system. Mass spectrometry also found the expected 
mass of the target compound, HRMS (ESI) m/z found 1069.2052 (M−H)
-
, C54H29F16N4O2 
requires 1069.2041. The successful formation of both 133 and 135, and the lack of 
reaction of 100 and 119 towards the amine, indicate both electronic and steric effects are 
controlling the nucleophilic substitution. The bulky carbazole rings, and the presence of a 
repulsive para-fluorine atom disfavor addition of a nucleophile in both 100 and 119.   
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Scheme 60. Attempted synthesis of a potential bis-intercalator from carbazole derivative 
(119)     
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Scheme 61. Synthesis of a potential bis-intercalator from carbazole derivative (120)                         
                     
2.2.8.7. Study the synthesis of a potential bis intercalator from carbazole derivative 
(105) 
In order to study the possibility of synthesise a potential bis-intercalator from carbazole 
derivative 105 it was planned to investigate the reaction under different conditions 
(Scheme 62). The reaction was carried out in boiling dioxane for 24 h and the starting 
carbazole derivative 105 and the amine chain 125 was in ratio 2:1 equivalents. And also 
the reaction was studied in a mixture of THF and DMF under reflux at 66 °C for 24 h and 
again the starting carbazole derivative 105 and the amine chain 125 was in ratio 2:1 
equivalents. Unfortunately the reaction did not work well in either condition and the 
starting carbazole derivative 105 was recovered each time. 19F NMR spectrum showed the 
two signals which consistent with the starting carbazole derivative 105. As well as 1H 
NMR spectroscopy was consistent with the starting 105 but did not show the expected 
signals of the target compound 136. GC-MS found the mass of the starting carbazole 
 89 
derivative 105 at 329 and all these information suggested the failure of the reaction. The 
similar de-activating effects present in 100 and 119 may also operating in compound 105.    
         
Scheme 62. Attempted synthesis of a potential bis intercalator from carbazole derivative 
(105)                          
  
2.2.8.8. Study the reaction of trifluoro tetracyclic compound (90) with amine chain 
(125)  
Moving to new type of a potential intercalator it was hoped to study the possibility to 
form bis adduct to amine chain 125 using trifluoro tetracyclic compound 90 prepared as 
discussed earlier (Section 2.2.5.2). According to the spectroscopic analysis the reaction of 
tetracyclic 90 and amine chain 125 in boiling dioxane failed to form the potential bis-
intercalator 137 (Scheme 63). It was expected the amine would attack the more exposed 
ortho position of the fluorinated pyridine ring, which would also be the electronically 
preferred site of attack para to carbon. The 1H NMR and 19F NMR spectra of the reaction 
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product however were very complicated and TLC showed tailing, because of that the 
compound could not be purified. Due to the low yield and the difficulty of forming the 
starting 90, as well the lack of time, it was not possible to modify the conditions and no 
further studies on this idea were pursued.  
 
Scheme 63. Attempted synthesis of a potential bis intercalator from trifluoro tetracyclic 
compound (90) 
                  
 
2.2.8.9. Investigation of the reaction of compound (68) with amine chain (125) 
To develop further examples of possible intercalators the reaction of compound 68 with 
amine chain 125 was carried out in boiling dioxane for 24 h and the starting compound 68 
and the amine chain 125 was in ratio 2:1 equivalents (Scheme 64). Unfortunately the 
reaction did not work and the starting 68 was recovered as shown by the 19F NMR 
spectrum with the same four fluorine signals for the starting 68. Mass spectrometry could 
not find the expected mass of the target compound 138. It is not clear at which of the four 
fluorinated carbons attack would have occurred although attack para to sulfur may be the 
most likely. 
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Scheme 64. Attempted synthesis of a potential bis intercalator from compound (68)                           
2.2.8.10. Study the reaction of compound (85) with amine chain (125) 
After successful synthesis of compound 85 it was planned to study the possibility to 
synthesise a potential bis intercalator 139 (Scheme 65). Compound 85 was reacted with 
amine chain 125 in the ratio of 2:1 equivalents in the presence of a mixture of THF and 
DMF under reflux at 66 °C for 24 h. The reaction did not work and only the starting 85 
was detected with the spectroscopic analysis. Unfortunately the reaction could not be 
studied further due to the low yield and the difficulty of forming the starting 85, as well as 
the lack of time, it was not possible to modify the conditions, and no further studies on 
this idea were pursued.      
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Scheme 65. Attempted synthesis of a potential bis intercalator from compound (85)                        
2.2.9. Investigation of the addition of amine side chains to the synthesised compounds 
in the study  
During the biological assays it had been found that some of the compounds had poor 
solubility in the buffers employed.  For the purpose of enhancing the water solubility of 
the novel synthesised compounds in the project it was planned to study the possibility to 
introduce one or more hydrophilic side chains to the compounds. Addition of such 
solubilizing groups could again be achieved by SNAr reaction of one of the remaining 
fluorine atoms in the molecule. 
2.2.9.1. Control reaction of adding side chain to carbazole derivative (100) 
The lack of reaction of the bis-carbazole derivatives 100 and 119 prompted further 
investigation to see if other nucleophiles could be introduced at the less reactive positions 
(2-, 3-, 5-, 6-) in the 1,4-disubstituted derivatives. To study the possibility of introducing a 
more reactive nucleophile to carbazole derivative 100 as a third substituent, ethoxide was 
used as a control reaction for a start to the idea. The reaction worked in THF at RT in 
ratio 1:1 equivalents of ethanol and compound 100 in the presence of NaH as base to 
generate ethoxide ion (Scheme 66). The final product was a mixture of carbazole 
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derivative 140 and the starting compound 100 as shown by GC-MS with m/z values at 480 
and 506 for both starting compound 100 and the target compound 140 respectively. TLC 
showed tailing and compound 140 not isolated by column chromatography. 
In order to add two side chains to carbazole derivative 100 ethoxide and carbazole 
derivative 100 was used in ratio 2:1 equivalents in a mixture of THF and DMF under 
reflux at 66 °C. 19F NMR spectroscopy suggested that the product was a mixture of 
carbazole derivative 140 and 141 and 142 in which two ethoxide ions had added, δF (376 
MHz, CDCl3) (for 140) 26.59 (1F, d, J 10 Hz), 19.34 (1F, dd, J 23 and 10 Hz), 18.64 (1F, 
d, J 23 Hz), (for 141 and 142) 25.24 (2F, s), 25.08 (2F, s). GC-MS found the expected 
mass for compound 140 with m/z values at 506 and the expected mass for compound 141 
and 142 at 532. Again the compounds was not isolated by column chromatography, and 
also attempted recrystallization failed to separate the three compounds. Reaction with 
ethoxide demonstrated it was possible to effect substitution of the remaining fluorines in 
bis-carbazole 100. 
 
Scheme 66. Control reaction of adding ethoxide to carbazole derivative (100) 
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2.2.9.2. Study the reaction of carbazole derivative (100) with amine chain (125)  
After the success of adding one and two side chains to carbazole derivative 100 it was 
planned to study further the reaction of carbazole derivative 100 with amine chain 125 
(Scheme 67). Carbazole derivative 100 was therefore treated with amine chain 125 in the 
presence of NaH as base in a mixture of THF and DMF as solvents. 19F NMR 
spectroscopy showed three signals, which could be consistent with the target product, 
compound 143, however 1H NMR spectroscopy was not consistent with the expected 
compound. In addition mass spectrometry could not find the exact mass of the desired 
compound and no conclusive prove of the formation of 143 could be obtained.  
      
Scheme 67. Attempted reaction of carbazole derivative (100) with the amine chain (125) 
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2.2.9.3. Investigation of the reaction of carbazole derivative (119) with amine chain 
(125)  
In order to extend the reaction of amine chain 125 with previously synthesised carbazole 
derivatives, compound 119 was used. To study the possibility of adding two amine side 
chains to carbazole derivative 119, two equivalents of amine chain 125 were reacted with 
one equivalent of carbazole derivative 119 in boiling THF for 24 h (Scheme 68). 19F 
NMR spectroscopy suggested the presence of the starting carbazole derivative 119 by 
observing two signals identical to the starting compound. The 1H NMR spectrum was also 
consistent with the starting compound and mass spectrometry could not find the expected 
mass of the target product, suggesting no reaction even with an excess of the amine.  
  
Scheme 68. Attempted reaction of carbazole derivative (119) with amine chain (125)                    
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2.2.9.4. Study the reaction of carbazole derivative (105) with amine chain (125) 
Then it was hoped to investigate the ability to adding one amine chain 125 to carbazole 
derivative 105 in ratio 1:1 equivalents in boiling THF for 24 h (Scheme 69). 19F NMR 
spectroscopy showed two signals identical to the starting carbazole 105 and GC-MS 
found the expected mass of the starting carbazole at 329. It appears the fluorines in 105 
are resistant to nucleophilic substitution due to similar steric and electronic reasons as 
described for 100 and 119.       
Scheme 69. Attempted reaction of carbazole derivative (105) with amine chain (125)                 
 
     
2.2.9.5. Study the reaction of carbazole derivative (103) with amine chain (125) 
Then it was planned to study the possibility of adding two amine chains 125 to the pyridyl 
carbazole derivative 103 by treating it with two equivalents of amine chain 125 in boiling 
THF for 24 h (Scheme 70). 19F NMR spectroscopy showed one singlet peak at 40.07 (s) 
for two equivalent fluorine atoms, which suggested the formation of compound 147, 
where it was expected to see two different signals for each fluorine atom if carbazole 
derivative 146 was formed as may be expected if addition occurred to avoid the presence 
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of a para-fluorine atom. Mass spectrometry could not find the expected molecular 
formula for neither 147 nor 146. 1H NMR spectroscopy showed the expected signals of 
carbazole ring at the range 7-8 ppm and abroad signal for NH at 5.25 ppm, and there are 
signals at the range 3-4 ppm, but still not completely consistent with compound 147. 
Further investigation is still required to fully characterize the product.    
 
 
Scheme 70. Reaction of carbazole derivative (103) with amine chain (125) 
 
2.2.10. Synthesis of positively charged compounds   
In medicinal chemistry most of the effective DNA intercalating agents are positively 
charged compounds, which improves binding to the DNA, which has a negatively 
charged phosphate backbone. Ethidium bromide (EB) a well known DNA intercalating 
agent includes a positive charge in its structure (Figure 23).45 Another example of 
positively charged DNA binding compound is daunomycin (Figure 24) a drug of the 
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anthracycline antibiotics family which have a good effect in treating a variety of 
cancers.92, 93  
 In order synthesise biologically active positively charged compound it was planned to 
design a positively charged scaffold and then investigate the possibility to introduce the 
charged scaffold to the previously synthesised compounds in the project by SNAr reaction. 
Such charged compounds would also exhibit improved water solubility.   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. The structure of ethidium bromide                
Figure 24. The structure of daunomycin   
2.2.10.1. Synthesis of the positively charged scaffold (150) 
In order to prepare a suitable positively charged unit which could be introduced into the 
perfluoroarene derivatives synthesised by SNAr reaction it was decided to alkylate a 
nitrogen heterocycle, such as isoquinoline, to form an isoquinolinium salt in which the   
N-alkyl substituent could be easily deprotonated to form a positive nitrogen which could 
act as a nucleophile in the proposed SNAr reactions.      
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The positively charged scaffold has been synthesised according to Krohnke and Angew94 
by reacting isoquinoline 148 with ethyl bromoacetate 149 in boiling ethyl acetate 
(Scheme 71). The reaction worked well and the known target compound 150 was afforded 
in 73 % yield. Mass spectrometry found the expected molecular formula of the target 
compound cation only, HRMS (ESI) m/z found 216.1015, C13H14NO2 requires 216.1019 
and IR found carbonyl group signal, vmax/cm-1 (film) 1740 (C=O) in accordance with 
literature data.     
Scheme 71. Reaction of isoquinoline with ethyl bromoacetate 
 
2.2.10.2. Reaction of the positively charged scaffold (150) with carbazole derivative 
(103)  
 In order to improve the biological activity of the previously synthesised carbazole 
derivative 103 it was planned to study the possibility of replacing one fluorine atom with 
the positive scaffold 150 (Scheme 72). The positive scaffold 150 was treated with one 
equivalent of NaH in the presence of DMF at RT to deprotonate the methylene group of 
compound 150, one equivalent of carbazole derivative 103 was added to the reaction with 
the aim of nucleophilic substitution of one fluorine atom of compound 103 with the 
positively charged scaffold 150. Unfortunately 1H NMR spectroscopy was not consistent 
with the target product 151 and only carbazole ring signals were shown. 19F NMR 
spectroscopy showed several new signals, which were not consistent with 151 and 
suggested a mixture of products had formed. Unfortunately it was not possible to separate 
these chromatographically.      
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Scheme 72. Attempted reaction of the positive scaffold (150) with carbazole derivative (103) 
   
2.2.10.3. Investigation of the reaction of the positive scaffold (150) with carbazole 
derivative (102)    
For further investigation of the possibility of adding the positively charged scaffold 
compound 150 to previously synthesised carbazole derivative 102 again compound 150 
was treated with one equivalent of NaH in the presence of DMF at RT to deprotonate the 
methylene group of compound 150 (Scheme 73). One equivalent of carbazole derivative 
102 was added to the reaction with the aim of nucleophilic substitution of one fluorine 
atom of carbazole derivative 102 with the positively charged scaffold 150. 1H and 19F 
NMR spectrum were consistent with the starting carbazole derivative 102 and no 
evidence for the formation of 152 was obtained.       
 
Scheme 73. Attempted reaction of the positive scaffold (150) with carbazole derivative (102)             
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2.3. DNA binding studies 
2.3.1. DNA thermal denaturation assay 
In the present study it was planned to investigate DNA binding activity of the novel 
synthesised fluorinated compounds with a number of different assays. One of the most 
common assays that determine the DNA binding activity of organic compounds is the 
study of the melting temperature of the DNA in the presence or absence of the organic 
molecule.  
Actinomycin D (ACTD) was used as a standard DNA intercalating agent in DNA binding 
studies. ACTD (Figure 25) is a well-known antibiotic and anticancer drug which has a 
high affinity for interacting with double strand DNA and dissociates slowly, leading to 
termination of DNA transcription and replication.95,96,97 As a result, ACTD can be used as 
a lead compound to synthesise and develop more effective double stranded DNA 
intercalating agents96.  
The Tm values for a selection of the synthesised fluorinated heterocycles were measured 
in triplicate using calf thymus DNA in trisma base buffer. The mean values were 
calculated and the results are displayed in Figure 26. In addition ∆Tm values were 
investigated (∆Tm = Tm DNA-compound complex − Tm DNA) (See appendix 5.2 for the 
full data). The main source of errors that might interfere the results the apparatus and 
experimental errors were considered. 
                                     
Figure 25. The structure of actinomycin D  
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Figure 26. Comparison of Tm values of novel fluorinated compounds-DNA complex 
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According to figure 26, the Tm values for DNA and DNA-ACTD complex was 67 °C and 
84 °C respectively and ∆Tm of DNA-ACTD was 17 °C. The tested compounds showed an 
increase in Tm values relative to the value for the DNA. Interestingly compounds 87 and 
105 recorded the highest reading of 78 °C with ∆Tm 11 °C for naphthalene compound 87, 
and of 80 °C with ∆Tm 13 °C for carbazole derivative 105 (close to the ACTD value). 
These compounds contain larger aromatic groups, the bromonaphthalene and carbazole 
rings, which would be expected to function better as intercalators. It was expected 
compound 100 containing two carbazole rings to bind most strongly. However the Tm 
value was slightly lower (77 °C with ∆Tm 10 °C) than for monocarbazole derivative 105. 
This could be due to the non-planar nature of the molecule as was shown by X-ray 
crystallography (Section 2.2.7.1). The X-ray structure showed the carbazole ring to be 
twisted out of the plane of the tetrafluorobenzene ring. The rest of tested compounds 
recorded higher Tm values than the value of the DNA, but the low ∆Tm in the range 3-6 
°C suggested only weak binding. As a result the tested compounds all showed potential 
DNA binding activity.      
 
2.3.2. UV-visible absorption spectroscopy assay 
The interaction of the fluorinated synthesised compounds with DNA was determined by 
UV absorption spectroscopy assay. The changes in the absorbance of the tested compound 
in the presence or absence of DNA gives an idea about the interaction of the organic 
molecule with DNA. Based upon the variation in absorbance, the intrinsic binding 
constant/association constant (K) of the drug with DNA can be determined according to 
Benesi-Hildebrand equation: 98 
 
 
 
Where K is the association / binding constant, Ao and A are the absorbances of the drug 
and its complex with DNA, respectively, and εG and εH-G are the absorption coefficients of 
the drug and the DNA-drug complex, respectively. The K value was determined from the 
intercept -to- slope ratio of Ao / A-Ao vs. 1/ [DNA] plot. 
In addition the Gibbs free energy (∆G) was calculated for each complex by the following 
equation:98  
ΔG = -RT lnK 
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Where R is the general gas constant (8.314 JK-1mol-1) and T is the room temperature (298 
K). 
2.3.2.1. UV-visible spectra of netropsin 
According to figure 27, netropsin as a known DNA binding agent showed a strong 
absorption at 300 nm. A decrease in the absorption was observed on increasing the DNA 
concentration starting with 9.6 µM, 18 µM, 27 µM, 35 µM, 43 µM, and 50 µM DNA. The 
K value was found to be (1 × 105 M-1) and ∆G was -28.5 kJ.mol-1.   
nm.
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Figure 27. UV-visible spectra of netropsin in presence and absence of DNA 
Absorption spectra of 1  10-5 M of netropsin in absence (a), and in the presence of 9.6 µM (b), 18 
µM (c), 27 µM (d), 35 µM (e), 43 µM (f), and 50 µM (g) DNA. The arrow shows increasing  
DNA concentration. Inside graph is the plot of A0 / (A-A0) vs. 1/ [DNA] for determination of K 
and ∆G values. (R2=0.8614 for six points). 
 
The comparison of the binding constant value of netropsin with the binding constant 
values of the synthesised compounds are shown in figure 28. All the synthesised 
compounds showed affinity to bind with DNA in UV-visible spectroscopy assay. 
Interestingly carbazole derivative 120 showed high binding affinity, and it is possible that 
this compound acts as an intercalator. The tetrafluorotolyl carbazole 105 showed a high 
∆Tm value in the DNA thermal denaturation experiments supporting the idea that a 
carbazole group was beneficial to binding. The ∆Tm value unfortunately could not be 
obtained for 120 due to technical problems with the instrument at this stage in the project.  
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The potential bis-intercalators 133 and 135 were expected to show significantly increased 
binding if the two aromatic moities in each compound could both act as intercalators. 
Disappointingly both compounds showed weaker binding than 120, suggesting alternative 
interaction with the DNA.   
 
 
                                                                                          
  
 
 
 
 
 
                                   133                                                                   135 
 
Other compounds 46, 68, 71, 76, 102, 111, and 117 showed very weak DNA binding 
affinity. Compounds 42, 48, 59, 83, 84, 87, 90, 96, 100, 103, 105, 109, 114 and 116 
showed a good DNA binding affinity but not high as the reference compound netropsin. 
Further work however is required to gain a detailed understanding of the nature of the 
binding. (UV spectra for tested compounds are presented in appendix 5.3).  
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Figure 28. Binding constant values from UV-visible spectroscopy assays of the synthesised compounds compared with netropsin, and showing the 
structure of carbazole derivative (120) displaying the highest binding 
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2.3.3. EB fluorescence displacement assay 
The quenching fluorescence assay is one method which provides further information 
about the binding mode of drugs with DNA. In this study ethidium bromide (EB) is one of 
the common fluoroprobes and was selected as a probe to investigate the interactions of the 
synthesised compounds with DNA by a spectral method. It can insert into the DNA base 
pairs and bind to DNA strongly as an intercalator, which causes an increase in the 
fluorescence intensity (emission wavelength 605). The improved fluorescence in presence 
of EB can be quenched by the addition of a second molecule. Therefore by intercalating a 
second molecule into DNA, the fluorescence intensity of the EB-DNA will decrease, 
because the drug will compete with EB in binding with DNA. In addition the extent of 
interaction between the drug and DNA can be determined by the extent of fluorescence 
quenching of EB bound to DNA.70,47 When EB is intercalatively bound to DNA, the EB 
fluorescence increases in intensity from 20-100 times that of the free nonintercalatively 
bound dye (Figure 29). The extent of interaction between the drug and DNA can be 
determined by the extent of fluorescence quenching of EB bound to DNA.45 
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Figure 29. Emission spectra of EB 1  10-6 M in the absence of DNA (1) and in the presence 
of DNA 1.5  10-4 M (2)             
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2.3.3.1. EB fluorescence displacement assay of netropsin 
In the present study netropsin was used as reference DNA binding agent to displace the 
ethidium bromide. According to figure 30, by increasing the netropsin concentration the 
fluorescence intensity decreased which indicated netropsin interacts with DNA as a 
groove binder and releases EB from EB-DNA system. Another possibility is netropsin 
binds to DNA in different binding sites and changes the conformation of DNA, which 
causes a decrease in the fluorescence intensity. The K value for netropsin-DNA complex 
was found to be 7.1 × 104 M-1 and the Gibbs free energy was -27.6 kJ.mol-1, the negative 
value of ∆G showing a spontaneous process. 
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Figure 30. Emission spectra of DNA-EB in trisma base buffer on titration of netropsin. 
Kex = 480 nm; [EB] = 1  10-6 M; [DNA] 1.5 10-4 M. The arrow shows the increase of 
the complex concentration, [netropsin] (a) 0.0, (b) 1  10-6, (c) 2  10-6, (d) 4  10-6, (e)  
6  10-6, (f) 8  10-6, (g) 1  10-5 M. Inside graph is the plot of I0 / I vs. complex 
concentration for determination of the K and ∆G values. (R2= 0.94173 for six points). 
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Figure 31. Binding constant values from EB displacement assay of the synthesised compounds  
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According to figure 31, all the synthesised compounds showed some affinity to bind with 
DNA in the EB displacement assay, although in comparison to the reference compound 
netropsin binding were very weak (netropsin K = 7.1 × 104 M-1). Compounds 76, 96, 102 
and 105 indicated the highest K values compared to other compounds. Therefore these 
compounds showed the stronger affinity to bind with DNA than the other synthesised 
compounds. The decrease in fluorescence suggests these compounds could be binding to 
the DNA as grove binders, although the exact nature of the interaction is not yet known. 
The higher values for 102 and 105, which contain a carbazole ring, suggest this group is 
beneficial for binding as was observed in the thermal melting and UV studies.    
2.3.4. Vapour diffusion DNA-compound complex crystallization  
For a deep investigation of the DNA binding activity of the novel fluorinated compounds 
that were synthesised in the project, it was hopped to co-crystallize the compound with 
the well known synthetic short DNA sequence CGCGAATTCGCG.99 The X-ray structure 
of CGCGAATTCGCG oligo is well known in the literature39 and the stereo structure of 
the Netropsin-CGCGAATTCGCG complex is well known as well.56 
The hanging drop crystallization method was studied in cacodylate buffer in the presence 
of magnesium chloride, with the purpose of obtaining crystals suitable for X-ray 
crystallography. Multiwell plates were used as well as capillary tubes under different 
conditions at RT and at 3 °C in the refrigerator. Compounds 41, 42, 46, 48, 59, 68, 71, 76, 
82, 83, 84, 87, 90, 91, 96, 100, 102, 103, 105, 111, 114, 116, 117, 119, 120, 127, 133, 135 
were all investigated.   
Unfortunately all attempts failed to yield suitable crystals for X-ray crystallography, 
although the samples were left to crystallize for a long time, up to 6-8 months. In some 
cases clustered crystals formed, but were not suitable for X-ray crystallography to obtain 
the X-ray crystal structure. Disappointingly no crystals obtained to give information about 
the detailed binding interactions of any of the compounds studied.            
2.4. Antimicrobial activity 
In vitro biological screening tests of the synthesised fluorinated compounds were carried 
out for antibacterial cytotoxicity. The antibacterial activity was tested against two 
bacterial strains Gram-positive strain (Escherichia coli) and Gram-negative strain 
(Staphylococcus aureus). The disk diffusion method was used in these assays and each 
experiment was performed in triplicate. Criteria for activity is based on the diameter of 
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the inhibition zone (mm); an inhibition zone more than 20 mm indicates significant 
activity, for 18-20 mm inhibition is good, 15-17 mm is low, and below 11-14 mm is non-
significant activity.70,100 The following compounds in 10-2 M were tested, 42, 46, 48, 59, 
68, 71, 76, 82, 84, 87, 90, 91, 96, 102, 105, 114, 116, 117, 119, 120, 127, 133, 135 but 
showed no zone inhibition at all. Compounds 83, 100, 103, 109 and 111 showed 
inhibition zone and reading of the zone inhibition represents the mean value of these 
readings, which are shown in table 2. Disappointingly the antibacterial activity assay 
demonstrated that the tested compounds showed non-significant activity against the 
bacteria because the inhibition zones were below 11-14 mm. Because the high 
concentration 10-2 M did not show a significant inhibition, the lower concentrations of the 
compounds did not studied.  Consequently the fluorinated synthesised compounds in the 
present study did not show a good antibacterial activity against (Escherichia coli) or 
(Staphylococcus aureus) strains, despite the evidence for DNA binding. Further studies 
would be required to understand the exact interaction of the compounds with bacterial 
cells.   
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Table 2. Antimicrobial activity of some fluorinated synthesised compounds 
 
Compound 
Average zone of inhibition (mm) 
Escherichia coli 
Staphylococcus 
aureus 
Compound 83 
 
 
0 7 
Compound 100 
 
 
 
 
7 0 
Compound 103 
 
 
 
0 7 
Compound 109 
 
 
 
 
 
0 7 
Compound 111 
 
 
 
 
 
0 8 
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2.5. Conclusions 
The research in this project has resulted in the successful synthesis and characterisation of 
31 new fluorinated organic compounds by nucleophilic aromatic substitution of fluorine 
in commercially available perfluoroarenes including hexafluorobenzene, 
pentafluoropyridine, pentafluorotoluene, pentafluorobenzaldehyde, ethyl 
pentafluorobenzoate and decafluorobiphenyl.  A number of novel substituted, and ring 
fused, fluorinated heterocycles have been prepared including indole, carbazole and 
benzofuran derivatives. A Smiles rearrangement has been identified during attempts to 
cyclize a bromonaphthyloxytetrafluoro pyridine. Carbazole was successfully introduced 
into number of perfluoroaromatics and pentafluoropyridine by nucleophilic aromatic 
substitution reaction with its N-anion. Carbazole was introduced into perfluoroaromatics 
and pentafluoropyridine in one, two or three positions by nucleophilic aromatic 
substitution reaction. The novel fluorinated compounds that had been synthesised in the 
study were used to synthesise potential bis-intercalating agents using 2,2-
(ethylenedioxy)bis(ethylamine). The new structures of the new compounds have been 
determined by a combination of 1H and 19F NMR spectroscopy, mass spectrometry, IR 
spectroscopy and in some cases elemental analysis. The X-ray crystal structures of 9 
compounds have been determined.  
A number of compounds synthesised have been shown to bind to DNA by a combination 
of thermal melting, UV absorption and fluorescence measurements, although the exact 
nature of the binding has not been determined. Attempts to co-crystallize the compounds 
with a synthetic oligonucleotide were unsuccessful. Studies on the antimicrobial activity 
of a range of the new compounds showed they had little activity against Gram-positive 
strain (Escherichia coli) and Gram-negative strain (Staphylococcus aureus).        
2.6. Future work 
The synthetic work has generated several areas where further investigation would be 
desirable. Reductive cyclization of 2-bromoaryl perfluoroaryl ethers, sulfides and amines 
using reactive methods such as Rieke magnesium, iron or copper could be explored as an 
alternative to the bromine-lithium exchange promoted by n-BuLi in which side reactions 
and addition of butyl groups to the substrate can occur. Study of the effect of such 
methods on cyclization versus Smiles rearrangement would be of interest. Further 
development of methods to predict and control the stepwise addition of nucleophiles to 
perfluoroarenes should be undertaken to study the orientation effects of the added groups, 
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and to improve reactivity as the number of available fluorines atoms falls with progressive 
substitution.  
In terms of the biological properties of the compounds further work should be undertaken 
to improve water solubility of the molecules by adding hydrophilic amino or hydroxyl 
containing groups. Further synthesis of positively charged derivatives or those containing 
basic groups capable of protonation should be undertaken. 
Further attempts to co-crystallize the products synthesised with DNA strands of known 
composition should be carried out, to allow a more detailed understanding of the 
molecular interactions involved in binding activity. A number of the compounds 
described in this thesis are being taken forward in a further project to test for in vitro anti-
cancer activity.     
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Chapter 3 
Experimental 
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3. Experimental 
3.1. General  
Anhydrous conditions were obtained by using oven/flame-dried glassware being purged 
with nitrogen prior to the addition of chemical reagents. A nitrogen atmosphere was 
maintained throughout reactions where necessary through the use of a nitrogen balloon. 
Commercially available solvents were used and not subjected to further purification, 
except THF, which was distilled as needed from benzophenone and sodium. DMSO was 
purchased dry from a commercial supplier. Light petroleum refers to the fractions with a 
boiling point between 40-60 °C.  
NMR spectra were recorded (1H, 19F and 13C) using a Bruker 400 MHz NMR instrument 
or a Jeol ECS-400 instrument with internal standard tetramethylsilane or 
hexafluorobenzene for 19F NMR spectra. Chemical shifts are reported in ppm for both 
forms of spectra and coupling constant are recorded in hertz. 1H NMR spectra were 
recorded at 400 MHz, 19F NMR spectra at 376 MHz and 13C NMR spectra were recorded 
at 100 MHz. DEPT was used to assign environment (CH, CH2, CH3) to each carbon atom 
in the 13C NMR spectra. The solvent system used for NMR measurements is specified in 
brackets. 
A Thermofisher Exactive (orbitrap) mass spectrometer was used to obtain high-resolution 
mass spectra, with ESI as the ionization mode. The solvent used for all samples was 
methanol.  
 GC-MS was performed on a Fisons 8060 with a DB5MS column of 30 m length and split 
less injection.    
A Perkin-Elmer spectrum 65FT-IR spectrophotometer was used to obtain infrared spectra. 
Liquid sample were acquired using a thin film on a sodium chloride disc. Solid samples 
were acquired using a KBr disc. 
Melting points were recorded using as Electro thermal-IA 9100 melting point instrument. 
TLC analysis was carried out on Merck TLC silica gel 60 F254 aluminum backed plates 
and were visualized by vanillin stain or under UV light at 254 nm using a U.V.P 
chromate-vue cabinet model CC-60. 
Column chromatography was carried out on Merck Kiesel 60 silica gel. The eluent and 
concentration used is specified in brackets. 
For biological activity assays calf thymus DNA and salmon sperm DNA and short 
synthetic CGCGAATTCGCG DNA were purchased from Sigma. Spectra UV at 250 was 
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used for UV absorption assays and Perkin Elmer Luminescence Spectrometer S50B was 
used for fluorescence assay and a UV- visible spectrophotometer Varian Cary 300 Bio 
was used for melting temperature assay. Muller Hinton agar, petri dish 90 × 14 mm 
(diameter and height respectively) and Townson + Mercer incubator was used to incubate 
the bacteria in anti microbial activity study.   
3.2. Organic synthesis 
3.2.1. Reaction of (2-nitrophenyl)-acetic acid ethyl ester with pentafluoropyridine  
 
 
 
41 
 
2-Nitrophenylacetic acid (4.13 g, 20 mmol) was dissolved in ethanol (50 mL) and conc. 
H2SO4 (3 drops) was added to the mixture. The mixture was heated under reflux at 78 °C 
for 24 h. The reaction mixture was allowed to cool to RT and NaHCO3 (2 spatulas) was 
added and filtered. The solvent was evaporated to dryness to reveal 41 as a pale yellow 
crystals (1.56 g, 37 %); m.p. 66-69 °C; δH (400 MHz, CDCl3) 8.13 (1H, dd, J 8.4 and 1.2 
Hz), 7.60 (1H, td, J 7.2 and 1.2 Hz), 7.48 (1H, td, J 8.4 and 1.6 Hz), 7.36 (1H, dd, J 7.6 
and 0.8 Hz), 4.18 (2H, q, J 6.8 Hz), 4.02 (2H, s), 1.26 (3H, t, J 6.8 Hz); HRMS (ESI) m/z 
found 232.0576, C10H11NO4Na+ requires 232.0580; vmax/cm-1 (film) 1734 (C=O), 1540 
(NO2), 1345 (NO2), 1215, 1179; Analysis (%) calculated for C10H11NO4 (209): C, 57.4; 
H, 5.30; N, 6.70. Found C, 56.82; H, 4.90; N, 6.70.  
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A solution of (2-nitrophenyl)-acetic acid ethyl ester 41 (0.62 g, 3 mmol) in THF (5 mL) 
was added dropwise to a stirred suspension of NaH (60 % dispersion in mineral oil) (0.18 
g, 8 mmol) in THF (5 mL) under N2 and left to stir at RT for 1 h. A solution of 
pentafluoropyridine (0.98 g, 6 mmol) in THF (5 mL) was added dropwise to the reaction 
mixture and left to stir at RT for 24 h. The solvent was evaporated and then water (10 mL) 
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was added dropwise to the residue. The reaction mixture was extracted with 
dichloromethane (DCM) (25 mL × 3) and the combined organic layers dried over MgSO4, 
filtered and evaporated to give 42 as a brown oil (1.00 g, 93 %); δH (400 MHz, CDCl3) 
8.09 (1H, dd, J 8.0 and 1.6 Hz), 7.56 (1H, td, J 7.6 and 1.2 Hz), 7.49 (1H, td, J 8.0 and 1.2 
Hz), 7.12 (1H, d, J 7.6 Hz), 6.19 (1H, s), 4.21 (2H, q, J 6.8 Hz), 1.19 (3H, t, J 6.8 Hz); δF 
(376 MHz, CDCl3) 72.91-72.73 (2F, m), 21.17-20.99 (2F, m); HRMS (ESI) m/z found 
357.0512 (M−H)
-
, C15H9F4N2O4 requires 357.0504.; vmax/cm-1 (film) 1737 (C=O), 1654, 
1531 (NO2), 1348 (NO2), 1469, 1202, 1106, 1094.  
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The cyclization of fluorinated ethyl ester 42 was done in the presence of iron powder as 
electron donor and aqueous HCl as a source of hydrogen (Scheme 20). Ethanol (7.5 mL) 
was added to the mixture of compound 42 (0.35 g, 1 mmol), iron powder (0.16 g, 3 
mmol) and HCl (1 M, 7.5 mL) and the mixture refluxed at 78 °C for 2 h. Some solid 
particles appeared in the mixture and then the mixture allowed cooling at room 
temperature, filtered and washed with DCM. The filtrate extracted with DCM (25 mL × 
3) and the combined organic layers dried over MgSO4, filtered and evaporated to afford a 
yellow oil. Column chromatography purification using 10:1 light petrol:diethyl ether as 
eluting solvent  afforded orange crystals (0.048 g). m.p. 159-162 °C. Neither 1H nor the 
19F NMR spectra were fully consistent with proposed structure 43a. The mass spectrum 
did show a signal consistent with the required molecular formula 43a, HRMS (ESI) m/z 
found 307.0705 (M−H)
-
, C15H10F3N2O2 requires 307.0700. The IR spectrum suggested 
the presence of a carbonyl group, vmax/cm-1 (film) 1735 (C=O). The spectroscopic data 
suggested some of the product 43a had formed but the material could not be obtained 
completely pure. 
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3.2.2. Reaction of pentafluorotoluene with benzonitrile 
                                                                             46                                                                             
A solution of pentafluorotoluene (0.36 g, 2 mmol) in THF (2 mL) was added dropwise to 
a stirred suspension of NaH (60 % dispersion in mineral oil) (0.20 g, 5 mmol) in THF (2 
mL) under N2 and left to stir at RT for 1 h. A solution of benzonitrile (0.41 g, 4 mmol) in 
THF (2 mL) was added dropwise to the reaction mixture and left to stir at RT for 24 h. 
The solvent was evaporated and then water (10 mL) was added to the residue. The 
reaction mixture was extracted with diethyl ether (25 mL × 3) and the combined organic 
layers dried over MgSO4, filtered and evaporated to give 46 as a colorless oil (0.64 g, 
essentially quantitative). δH (400 MHz, CDCl3) 7.69-7.66 (2H, m), 7.62 (1H, tt, J 7.6 and 
1.2 Hz), 7.49 (2H, t, J 7.6 Hz), 7.28 (1H, s), (NH signal not observed); δF (376 MHz, 
CDCl3) 17.21-17.18 (1F, m), 17.15-17.11 (1F, m), 2.99-2.96 (1F, m), 2.93-2.90 (1F, m); 
HRMS (ESI) m/z found 264.0446 (M−H)
-
, C14H6F4N requires 264.0442; vmax/cm-1 (film) 
3066 (N-H), 1491, 1448, 1070. 
 
3.2.3. Reaction of pentafluorotoluene with acetonitrile        
                                                                             
                                                                             48 
 
 A solution of pentafluorotoluene (0.73 g, 4 mmol) in acetonitrile (2 mL) was added 
dropwise to a stirred suspension of NaH (60 % dispersion in mineral oil) (0.40 g, 10 
mmol) in acetonitrile (2 mL) under N2 and left to stir at RT for 24 h. The solvent was 
evaporated and then water (10 mL) was added to the residue. The reaction mixture was 
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extracted with diethyl ether (25 mL × 3) and the combined organic layers dried over 
MgSO4, filtered and evaporated to give 48 as a reddish-brown oil (0.42 g, 52 %). δH (400 
MHz, CDCl3) 7.28 (1H, s), 2.20 (3H, s), (NH signal not observed); δF (376 MHz, CDCl3) 
20.63-20.59 (1F, m), 20.08-19.99 (1F, m), 17.23-17.14 (1F, m), 2.99-2.91 (1F, m); HRMS 
(ESI) m/z found 202.0289 (M−H)
-
, C9H4F4N, requires 202.0285; vmax/cm-1 (film) 3400 
(NH), 2924 (CH), 2854 (CH), 1496, 1463, 1377.  
 
3.2.4. Reaction of pentafluorotoluene with 2-pyridinecarbonitrile 
 
 
57 
 
A solution of pentafluorotoluene (0.72 g, 4 mmol) in THF (2 mL) was added dropwise to 
a stirred suspension of NaH (60 % dispersion in mineral oil) (0.40 g, 10 mmol) in THF (2 
mL) under N2 and left to stir at RT for 1 h. A solution of 2-pyridinecarbonitrile (2.12 g, 8 
mmol) in THF (2 mL) was added dropwise to the reaction mixture and left to stir at RT 
for 24 h. The solvent was evaporated and then water (10 mL) was added to the residue. 
The reaction mixture was extracted with DCM (25 mL × 3) and the combined organic 
layers dried over MgSO4, filtered and evaporated to give creamy crystals of trimer 
product  57 (0.37 g, 43 %). m.p. 243-248 °C; δH (400 MHz, CDCl3) 8.91 (3H, dd, J 4.8 
and 0.8 Hz), 8.81 (3H, dd, J 8.0 and 0.8 Hz), 8.51 (1H, d, J 4.0 Hz), 8.15 (1H, dt, J 8.8 
and 1.2 Hz), 7.92 (3H, td, J 7.6 and 1.6 Hz), 7.79 (1H, td, J 7.6 and 1.6 Hz), 7.50 (3H, dd, 
J 7.6 and 4.8 Hz), 7.39 (1H, ddd, J 7.6, 4.8 and 1.2 Hz) (NH2 signal not observed); 19F 
(376 MHz, CDCl3) No signals observed; HRMS and GC-MS could not find the expected 
mass of either component of either of the formed compound; vmax/cm-1 (film) 3369 (N-H), 
1693 (C-O). 
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3.2.5. Reaction of pentafluoropyridine with thiobenzamide 
  
59  
A solution of thiobenzamide (0.50 g, 4 mmol) in THF (3 mL) was added dropwise to a 
stirred suspension of NaH (60 % dispersion in mineral oil) (0.48 g, 12 mmol) in THF (3 
mL) under N2 and left to stir at RT for 1 h. A solution of pentafluoropyridine (2.01 g, 12 
mmol) in THF (1 mL) was added dropwise to the reaction mixture and left to stir at RT 
for 24 h. The solvent was evaporated and then water (10 mL) was added to the residue. 
The reaction mixture was extracted with diethyl ether (25 mL × 3) and the combined 
organic layers dried over MgSO4, filtered and evaporated to give a brown oil. Column 
chromatography purification with light petrol as eluting solvent afforded 59 as a yellow 
oil (0.914 g, 80 %). δH (400 MHz, CDCl3) 7.68-7.48 (5H, m), 7.29 (1H, bs, NH); δF (376 
MHz, CDCl3) 74.27-74.03 (2F, m), 27.01-26.83 (2F, m); HRMS (ESI) m/z found 
286.0273, C12H6F4N2S requires 286.0182, vmax/cm-1 (film) 1624 (C=N), 1377, 1234. 
 
3.2.6. Reaction of pentafluoropyridine with naphthalene-1-thiocarboxamide   
 
 
         21                                  64                                               63                                 67 
 
A solution of naphthalene-1-thiocarboxamide (0.37 g, 2 mmol) in THF (2 mL) was added 
to a stirred suspension of NaH (60 % dispersion in mineral oil) (0.24 g, 6 mmol) in THF 
(2 mL) under N2 and left to stir at RT for 1 h. A solution of pentafluoropyridine (1.01 g, 6 
mmol) in THF (2 mL) was added to the reaction mixture and left to stir at RT for 24 h. 
The solvent was evaporated and then water (20 mL) was added to the residue. Solid 
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particles precipitated, and were filtered to give 1.04 g of white crystals which was a 
mixture of 63 and 67, m.p. 59-61 °C.  
Compound 63, δF (376 MHz, DMSO-d6) 74.16-73.94 (2F, m), 26.88-26.72 (2F, m); 
HRMS (ESI) m/z found 181.9692 (M−H)
-
, C5F4NS, requires 181.9693; vmax / cm-1 (film) 
3460 (N-H) and 1627 (C=S). 
Compound 67, δH (400 MHz, DMSO-d6) 8.33 (1H, d, J 8.4 Hz), 8.18 (1H, dd, J 7.2 and 
0.8 Hz), 8.13 (2H, t, J 8.0 Hz), 7.82(1H, td, J 7.2 and 1.2 Hz), 7.74 (1H, td, J 7.2 and 1.2 
Hz), 7.69 (1H, dd, J 8.4 and 7.2 Hz); HRMS (ESI) m/z found 153.0584, C11H7N requires 
153.0584, and; vmax / cm-1 (film) 2224 (C≡N). 
 
3.2.7. Reaction of hexafluorobenzene with naphthalene-1-thiocarboxamide 
  
68 
A solution of hexafluorobenzene (1.116 g, 6 mmol) in THF (2 mL) was added dropwise 
to a stirred suspension of NaH (60 % dispersion in mineral oil) (0.24 g, 6 mmol) in THF 
(2 mL) under N2. A solution of naphthalene-1-thiocarboxamide (0.374 g, 2 mmol) in THF 
(3 mL) was added dropwise to the reaction mixture and left to stir at RT for 48 h. The 
solvent was evaporated and then water (10 mL) was added to the residue. The reaction 
mixture was extracted with DCM (25 mL × 3) and the combined organic layers dried over 
MgSO4, filtered and evaporated to give 68 as yellow crystals (0.108 g, 16 %). m.p. 165-
168 °C; δH (400 MHz, CDCl3) 8.28 (1H, dd, J 8.0 and 0.8 Hz), 8.12 (1H, d, J 8.0 Hz), 
7.97-7.94 (2H, m), 7.73 (1H, td, J 6.8 and 1.2 Hz), 7.66 (1H, td, J 6.8 and 1.2 Hz), 7.57 
(1H, dd, J 8.4 and 7.2 Hz); δF (376 MHz, CDCl3) 23.80 (1F, dd, J 20 and 15 Hz), 14.79 
(1F, dd, J 19 and 14 Hz), 3.96 (1F, t, J 19 Hz), 3.24 (1F, t, J 20 Hz); GC-MS (EI) m/z 
333; vmax / cm-1(film) 2923, 1514, 1466, 1340.  
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3.2.8. Reaction of pentafluoropyridine with 2-mercaptobenzimidazole  
 
 
                                                                    71   
 
A solution of pentafluoropyridine (16.90 g, 100 mmol) in THF (2 mL) and a solution of             
2-mercaptobenzimidazole (3 g, 20 mmol) in DMF (3 mL) and THF (10 mL) were added 
dropwise to a stirred suspension of NaH (60 % dispersion in mineral oil) (1.6 g, 50 mmol) 
in THF (4 mL) under N2 and left to stir at RT for 24 h. The solvent was evaporated and 
then water (20 mL) was added to the residue. The reaction mixture was extracted with 
DCM (25 mL × 3) and the combined organic layers dried over MgSO4, filtered and 
evaporated to give 71 as creamy crystals (2.44 g, 27 %). m.p. 112-115 °C; δH (400 MHz, 
CDCl3) 7.85-7.80 (1H, m), 7.49-7.45 (2H, m), 7.23-7.19 (1H, m); δC (100 MHz, CDCl3) 
145-134 (a cluster of weak signals was observed due to the pyridine ring carbons 
exhibiting multiplet coupling to fluorine), 143.38 (Cq), 134.94 (Cq), 126.07 (CH), 124.99 
(CH), 120.80 (CH), 110.05 (CH); δF (376 MHz, CDCl3) 77.42-77.05 (2F, m), 74.37-73.97 
(2F, m), 27.03-26.87 (2F, m), 19.26-19.12 (2F, m); HRMS (ESI) m/z found 446.9962 
(M−H)
-
, C17H3F8N4S requires 446.9956; vmax /cm-1 (film) 1630, 1474, 1246, 975, 952; 
Analysis (%) calculated for C17H4F8N4S (448): C, 45.55; H, 0.90; N, 12.50. Found C, 
45.41; H, 0.92; N, 12.00.    
 
3.2.9. Reaction of pentafluoropyridine with 2-mercapto-4(3H)-quinazolinone        
 
 
                                             74                                  75 
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A solution of 2-mercapto-4(3H)-quinazolinone (0.712 g, 4 mmol) in THF (8 mL) and 
DMF (1 mL) was added dropwise to a stirred suspension of NaH (60 % dispersion in 
mineral oil) (0.40 g, 10 mmol) in THF (4 mL) under N2 and left to stir at RT for 1 h. A 
solution of pentafluoropyridine (1.014 g, 6 mmol) in THF (3 mL) was added dropwise to 
the reaction mixture and left to stir at RT for 24 h. The solvent was evaporated and then 
water (10 mL) was added to the residue. The reaction mixture was extracted with diethyl 
ether (25 mL × 3) and the combined organic layers dried over MgSO4, filtered and 
evaporated to give yellow oil. Recrystallization with diethyl ether afforded 74 or 75 as 
creamy crystals (0.045 g, 4%). m.p. 242-246 °C; δH (400 MHz, CDCl3) 8.34 (1H, ddd, J 
8.0, 1.6 and 0.4 Hz), 7.79 (1H, td, J 7.2 and 1.6 Hz), 7.61 (1H, dd, J 7.6 and 0.4 Hz), 7.50 
(1H, td, J 7.6 and 1.2 Hz); δF (376 MHz, CDCl3) 106.50 (1F, dd, J 30 and 10 Hz), 74.44 
(1F, dd, J 22 and 10 Hz), 16.26 (1F, dd, J 29 and 22 Hz); GC-MS (EI) m/z 307;             
vmax / cm-1(film) 1712 (C=O), 1147, 1124, 1022. 
 
 
 
                                                               76    
 
A solution of 2-mercapto-4(3H)-quinazolinone (1.424 g, 8 mmol) in THF (16 mL) and 
DMF (2 mL) was added dropwise to a stirred suspension of NaH (60 % dispersion in 
mineral oil) (0.40 g, 10 mmol) in THF (4 mL) under N2 and left to stir at RT for 1 h. A 
solution of pentafluoropyridine (2.704 g, 16 mmol) in THF (3 mL) was added dropwise to 
the reaction mixture and left to stir at RT for 24 h. The solvent was evaporated and then 
water (10 mL) was added to the residue, creamy crystals was formed, and were filtered to 
give 76 (0.57 g, 22 %). m.p. 206-210 °C; δH (400 MHz, DMSO-d6) 8.06 (1H, dd, J 8.0 
and 1.2 Hz), 7.74 (1H, td, J 7.2 and 1.6 Hz), 7.48 (1H, td, J 7.2 and 1.2 Hz), 7.38 (1H, dd, 
J 8.0 and 0.4 Hz), (NH signal not observed); δF (376 MHz, DMSO-d6) 70.60-70.43 (2F, 
m), 28.73-28.54 (2F, m); HRMS (ESI) m/z found 326.0023  (M−H)
-
, C13H4F4N3OS 
requires 326.0017; vmax / cm-1 (film) 3583 (N-H), 1688 (C=O), 1466, 1264, 1161. 
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3.2.10. Reaction of pentafluorobenzaldehyde with 2-mercapto-4(3H)-quinazolinone   
 
 
78 
 
A solution of 2-mercapto-4(3H)-quinazolinone (2.67 g, 30 mmol) in THF (50 mL) and 
DMF (5 mL) was added dropwise to a stirred suspension of NaH (60 % dispersion in 
mineral oil) (0.80 g, 20 mmol) in THF (3 mL) under N2 and left to stir at RT for 1 h. A 
solution of pentafluorobenzaldehyde (5.88 g, 30 mmol) in THF (3 mL) was added 
dropwise to the reaction mixture and left to stir at RT for 24 h. The solvent was 
evaporated and then water (10 mL) was added to the residue, solid particles formed, and 
were filtered and recrystallized from hot ethanol to give 78 as white crystals (3.07 g, 29 
%). m.p. 250-252 °C; δH (400 MHz, DMSO-d6) 13.5-12.7 (1H, bs, NH), 10.23 (1H, s), 
8.05 (1H, dd, J 8.0 and 1.2 Hz), 7.71 (1H, td, J 7.2 and 1.6 Hz), 7.45 (1H, td, J 8.0 and 0.8 
Hz), 7.31 (1H, d, J 7.6 Hz); δF (376 MHz, DMSO-d6) 30.19-30.10 (2F, m), 16.27-16.17 
(2F, m); HRMS (ESI) m/z found 353.0018 (M−H)
-
, C15H5F4N2O2S requires 353.0013; 
vmax / cm-1(film) 3583 (N-H), 1682 (C=O), 1592, 1384, 1246. 
 
3.2.11. Reaction of pentafluoropyridine with 2-bromothiophenol31  
 
 
82 
 
A solution of 2-bromothiophenol (3.78 g, 20 mmol) in DMF (1 mL) was added dropwise 
to a stirred suspension of NaH (60 % dispersion in mineral oil) (1.6 g, 40 mmol) in DMF 
(4 mL) under N2 and left to stir at RT for 1 h. A solution of pentafluoropyridine (10.14 g, 
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60 mmol) in DMF (1 mL) was added dropwise to the reaction mixture and left to stir at 
RT for 24 h. The solvent was evaporated and then water (10 mL) was added to the 
residue. The reaction mixture was extracted with DCM (25 mL × 3) and the combined 
organic layers dried over MgSO4, filtered and evaporated to give 82 as reddish brown oil 
(1.405 g, 21 %). δH (400 MHz, CDCl3) 7.47 (1H, dd, J 7.6 and 1.2 Hz), 7.38 (1H, d, J 7.6 
Hz), 7.17 (1H, td, J 7.6 and 1.6 Hz), 7.11 (1H, td, J 7.6 and 2.0 Hz); δF (376 MHz, CDCl3) 
70.81-70.76 (2F, m), 25.38-25.28 (2F, m); GC-MS (EI) m/z 337 and 339; vmax / cm-1 (film) 
1507, 1447, 1234, 1103, 1020, data in agreement with literature values. 
 
3.2.12. Cyclization of 4-(2-bromophenylsulfanyl)-2,3,5,6-tetrafluoropyridine (82)31  
 
 
83 
 
A solution of 4-(2-bromophenylsulfanyl)-2,3,5,6-tetrafluoropyridine 82 (0.68 g, 2 mmol) 
in THF (10 mL) was stirred at -78 °C under N2 and treated dropwise with a solution of        
n-BuLi in hexane (2.5 M, 0.9 mL, 2 mmol). The mixture was stirred and allowed to warm 
to RT for 24 h. The solvent was evaporated and then water (10 mL) was added to the 
residue. The reaction mixture was extracted with diethyl ether (25 mL × 3) and the 
combined organic layers dried over MgSO4, filtered and evaporated to give 83 as a brown 
oil (0.315 g, 66 %). δH (400 MHz, CDCl3) 8.38-8.35 (1H, m), 7.95-7.92 (1H, m), 7.63-
7.16 (2H, m); HRMS (ESI) m/z found 240.0088 (M+H)+, C11H5F3NS requires 240.0045; 
vmax / cm-1 (film) 1618, 1480, 1438, 1253, 1025, consistent with the literature values.   
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3.2.13. Reaction of hexafluorobenzene with 2-bromothiophenol31 
 
 
84 
 
A solution of 2-bromothiophenol (0.78 g, 4 mmol) in DMF (1 mL) was added dropwise to 
a stirred suspension of NaH (60 % dispersion in mineral oil) (0.20 g, 5 mmol) in DMF (8 
mL) under N2. Hexafluorobenzene (0.38 g, 2 mmol) was added dropwise to the reaction 
mixture and stirred at RT for 24 h. The solvent was evaporated and then water (25 mL) 
was added to the residue. The reaction mixture was extracted with diethyl ether (25 mL × 
3) and the combined organic layers dried over MgSO4, filtered and evaporated to give 84 
as a yellow solid (0.85 g). Recrystallization from dichloromethane-light petroleum 
afforded pale yellow crystals (0.74 g 35 %). m.p. 138-139 °C (lit., 138 °C); δH (400 MHz, 
DMSO-d6) 7.62 (2H, d, J 8.0 Hz), 7.49 (2H, dd, J 7.6 and 1.2 Hz), 7.17-7.11 (2H, m), 
7.05-6.97 (2H, m); δF (376 MHz, DMSO-d6) 31.18 (4F, s); HRMS (ESI) m/z found 
521.8364, C18H879Br2F4 S2 requires 521.8376; vmax / cm-1(film) 1445, 1388, 1237, 1014, 
748. Data consistent with literature values.  
 
3.2.14. Cyclization of 1,4-bis-(2-bromophenylsulfanyl)-2,3,5,6-tetrafluorobenzene (84)31  
 
 
85 
 
A solution of 1,4-bis-(2-bromophenylsulfanyl)tetrafluorobenzene 84 (0.957 g, 0.0018 
mmol) in THF (2 mL) was stirred at -78 °C under N2 and treated dropwise with a solution 
of n-BuLi in hexane (2.5 M, 1.6 mL). The mixture was stirred and allowed to warm to RT 
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for 24 h. The solvent was evaporated and then water (20 mL) was added to the residue. 
The reaction mixture was extracted with DCM (25 mL × 3) and the combined organic 
layers dried over MgSO4, filtered and evaporated to give orange brown solid. 
Recrystallization from dichloromethane-light petroleum afforded 85 as fine pale yellow 
crystals (0.50 g, 85 %). m.p. 287-289 °C (lit., 287 °C) ; δH (400 MHz, CDCl3) 8.49-8.47 
(2H, m), 7.90-7.87 (2H, m), 7.56-7.54 (4H, m); δF (376 MHz, CDCl3) 37.9 (2F, s); HRMS 
(ESI) m/z found 326.0036, C18H8F2S2 requires 326.0036; Data in agreement with 
literature values.  
 
3.2.15. Reaction of pentafluoropyridine with 1-bromo-2-naphthol  
  
 
                                                                   87 
 
A solution of pentafluoropyridine (8.112 g, 48 mmol) in DMF (1 mL) and a solution of  
1-bromo-2-naphthol (3.568 g, 16 mmol) in DMF (3 mL) were added dropwise to a stirred 
suspension of NaH (60 % dispersion in mineral oil) (0.80 g, 20 mmol) in DMF (3 mL) 
under N2 and left to stir at RT for 24 h. The solvent was evaporated and then water (10 
mL) was added to the residue, creamy crystals formed, and were filtered and 
recrystallized from light petrol to give 87 (5.971 g, 100 %). m.p. 77-80 °C; δH (400 MHz, 
CDCl3) 8.28 (1H, d, J 8.4 Hz), 7.85 (2H, t, J 8.0 Hz), 7.67 (1H, t, J 7.2 Hz), 7.56 (1H, t, J 
7.2 Hz), 7.24 (1H, d, J 8.4 Hz); δF (376 MHz, CDCl3) 73.29-73.12 (2F, m), 6.10-5.94 (2F, 
m); HRMS (ESI) m/z found 369.9528 (M−H)
-
, C15H579BrF4NO requires 369.9496;       
vmax / cm-1(film) 1480, 1429, 1218, 1078; Analysis (%) calculated for C15H6BrF4NO 
(370): C,48.64; H, 1.62; N, 3.78. Found C, 48.52; H, 1.56; N, 3.80.  
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3.2.16. Lithiation reaction of 4-(3-bromonaphthalen-2-yloxy)-2,3,5,6-
tetrafluoropyridine (87) 
 
 
                                          88                                                   89 
 
A solution of 4-(3-bromonaphthalen-2-yloxy)tetrafluoropyridine 87 (0.370 g, 1 mmol) in 
THF (2 mL) was stirred at -78 °C and treated dropwise with a solution of n-BuLi in 
hexane (2.5 M, 0.539 mL, 1 mmol). The solution turned orange and then faded to yellow 
over 50 min. The mixture was stirred and allowed to warm to room temperature for 24 h. 
The solvent was evaporated and then water (20 mL) was added to the residue. The 
reaction mixture was extracted with DCM (25 mL × 3) and the combined organic layers 
dried over MgSO4, filtered and evaporated to give orange oil (0.182 g, approx. 60 % 
based on 88). Column chromatography purification using 9:1 light petrol:diethyl ether as 
eluting solvent yielded yellow oil (0.146 g) of a mixture of two compounds mainly 88 and 
a trace of 89.   
Compound 88, δH (400 MHz, CDCl3) 7.91 (1H, d, J 8.8 Hz), 7.87 (1H, d, J 7.6 Hz), 7.77-
7.69 (1H, bs, OH), 7.50 (1H, td, J 6.8 and 1.6 Hz), 7.43 (1H, td, J 7.2 and 1.6 Hz), 7.34 
(1H, d, J 7.6 Hz), 7.23 (1H, d, J 8.8 Hz); δF (376 MHz, CDCl3) 70.57-70.39 (2F, m), 
22.78-22.61 (2F, m); GC-MS (EI) m/z 293; vmax / cm-1 (film) 3411 (O-H). 
Compound 89, 1H NMR signals not visible in the mixture; 19F NMR signals were 
observed in the range 67-72 ppm and 23-36 consistent with the proposed structure, but 
signals from other minor compounds prevented full assignment; GC-MS (EI) m/z 273. 
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3.2.17. Lithiation reaction of 4-(3-bromonaphthalene-2-yloxy)-2,3,5,6-
tetrafluorpyridine (87) in the presence of TMEDA 
 
 
                                                               90 
 
A solution of 4-(3-bromonaphthalen-2-yloxy)tetrafluoropyridine 87 (3.70 g, 10 mmol) in 
THF (8 mL) and TMEDA (2 mL) was stirred at -78 °C and treated dropwise with a 
solution of n-BuLi in hexane (2.04 M, 4 mL, 10 mmol). The solution turned to orange and 
then faded to yellow over 1 h. The mixture was stirred and allowed to warm to room 
temperature for 24 h. The solvent was evaporated and then water (20 mL) was added to 
the residue. The reaction mixture was extracted with DCM (25 mL × 3) and the combined 
organic layers dried over MgSO4, filtered and evaporated to give yellow orange oil (2.319 
g). Column chromatography purification using light petrol as eluting solvent afforded 90 
as a white crystals (0.443 g, 16 %). m.p. 119-121 °C; δH (400 MHz, CDCl3) 8.34 (d, J 8.4 
Hz), 7.93-7.83 (m), 7.70 (td, J 7.2 and 1.6 Hz), 7.62-7.48 (m), 7.34-7.29 (m) (integral 
values not accurate); δF (376 MHz, CDCl3) 8.03 (1F, d, J 26 Hz), 1.76 (1F, d, J 21 Hz), 
72.81 (1F, dd, J 26 and 21 Hz); GC-MS (EI) m/z 273; vmax / cm-1 (film) 1624, 1594, 1496, 
1470, 1456, 1405, 1217. 
 
3.2.18. Reaction of hexafluorobenzene with 1-bromo-2-naphthol 
  
                                                                
                                                                  91 
 
A solution of 1-bromo-2-naphthol (1.784 g, 8 mmol) in DMF (4 mL) was added dropwise 
to a stirred suspension of NaH (60 % dispersion in mineral oil) (0.4 g, 10 mmol) in DMF 
(2 mL) under N2 and left to stir at RT for 1 h. A solution of hexafluorobenzene  (14.88 g, 
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80 mmol) in DMF (1 mL) was added dropwise to the reaction mixture and it was left to 
stir at RT for 24 h. The solvent was evaporated and then water (20 mL) was added to the 
residue. The reaction mixture was extracted with DCM (25 mL × 3) and the combined 
organic layers dried over MgSO4, filtered and evaporated to give reddish brown oil (1.598 
g) column chromatography purification using light petrol as eluting solvent afforded 91 as 
white crystals (0.348 g, 11 %). m.p. 112-114 °C; δH (400 MHz, CDCl3) 8.34 (1H, d, J 8.4 
Hz), 7.85 (1H, d, J 8.0 Hz), 7.80 (1H, d, J 9.2 Hz), 7.68 (1H, td, J 7.2 and 2.0 Hz), 7.54 
(1H, td, J 8.0 and 1.2 Hz), 7.01 (1H, d, J 8.8 Hz); δF (376 MHz, CDCl3) 7.86 (2F, d, J 17 
Hz), 2.41 (1F, t, J 23 Hz), 0.21-0.13 (2F, m); GC-MS (EI) m/z 388 and 390; vmax / cm-1 
(film) 1596, 1514, 1355, 1254, 989; Analysis (%) calculated for C16H6BrF5O (388): C, 
49.61; H, 1.55. Found C, 49.05; H, 1.50. 
 
3.2.19. Reaction of hexafluorobenzene with 2 equivalents of 1-bromo-2-naphthol 
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A solution of 1-bromo-2-naphthol (1.784 g, 8 mmol) in THF (3 mL) was added dropwise 
to a stirred suspension of NaH (60 % dispersion in mineral oil) (0.8 g, 20 mmol) in THF 
(2 mL) under N2 and left to stir at RT for 1 h. A solution of hexafluorobenzene  (0.744 g, 
4 mmol) in THF (1 mL) was added dropwise by syringe pump to the reaction mixture and 
left to stir at RT for 24 h. The solvent was evaporated and then water (20 mL) was added 
to the residue. The reaction mixture was extracted with DCM (25 mL × 3) and the 
combined organic layers dried over MgSO4, filtered and evaporated to give 92 as gray 
crystals after column chromatography purification using light petrol as eluting solvent 
(0.26 g, 11 %). m.p. 132-134 °C; δH (400 MHz, CDCl3) 8.07 (2H, d, J 8.4 Hz), 7.81 (2H, 
d, J 7.6 Hz), 7.77 (2H, d, J 8.8 Hz), 7.60 (2H, td, J 6.8 and 1.2 Hz), 7.42 (2H, td, J 8.0 and 
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1.2 Hz), 7.31 (2H, d, J 9.2 Hz); δF (376 MHz, CDCl3) 61.81 (4F, s); HRMS (ESI) could 
not observe the expected mass of the target compound; vmax / cm-1(film) 1502, 1255, 1237, 
1041, 1021.  
 
3.2.20. Reaction of 2-bromoaniline with p-toluenesulfonylchloride  
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A solution of 2-bromoaniline (2.61 g, 15 mmol) in pyridine (2 mL) was added dropwise 
to a solution of p-toluenesulfonylchloride (2.85 g, 15 mmol) in pyridine (2 mL) under N2 
and left to stir at RT for 72 h. The solvent was evaporated and diethyl ether (50 mL) was 
added to the residue, white solids precipitated, and were filtered and dried to give 95 as 
white crystals (4.21 g, 87 %). m.p. 93-96 °C; δH (400 MHz, CDCl3) 7.69 (1H, dd, J 8.4 
and 1.6 Hz), 7.67 (2H, d, J 8.4 Hz), 7.43 (1H, dd, J 8.0 and 1.6 Hz), 7.29 (1H, td, J 8.0 
and 1.2 Hz), 7.24 (2H, d, J 8.0 Hz), 6.99 (1H, td, J 7.2 and 1.6 Hz) + (1H, bs, NH), 2.40 
(3H, s); δC (100 MHz, CDCl3) 144.25 (Cq), 134.72 (Cq), 132.58 (CH), 129.67 (CH), 
128.59 (CH), 127.34 (CH), 126.27 (CH), 122.54 (CH), 21.60 (CH3), four Cq could not be 
observed. HRMS (ESI) m/z found 323.9702 (M−H)
-
, C13H1179BrNO2S requires 323.9699; 
vmax /cm-1 (film) 3297 (N-H), 1594, 1479, 1332 (SO2), 1166, 1089, 1026; Analysis (%) 
calculated for C13H11BrNO2S (324): C, 47.86; H, 3.71; N, 4.29. Found C, 47.83; H, 3.71; 
N, 4.29.  
 
3.2.21. Reaction of pentafluoropyridine with N-(2-bromophenyl)-4-
methylbenzenesulfonamide (95) 
 
96 
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A solution of pentafluoropyridine (3.38 g, 20 mmol) in THF (2 mL) and a solution of      
N-(2-bromophenyl)-4-methylbenzenesulfonamide 95 (0.792 g, 2 mmol) in THF (6 mL) 
and DMF (2 mL) were added dropwise to a stirred suspension of NaH (60 % dispersion in 
mineral oil) (0.16 g, 4 mmol) in THF (2 mL) and heated under reflux at 66 °C for 2 h 
under N2. After 2 h the reaction mixture allowed to stir at RT for 24 h. The solvent was 
evaporated and then water (20 mL) was added to the residue. The reaction mixture was 
extracted with DCM (25 mL × 3) and the combined organic layers dried over MgSO4, 
filtered and evaporated to give a dark green oil (1.13 g). Column chromatography 
purification using 9:1 light petrol:diethyl ether as eluting solvent afforded 96 as white 
crystals (0.22 g, 23 %). m.p. 95-97 °C; δH (400 MHz, CDCl3) 8.06 (1H, dq, J 8.0 and 1.6 
Hz), 7.59 (2H, d, J 8.0 Hz), 7.52 (1H, dd, J 8.0 and 1.2 Hz), 7.48 (1H, td, J 7.6 and 1.6 
Hz), 7.33 (1H, td, J 8.0 and 1.6 Hz), 7.29 (2H, d, J 8.0 Hz), 2.46 (3H, s); δC (100 MHz, 
CDCl3) 144.28 (Cq), 135.80 (Cq), 134.70 (Cq), 132.59 (CH), 129.69 (CH), 128.60 (CH), 
127.34 (CH), 126.29 (CH), 122.56 (CH), 115.72 (Cq), 21.62 (CH3), the signals expected 
for the tetrafluoropyridine ring could not be detected; δF (376 MHz, CDCl3) 72.82-72.65 
(2F, m), 8.53-8.37 (2F, m); HRMS (ESI) m/z found 472.9588 (M−H)
-
, 
C18H1079BrF4N2O2S  requires 472.9588; vmax / cm-1(film) 1596, 1589, 1478, 1397, 1337, 
1164, 1091. 
 
3.2.22. Reaction of hexafluorobenzene with carbazole to synthesise dicarbazole 
derivative  
 
100 
 
A solution of carbazole (1.336 g, 8 mmol) in THF (10 mL) was added dropwise to a 
stirred suspension of NaH (60 % dispersion in mineral oil) (0.40 g, 9 mmol) in THF (5 
mL) under N2 and left to stir at RT for 1 h. A solution of hexafluorobenzene (0.70 g, 4 
mmol) in THF (1 mL) was added dropwise to the reaction mixture and stirred at RT for 
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24 h. The solvent was evaporated and then water (20 mL) was added to the residue. 
Yellow crystals precipitated, and were filtered to give 100 (0.502 g, 26 %). m.p. 344-350 
°C; δH (400 MHz, CDCl3) 8.22 (4H, d, J 7.6 Hz), 7.56 (4H, t, J 7.2 Hz), 7.43 (4H, t, J 7.2 
Hz), 7.35 (4H, d, J 8.0 Hz); δF (376 MHz, CDCl3) 21.00 (4F, s); GC-MS (EI) m/z 480; 
vmax /cm-1(film) 1499, 1333, 1229, 1149, 1029. 
 
3.2.23. Reaction of hexafluorobenzene with carbazole to synthesise monocarbazole 
derivative  
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A solution of carbazole (0.33 g, 2 mmol) in THF (3 mL) and DMF (1 mL) was added 
dropwise to a stirred suspension of NaH (60 % dispersion in mineral oil) (0.2 g, 4 mmol) 
in THF (2 mL) under N2 and left to stir at RT for 1 h. A solution of hexafluorobenzene 
(3.72 g, 20 mmol) in THF (1 mL) was added dropwise to the reaction mixture and stirred 
at RT for 24 h. The solvent was evaporated and then water (20 mL) was added to the 
residue, creamy solid particles precipitated, and were filtered (0.49 g) and column 
chromatography using light petrol eluting solvent gave 102 as white crystals (0.075 g, 11 
%). m.p. 188-191 °C; δH (400 MHz, CDCl3) 8.19 (2H, d, J 7.2 Hz), 7.51 (2H, t, J 8.0 Hz), 
7.41 (2H, t, J 7.6 Hz), 7.17 (2H, d, J 8.0 Hz); δF (376 MHz, CDCl3) 19.80-19.49 (2F, m), 
8.82 (1F, t, J 22 Hz), 1.66-1.54 (2F, m); GC-MS (EI) m/z 333; vmax /cm-1 (film) 1523, 
1511, 1444, 1332, 1284, 1027. 
 
3.2.24. Reaction of pentafluoropyridine with carbazole 
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A solution of carbazole (1.67 g, 10 mmol) in THF (10 mL) and DMF (1 mL) was added 
dropwise to a stirred suspension of NaH (60 % dispersion in mineral oil) (0.8 g, 20 mmol) 
in THF (2 mL) under N2 and left to stir at RT for 1 h. A solution of pentafluoropyridine 
(8.45 g, 50 mmol) in THF (1 mL) was added dropwise to the reaction mixture and stirred 
at RT for 24 h. The solvent was evaporated and then water (20 mL) was added to the 
residue. Creamy solid particles precipitated, and were filtered (3.978 g) and purified by 
column chromatography using 8:2 light petrol:diethyl ether as eluting solvent to give 103 
as creamy crystals (1.62 g, 51 %). m.p. 190-194 °C; δH (400 MHz, CDCl3) 8.14 (2H, d, J 
7.6 Hz), 7.49 (2H, t, J 7.6 Hz), 7.40 (2H, t, J 7.6 Hz), 7.20 (2H, d, J 8.0 Hz); δF (376 
MHz, CDCl3) 74.44-74.27 (2F, m), 20.16-19.96 (2F, m) with very minor impurities;   
GC-MS (EI) m/z 316; vmax / cm-1(film) 1638, 1618, 1514, 1466, 1255, 1159, 1061.  
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In a one-off procedure following the same method as above to synthesise monocarbazole 
derivative 103 the tricarbazole derivative 104 was isolated as creamy crystals (0.303 g, 5 
%). m.p. 217-222 °C; δH (400 MHz, CDCl3) 8.19-8.09 (m), 7.63-7.56 (m), 7.48-7.38 (m), 
7.36-7.30 (m); δF (376 MHz, CDCl3) 39.65 (2F, s); GC-MS and HRMS could not observe 
the expected mass of the compound; vmax / cm-1 (film) 1599, 1577, 1453, 1312, 1227, 747; 
Analysis (%) calculated for C41H24F2N4 (610): C, 80.64; H, 3.96; N, 9.17. Found C, 
80.35; H, 3.97; N, 8.85.  
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  3.2.25. Reaction of pentafluorotoluene with carbazole 
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A solution of carbazole (2.672 g, 16 mmol) in THF (10 mL) and DMF (1 mL) was added 
dropwise to a stirred suspension of NaH (60 % dispersion in mineral oil) (1.6 g, 40 mmol) 
in THF (5 mL) under N2 and left to stir at RT for 1 h. A solution of pentafluorotoluene 
(14.56 g, 80 mmol) in THF (1 mL) was added dropwise to the reaction mixture under 
reflux at 66 °C for 48 h. The solvent was evaporated and then water (20 mL) was added to 
the residue, yellow orange solid particles precipitated, and were filtered (5.029 g). 
Column chromatography purification using light petrol as eluting solvent gave 105 as 
white crystals (1.93 g, 37 %). m.p. 153-155 °C; δH (400 MHz, CDCl3) 8.22 (2H, d, J 7.6 
Hz), 7.52 (2H, td, J 7.2 and 1.2 Hz), 7.41 (2H, td, J 7.6 and 0.8 Hz), 7.23 (2H, d, J 7.6 
Hz), 2.48 (3H, t, J 2.4 Hz); δF (376 MHz, CDCl3) 19.80-19.72 (2F, m), 17.14-17.05 (2F, 
m); GC-MS (EI) m/z 329; vmax / cm-1 (film) 1620, 1512, 1311, 1226, 1181; Analysis (%) 
calculated for C19H11F4N (329): C, 69.30; H, 3.34; N, 4.25. Found C, 69.47; H, 3.45; N, 
4.49. 
 
3.2.26. Reaction of pentafluorobenzoyl chloride with carbazole 
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A solution of carbazole (0.668 g, 4 mmol) in THF (5 mL) and DMF (1 mL) was added 
dropwise to a stirred suspension of NaH (60 % dispersion in mineral oil) (0.2 g, 4 mmol) 
in THF (2 mL) under N2 and left to stir at RT for 1 h. A solution of pentafluorobenzoyl 
chloride (0.94 g, 4 mmol) in THF (1mL) was added dropwise to the reaction mixture and 
stirred at RT for 24 h. The solvent was evaporated and then water (20 mL) was added to 
the residue. Orange yellow crystals precipitated and were filtered (1.32 g). 
Recrystallization from hot ethanol afforded 109 as creamy crystals (0.373 g, 36 %). m.p. 
216-221 °C; δH (400 MHz, CDCl3) 8.21 (1H, d, J 7.2 Hz), 8.11-8.06 (1H, m), 7.85-7.73 
(4H, m), 7.56 (1H, td, J 7.6 and 1.2 Hz), 7.52-7.48 (2H, m), 7.43 (1H, td, J 8.0 and 0.8 
Hz), 7.14-7.07 (6H, m); δF (376 MHz, CDCl3) 22.95-22.86 (2F, m), 22.54-22.43 (2F, m); 
HRMS (ESI) m/z found 509.1269 (M+H)
+
, C31H17F4N2O requires 509.1272; vmax /cm-1 
(film) 1689 (C=O), 1492, 1477, 1443, 1332, 1310, 1225.  
 
3.2.27. Reaction of pentafluorobenzamide with carbazole  
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A solution of carbazole (2.672 g, 16 mmol) in THF (10 mL) and DMF (4 mL) was added 
dropwise to a stirred suspension of NaH (60 % dispersion in mineral oil) (1.44 g, 36 
mmol) in THF (2 mL) under N2 and left to stir at RT for 1 h. A solution of 
pentafluorobenzamide (3.376 g, 16 mmol) in THF (10 mL) and DMF (4 mL) was added 
dropwise to the reaction mixture and stirred at RT for 24 h. The solvent was evaporated 
and then water (20 mL) was added to the residue. The reaction mixture was extracted with 
DCM (25 mL × 3) and the combined organic layers dried over MgSO4, filtered and 
evaporated to give 111 as yellow crystals (2.761 g, 48 %). m.p. 203-206 °C; δH (400 
MHz, CDCl3) 8.07 (2H, d, J 7.6 Hz), 7.42 (2H, t, J 8.0 Hz), 7.30 (2H, t, J 7.6 Hz), 7.08 
(2H, d, J 8.0 Hz), 6.1-5.9 (2H, bs, NH2); δF (376 MHz, CDCl3) 23.18-23.09 (2F, m), 
21.64-21.55 (2F, m); GC-MS (EI) m/z 358; vmax /cm-1 (film) 3321 (NH2), 1680 (C=O), 
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1486, 1477, 1449, 1226, 1154; Analysis (%) calculated for C19H10F4N2O (358): C, 63.68; 
H, 2.79; N, 7.82. Found C, 63.22; H, 2.72; N, 7.87.  
 
3.2.28. Reaction of 3-(pentafluorophenyl)propionamide with carbazole 
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A solution of carbazole (0.167 g, 0.1 mmol) in THF (2mL) was added dropwise to a 
stirred suspension of NaH (60 % dispersion in mineral oil) (0.008 g, 0.2 mmol) in THF (1 
mL) under N2 and left to stir at RT for 1 h. A solution of                                                     
3-(pentafluorophenyl)propionamide (0.025 g, 0.1 mmol) in THF (2 mL) was added 
dropwise to the reaction mixture and stirred at RT for 24 h. The solvent was evaporated 
and then water (20 mL) was added to the residue. Orange crystals formed, and were 
filtered to give 114 (0.023 g, 63 %). m.p. 205-207 °C; δH (400 MHz, CDCl3) 8.01 (2H, 
dd, J 7.6 and 0.8 Hz), 7.38-7.32 (m), 7.20-7.15 (m), 5.29-5.27 (1H, bs, NH), 2.98 (2H, t, J 
8.0 Hz), 2.45 (2H, t, J 8.0 Hz) (integral values for the aromatic signals could not be 
determined accurately); δF (376 MHz, CDCl3) 18.73-18.69 (1F, m), 5.36 (1F, t, J 21 Hz), 
-0.11 to -0.25 (1F, m); HRMS (ESI) m/z found 365.0912 (M−H)
-
, C21H12F3N2O requires 
365.0907; vmax /cm-1(film) 3418 (N-H), 1649 (C=O), 1501, 1450, 1335.  
 
3.2.29. Reaction of methyl pentafluorobenzoate with carbazole  
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A solution of carbazole (0.668 g, 4 mmol) in THF (8mL) was added dropwise to a stirred 
suspension of NaH (60 % dispersion in mineral oil) (0.369 g, 9 mmol) in THF (4 mL) 
under N2 and left to stir at RT for 1 h. A solution of methyl pentafluorobenzoate (1.808 g, 
8 mmol) in THF (2 mL) was added dropwise to the reaction mixture and stirred at RT for 
24 h. The solvent was evaporated and then water (20 mL) was added to the residue. The 
reaction mixture was extracted with diethyl ether (25 mL × 3) and the combined organic 
layers dried over MgSO4, filtered and evaporated to give a yellow oil. Recrystallization 
from ethanol afforded 116 as white crystals (0.24 g, 16 %). m.p. 148-152 °C; δH (400 
MHz, CDCl3) 8.05 (2H, d, J 8.0 Hz), 7.40 (2H, td, J 7.6 and 1.2 Hz), 7.29 (2H, t, J 7.2 
Hz), 7.08 (2H, d, J 8.0 Hz), 3.99 (3H, s); δF (376 MHz, CDCl3) 24.46-24.37 (2F, m), 
21.17-21.08 (2F, m); GC-MS (EI) m/z 373; vmax /cm-1 (film) 1736 (C=O), 1296 (C-O), 
1211, 1157, 1033. 
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A solution of carbazole (0.668 g, 4 mmol) in THF (8mL) was added dropwise to a stirred 
suspension of NaH (60 % dispersion in mineral oil) (0.72 g, 18 mmol) in THF (4 mL) 
under N2 and left to stir at RT for 1 h. A solution of methyl pentafluorobenzoate (1.808 g, 
8 mmol) in THF (2 mL) was added dropwise to the reaction mixture under reflux at 66 °C 
for 24 h. The solvent was evaporated and then water (20 mL) was added to the residue. 
The reaction mixture was extracted with diethyl ether (25 mL × 3) and the combined 
organic layers dried over MgSO4, filtered and evaporated to give a yellow oil. White 
crystals of 117 were afforded after recrystallization from hot ethanol (0.155 g, 15 %). m.p. 
179-181 °C; δH (400 MHz, CDCl3) 8.06 (4H, t, J 8.0 Hz), 7.45-7.39 (4H, m), 7.31-7.22 
(4H, m), 7.18 (4H, d, J 8.0 Hz), 3.26 (3H, s); δF (376 MHz, CDCl3) 40.64 (1F, d, J 13 
Hz), 29.01 (1F, d, J 22 Hz), 24.57 (1F, dd, J 22 and 13 Hz); HRMS (ESI) m/z found 
520.1387, C32H19F3N2O2 requires 520.1393; vmax /cm-1 (film) 1739 (C=O), 1621, 1475, 
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1444, 1331, 1227; Analysis (%) calculated for C32H19F3N2O2 (520): C, 73.84; H, 3.68; N, 
5.38. Found C, 73.00; H, 3.43; N, 5.27.  
 
3.2.30. Reaction of decafluorobiphenyl with carbazole to synthesise the di-carbazole 
derivative    
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A solution of carbazole (1.336 g, 8 mmol) in THF (5mL) and DMF (1 mL) was added 
dropwise to a stirred suspension of NaH (60 % dispersion in mineral oil) (0.32 g, 8 mmol) 
in THF (3 mL) under N2 and left to stir at RT for 1 h. A solution of decafluorobiphenyl 
(1.336 g, 4 mmol) in THF (2 mL) was added dropwise to the reaction mixture and stirred 
at RT for 24 h. The solvent was evaporated and then water (20 mL) was added to the 
residue, white crystals of 119 formed, and were filtered and washed with ethanol (1.913 g, 
76 %). m.p. 296-298 °C; δH (400 MHz, CDCl3) 8.18 (4H, d, J 7.6 Hz), 7.52 (4H, t, J 8.0 
Hz), 7.39 (4H, t, J 7.6 Hz), 7.29 (4H, d, J 8.4 Hz); δF (376 MHz, CDCl3) 25.69 (4F, s), 
20.90 (4F, s); GC-MS and HRMS could not observed the expected mass of the 
compound; vmax /cm-1 (film) 1625, 1507, 1474, 1257, 1225; Analysis (%) calculated for 
C36H16F8N2 (628): C, 68.78; H, 2.54; N, 4.45. Found C, 68.06; H, 2.43; N, 4.33.  
 
3.2.31. Reaction of decafluorobiphenyl with carbazole to synthesise mono-carbazole 
derivative 
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A solution of decafluorobiphenyl (2.672 g, 8 mmol) in THF (3mL) was added dropwise to 
a stirred suspension of NaH (60 % dispersion in mineral oil) (0.64 g, 16 mmol) in THF (2 
mL) under N2. A solution of carbazole (1.336 g, 8 mmol) in THF (4 mL) and DMF (1 
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mL) was added dropwise to the reaction mixture and left to stir at RT for 24 h. The 
solvent was evaporated and then water (20 mL) was added to the residue. White crystals 
formed, and were filtered (4.426 g). Column chromatography purification using light 
petrol as eluting solvent gave firstly di-carbazole compound 119 (22 %, data identical to 
the previous), secondly white crystals of 120 (1.114 g, 29 %). m.p. 258-260 °C; δH (400 
MHz, CDCl3) 8.19 (2H, d, J 7.6 Hz), 7.53 (2H, td, J 7.2 and 1.2 Hz), 7.41 (2H, td, J 7.6 
and 1.2 Hz), 7.27 (2H, d, J 8.0 Hz); δF (376 MHz, CDCl3) 25.36-25.27 (m), 25.05-24.61 
(m), 20.81-20.73 (m), 12.55 (1F, t, J 23 Hz), 1.94-1.83 (m) (integral values could not be 
determined accurately); GC-MS and HRMS could not observe the expected mass of the 
compound; vmax / cm-1(film) 1511, 1475, 1332, 1267, 1113, 1066; Analysis (%) calculated 
for C24H8F9N (481): C, 59.89; H, 1.68; N, 2.91. Found C, 59.77; H, 1.61; N, 2.98. 
 
 
 
 
121 
 
Further elution of the column using 9:1 light petrol:diethyl ether as eluting solvent 
afforded compound 121 as yellow crystals (0.173 g, 7 %). m.p. 218-221 °C; δH (400 
MHz, DMSO-d6) 9.0-8.6 (1H, bs, OH); δF (376 MHz, DMSO-d6) 22.37-22.17 (2F, m), 
13.61-13.58 (2F, m), 6.87 (1F, t, J 22 Hz), -0.69 to -0.90 (2F, m), -6.48 to -6.84 (2F, m); 
HRMS (ESI) m/z found 330.9813 (M−H)
-
, C12F9O requires 330.9811; vmax /cm-1(film) 
3000-2450 (O-H), 1638, 1486, 1468, 1088.  
 
3.2.32. Reaction of pentafluorobenzaldehyde with 2,2-(ethylenedioxy)bis(ethylamine) 
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A solution of pentafluorobenzaldehyde (7.84 g, 40 mmol) in DCM (5 mL) was added 
dropwise to a solution of 2,2-(ethylenedioxy)bis(ethylamine) (2.96 g, 20 mmol) in DCM 
(5 mL) containing MgSO4 (1 g) under N2 and left to stir at RT for 5 h. MgSO4 was filtered 
off and washed with DCM and the organic solvent evaporated to afford a yellow oil. A 
solution of sodium borohydride  (1.512 g, 40 mmol) in H2O (5 mL) and ethanol (10 mL) 
was added dropwise to the oil and the mixture left to stir at RT for 1 h. The ethanol was 
evaporated and the residue aqueous mixture was extracted with DCM (25 mL × 3) and the 
combined organic layers dried over MgSO4, filtered and evaporated to give 127 as a 
yellow oil (7.799 g, 77 %). δH (400 MHz, CDCl3) 3.89 (4H, s), 3.62-3.50 (8H, m), 2.73 
(4H, t, J 5.2 Hz); δF (376 MHz, CDCl3) 17.68-17.52 (4F, m), 5.80 (2F, t, J 20 Hz), -0.52 
to -0.73 (4F, m), with very minor impurity; HRMS (ESI) m/z found 509.1272 (M+H)
+
, 
C20H19F10N2O2 requires 509.1281; vmax /cm-1 (film) 3329 (N-H), 2895, 1463, 1301; 
Analysis (%) calculated for C20H19F10N2O2 (508): C, 47.25; H, 3.57; N, 5.51. Found C, 
47.21; H, 3.77; N, 6.08. 
 
3.2.33. Reaction of carbazole with bis-intercalator scaffold (127)  
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A solution of carbazole (0.334 g, 2 mmol) in THF (5mL) was added dropwise to a stirred 
suspension of NaH (60 % dispersion in mineral oil) (0.12 g, 3 mmol) in THF (2 mL) 
under N2 and left to stir at RT for 1 h. A solution of compound 127 (0.508 g, 1 mmol) in 
THF (2 mL) was added dropwise to the reaction mixture and stirred at RT for 24 h. The 
solvent was evaporated and then water (20 mL) was added to the residue. The reaction 
mixture was extracted with DCM (25 mL × 3) and the combined organic layers dried over 
MgSO4, filtered and evaporated to give 130 as a sticky yellow oil (0.776 g). Column 
chromatography purification using light petrol as eluting solvent afforded yellow crystals 
(0.018 g). m.p. 238-241 °C; HRMS (ESI) m/z found 803.2627 (M+H)
+
, C44H35F8N4O2 
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requires 803.2627; 1H and 19F NMR data were not fully consistent with the expected 
structure and further investigation is still required to characterize the product.   
 
3.2.34. Reaction of mono carbazole derivative (103) with amine chain (125) 
 
133 
 
A solution of carbazole derivative 103 (0.474 g, 1.5 mmol) in THF (5mL) and DMF        
(1 mL) was added dropwise under N2 to a solution of amine chain 125 (0.111 g, 0.7 
mmol) and Et3N (0.227 g, 2.2 mmol) in THF (2 mL) under reflux at 66 °C for 24 h. The 
solvent was evaporated and then water (20 mL) was added to the residue, creamy crystals 
were afforded (1.45 g). Column chromatography purification using 1:1 light petrol:diethyl 
ether as eluting solvent gave 133 as white crystals (0.332 g, 64 %). m.p. 66-73 °C; δH 
(400 MHz, CDCl3) 8.13 (4H, d, J 7.6 Hz), 7.45 (4H, td, J 7.2 and 1.2 Hz), 7.35 (4H, td, J 
7.6 and 0.8 Hz), 7.20 (4H, d, J 8.0 Hz), 5.22-5.13 (2H, bs, NH), 3.79-3.72 (8H, m), 3.75 
(4H, s); δF (376 MHz, CDCl3) 70.95-70.78 (m), 15.36-15.24 (m), 1.71-1.63 (m) 
(integration values would not be determined accurately); HRMS (ESI) m/z found 
741.2407 (M+H)
+
, C40H31F6N6O2 requires 741.2407; vmax / cm-1(film) 3407 (N-H), 1509, 
1249; elemental analysis was close to the calculated values although the value for the 
percentage of carbon was high, Analysis (%) calculated for C40H30F6N6O2 (740): C, 
64.86; H, 4.08; N, 11.35. Found C, 67.52; H, 3.73; N, 11.97. 
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3.2.35. Reaction of biphenyl carbazole derivative (120) with amine chain (125)   
  
 
135 
 
A solution of carbazole derivative 120 (0.481 g, 1 mmol) in dioxane (4 mL) was added 
dropwise under N2 to a solution of amine chain 125 (0.074 g, 0.5 mmol) and Et3N (0.151 
g, 1.5 mmol) in dioxane (2 mL) under reflux at 101 °C for 24 h. The solvent was 
evaporated and then water (20 mL) was added to the residue, creamy crystals were 
afforded and recrystallized from hot ethanol to give 135 (0.500 g, 93 %). m.p. 106-111 
°C; δH (400 MHz, CDCl3) 8.18 (4H, d, J 7.6 Hz), 7.49 (4H, td, J 7.2 and 1.2 Hz), 7.38 
(4H, td, J 8.0 and 0.8 Hz), 7.26 (4H, d, J 8.0 Hz), 4.73-4.65 (2H, bs, NH), 3.80-3.72 (8H, 
m), 3.76 (4H, s); δF (376 MHz, CDCl3) 24.86-24.82 (4F, m), 21.13-21.09 (4F, m), 19.42-
19.37 (4F, m), 2.06-1.91 (4F, m); The 1H NMR and 19F NMR spectra showed the 
presence of a minor by-product possibly the mono-arylated amine; HRMS (ESI) m/z 
found 1069.2052 (M−H)
-
, C54H29F16N4O2 requires 1069.2041; vmax / cm-1(film) 3428    
(N-H), 1511, 1476, 1227, 1130; Analysis (%) calculated for C54H30F16N4O2 (1070): C, 
60.57; H, 2.82; N, 5.23. Found C, 59.10; H, 2.56; N, 4.66. 
 
3.2.36. Reaction of bis-carbazole derivative with ethoxide 
  
                             140                                141                              142 
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A solution of ethanol (0.092 g, 2 mmol) in THF (2mL) was added dropwise to a stirred 
suspension of NaH (60 % dispersion in mineral oil) (0.08 g, 2 mmol) in THF (2 mL) 
under N2 and left to stir at RT for 1 h. A solution of carbazole derivative 100 (0.48 g, 1 
mmol) in THF (5 mL) and DMF (1 mL) was added dropwise to the reaction mixture and 
stirred under reflux at 66 °C for 24 h. The solvent was evaporated and then water (20 mL) 
was added to the residue. The reaction mixture was extracted with diethyl ether (25 mL × 
3) and the combined organic layers dried over MgSO4, filtered and evaporated to give 
sticky creamy crystals. Recrystallization from ethanol afforded white crystals of a mixture 
of compounds 140, 141 and 142 in ratio 8.3:1.25:1 with 140 being the major component 
(0.221 g). δH (400 MHz, CDCl3) 8.12 (d, J 7.6 Hz), 7.49-7.42 (m), 7.36-7.28 (m), 7.25 (d, 
J 8.4 Hz), 3.69-3.65 (m), 0.77 (t, J 7.2 Hz), small multiplets were observed at 7.7 and 7.04 
which could be due to the minor components 141 and 142 (integral values could not 
determined accurately). 
Compound 140, δF (376 MHz, CDCl3) 26.59 (1F, d, J 10 Hz), 19.34 (1F, dd, J 23 and 10 
Hz), 18.64 (1F, d, J 23 Hz); GC-MS (EI) m/z 506.  
Compounds 141 and 142, δF (376 MHz, CDCl3) 25.24 (2F, s), 25.08 (2F, s); GC-MS (EI) 
m/z 532 and a signal at 21.0 suggested some starting 100 was present (m/z 480). 
 
3.2.37. Reaction of isoquinoline with ethyl bromoacetate94  
 
 
150 
 
A solution of isoquinoline (0.97 g, 7.5 mmol) in ethyl acetate (2 mL) was added dropwise 
under N2 to a solution of ethyl bromoacetate (0.835 g, 5 mmol) in ethyl acetate (2 mL) 
under reflux at 77 °C for 24 h. After 24 h refluxing 150 was afforded as yellow crystals 
and filtered (1.076 g, 73 %). m.p. 199-201 °C (lit., 199-201 °C);101 δH (400 MHz, DMSO-
d6) 10.08 (1H, s), 8.78 (1H, dd, J 6.8 and 1.2 Hz), 8.68 (1H, d, J 6.8 Hz), 8.56 (1H, d, J 
8.0 Hz), 8.42 (1H, d, J 8.0 Hz), 8.34 (1H, td, J 6.8 and 0.8 Hz), 8.13 (1H, td, J 8.0 and 0.8 
Hz), 5.81 (2H, s), 4.28 (2H, q, J 7.2 Hz), 1.28 (3H, t, J 7.2 Hz); δC (100 MHz, DMSO-d6) 
165.60 (C=O), 150.81 (CH), 136.78 (CH), 136.33 (Cq), 135.22 (CH), 130.57 (CH), 
129.74 (CH), 126.46 (CH), 125.77 (Cq), 124.53 (CH), 61.42 (CH2), 59.25 (CH2), 13.01 
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(CH3). HRMS (ESI) m/z found 216.1015, C13H14NO2 requires 216.1019; vmax / cm-1 (film) 
2918, 1740 (C=O), 1470, 1225. Data in agreement with literature values.  
3.3. Biological activity studies 
3.3.1. DNA thermal denaturation assay 
Trisma base buffer 2.5×10-3 M with pH 7.55 was prepared by dissolving 2-amino-          
2-(hydroxymethyl)-1,3-propanediol (0.30 g) in water (500 mL). 
The stock solution of ACTD (1 mg/mL) was prepared by dissolving ACTD (5 mg) in 
DMSO (5 mL). The working solution of ACTD was prepared by dissolving ACTD stock 
solution (400 µL) in trisma base buffer (4 mL).  
Ethylenediaminetetraacetic acid (EDTA) 10-2 M was prepared by dissolving solid EDTA 
(0.15 g) in distilled water (40 mL). EDTA solution 1.5×10-3 M was prepared by 
dissolving EDTA 10-2 M (1.5 mL) in distilled water (8.5 mL).  
With the purpose of preparation 450 µg/mL DNA concentration of double strand calf 
thymus DNA a solution of DNA (0.01 g) in trisma base buffer (22.22 mL) was prepared 
and mixed thoroughly to allow DNA to dissolve in the solution. The solution transferred 
into small Eppendorf tubes and each tube contained (0.5 mL) and stored at -80 °C.    
The stock solutions of the synthesised fluorinated compounds at a concentration of 10-2 M 
were prepared in DMSO. 
The samples prepared according to table 3 were sealed in 3000 µL quartz cells and 
monitored at 260 nm on a UV- visible spectrophotometer. The thermal denaturation was 
followed between 50 °C and 90 °C.  
 
Table 3. Preparation of DNA-compound complex samples for UV absorption to investigate 
Tm values 
DNA without the synthesised fluorinated 
compound 
DNA with the synthesised fluorinated 
compound 
DMSO 70 µL 
 
DMSO 70 µL 
EDTA 100 µL 
 
EDTA 100 µL 
 
DNA 100 µL 
 
DNA 100 µL 
 
Buffer 2.7 mL Buffer 2.7 mL 
 
DMSO 30 µL 
 
Fluorinated compound 30 µL 
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3.3.2. UV-visible absorption spectroscopy   
Salmon sperm DNA (SS-DNA) (15 mg) was dissolved in distilled water (20 mL) pH 7.0 
and stirred overnight and kept at 4 °C. Trisma base buffer 2.5×10-3 M with pH 7.55 was 
prepared by dissolving (0.30 g) in water (500 mL). A solution of SS-DNA in the buffer 
gave a ratio of UV absorbance at 260 and 280 nm (A260 / A280) of 1.9, indicating that the 
DNA was sufficiently free of protein. The DNA concentration was determined via 
absorption spectroscopy using the molar absorption coefficient of 6600 M-1cm-1 (260 nm) 
for SS-DNA102 and was found to be 1.5×10-4 M. The compounds were dissolved in 
DMSO at a concentration of 10-2 M and the UV absorption titration were performed by 
keeping the concentration of the test compound fixed while varying the SS-DNA 
concentration. Compound-DNA solutions were allowed to incubate for 30 min at room 
temperature before measurements were made. Absorption spectra were recorded using 
cuvettes of 1 cm path length at room temperature (25± 1°C).  
    
3.3.3. Fluorescence spectroscopy 
EB solution (0.3 mL) at a concentration of 1×10-6 in trisma base buffer was added to SS-
DNA (0.3 mL) solution and then aliquots of each test compound solution (30, 60, 120, 
180, 240, 300 µL of 10-6 M) was titrated into DNA/EB mixture. Each mixture was diluted 
up to 3 mL with trisma buffer, making the solution with varied concentrations of             
(1×10-6, 2×10-6, 4×10-6, 6×10-6, 8×10-6 and 1×10-5 M) each compound to SS-DNA. The 
mixtures was shaken and incubated at room temperature for 30 min. The fluorescence 
spectra of EB bound to SS-DNA were measured at an emission wavelength of 605 nm 
with excitation at 480 nm. 
 
3.3.4. Hanging drop DNA crystallization method 
Commercial cacodylate buffer, pH 6.5 was used; 50 mM isopropanol 15 % was used to 
prepare a stock buffer solution containing MgCl2 (10 mM) by adding MgCl2 (9 mg) to 
cacodylate buffer (10 mL). DNA solution (0.5 mM) was prepared by adding (600 µL) of 
buffer stock solution to the synthetic oligonucleotide CGCGAATTCGCG vial, which 
contained 314 nmol. 
The synthesised fluorinated organic compounds were prepared in concentration (0.01 
mol) in DMSO. 
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In hanging drop DNA crystallization method a 24-well multiwell plate, with low 
evaporation lid, were used. In order to set some drops on the lid of the plate for 
crystallization, DNA solution (20 µL) was added to the compound solution (2 µL). 
Dehydrating brine solution was placed in the wells under the drops; the plates left at RT 
or in the refrigerator until the drops dried or some crystals appeared and become ready for 
X-ray analysis. 
 
3.3.5. Antimicrobial activity studies The synthesised compounds at 10-2 M concentration were tested against two bacterial 
strains Gram-positive strain (Escherichia coli) and Gram-negative strain (Staphylococcus 
aureus) The disk diffusion method was used for the determination of antibacterial 
activity. The bacteria (100 µL) were added to Muller-Hinton agar media (25 mL), mixed 
well and poured into 90×14 mm petri plate (diameter and height respectively) and the 
media was allowed to solidify. Sterilized disks (6 mm in diameter) were saturated with the 
compound solution and placed gently on the inoculated agar plates. Each plate contained 
a blank disk, which was saturated with DMSO, the compound-containing disk and a 
control disk containing the known antibiotic ACTD. The petri plates were incubated at 37 
°C for 48 h.       
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5. Appendix 
5.1. X-ray crystallography data 
5.1.1. Compound 57 X-ray crystal structure data   
 
 
Table 1.  Crystal data and structure refinement for gwals1. 
 
Identification code  gwals1 
Chemical formula  C24H18N8O 
Formula weight  434.46 
Temperature  150(2) K 
Radiation, wavelength  synchrotron, 0.7749 Å 
Crystal system, space group  orthorhombic, Pbca 
Unit cell parameters a = 7.3663(10) Å 〈 = 90° 
 b = 19.902(3) Å  = 90° 
 c = 27.418(4) Å  = 90° 
Cell volume 4019.6(10) Å3 
Z 8 
Calculated density  1.436 g/cm3 
Absorption coefficient  0.113 mm1 
F(000) 1808 
Crystal colour and size colourless, 0.25  0.02  0.02 mm3 
Reflections for cell refinement 5536 ( range 3.24 to 29.88°) 
Data collection method Bruker APEX 2 CCD diffractometer 
  rotation with narrow frames 
 range for data collection 3.24 to 30.23° 
Index ranges h 9 to 9, k 25 to 25, l 35 to 35 
Completeness to  = 30.23° 99.4 %  
Intensity decay 0% 
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Reflections collected 45021 
Independent reflections 4596 (Rint = 0.0975) 
Reflections with F2>2⌠ 3471 
Absorption correction semi-empirical from equivalents 
Min. and max. transmission 0.972 and 0.998 
Structure solution direct methods 
Refinement method Full-matrix least-squares on F2 
Weighting parameters a, b 0.0334, 1.1084 
Data / restraints / parameters 4596 / 0 / 370 
Final R indices [F2>2⌠] R1 = 0.0472, wR2 = 0.1191 
R indices (all data) R1 = 0.0649, wR2 = 0.1321 
Goodness-of-fit on F2 1.031 
Largest and mean shift/su 0.001 and 0.000 
Largest diff. peak and hole 0.263 and 0.195 e Å3 
 
 
Table 2.  Atomic coordinates and equivalent isotropic displacement parameters (Å2) 
for gwals1.  Ueq is defined as one third of the trace of the orthogonalized Uij tensor. 
 
      x      y      z      Ueq 
 
N(1) 0.73160(17) 0.43676(6) 0.74713(4) 0.0246(3) 
C(1) 0.69099(19) 0.40316(7) 0.70633(5) 0.0231(3) 
N(2) 0.62401(16) 0.34107(6) 0.70407(4) 0.0246(3) 
C(2) 0.59711(19) 0.31225(7) 0.74751(5) 0.0227(3) 
N(3) 0.62790(16) 0.34141(6) 0.79061(4) 0.0249(3) 
C(3) 0.69554(19) 0.40361(7) 0.78827(5) 0.0231(3) 
C(4) 0.72419(19) 0.43943(7) 0.65933(5) 0.0240(3) 
C(5) 0.8081(2) 0.50186(7) 0.65956(5) 0.0268(3) 
C(6) 0.8361(2) 0.53435(7) 0.61555(6) 0.0306(3) 
C(7) 0.7807(2) 0.50312(7) 0.57323(6) 0.0317(3) 
C(8) 0.6974(2) 0.44093(8) 0.57647(6) 0.0321(3) 
N(4) 0.66935(17) 0.40856(6) 0.61850(4) 0.0279(3) 
C(9) 0.72763(19) 0.43743(7) 0.83602(5) 0.0243(3) 
C(10) 0.6975(2) 0.40240(7) 0.87889(5) 0.0292(3) 
C(11) 0.7191(2) 0.43546(8) 0.92276(6) 0.0346(4) 
C(12) 0.7693(2) 0.50211(8) 0.92246(6) 0.0330(3) 
C(13) 0.8010(2) 0.53256(8) 0.87787(6) 0.0316(3) 
N(5) 0.78175(17) 0.50183(6) 0.83484(4) 0.0287(3) 
C(14) 0.52692(19) 0.24224(7) 0.74889(5) 0.0234(3) 
C(15) 0.5004(2) 0.20940(8) 0.79265(5) 0.0318(3) 
C(16) 0.4361(2) 0.14401(8) 0.79186(6) 0.0340(4) 
C(17) 0.4006(2) 0.11371(7) 0.74802(5) 0.0285(3) 
C(18) 0.4300(2) 0.15048(7) 0.70596(5) 0.0302(3) 
N(6) 0.49213(18) 0.21340(6) 0.70581(4) 0.0270(3) 
N(7) 0.4801(2) 0.26725(7) 0.60734(5) 0.0352(3) 
C(19) 0.4457(2) 0.22246(7) 0.57309(6) 0.0297(3) 
O(1) 0.41757(17) 0.16238(5) 0.58066(4) 0.0401(3) 
C(20) 0.4403(2) 0.24883(7) 0.52151(5) 0.0279(3) 
C(21) 0.4153(2) 0.20453(8) 0.48329(6) 0.0345(4) 
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C(22) 0.4048(2) 0.22959(9) 0.43644(6) 0.0400(4) 
C(23) 0.4205(3) 0.29753(9) 0.42961(6) 0.0411(4) 
C(24) 0.4487(3) 0.33805(8) 0.46970(6) 0.0378(4) 
N(8) 0.45801(19) 0.31518(6) 0.51525(5) 0.0327(3) 
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Table 3.   Bond lengths [Å] and angles [°] for gwals1. 
 
N(1)–C(3)  1.3336(17) N(1)–C(1)  1.3373(17) 
C(1)–N(2)  1.3320(17) C(1)–C(4)  1.4970(19) 
N(2)–C(2)  1.3365(17) C(2)–N(3)  1.3359(17) 
C(2)–C(14)  1.4867(19) N(3)–C(3)  1.3360(17) 
C(3)–C(9)  1.4911(19) C(4)–N(4)  1.3394(18) 
C(4)–C(5)  1.3878(19) C(5)–C(6)  1.385(2) 
C(6)–C(7)  1.378(2) C(7)–C(8)  1.384(2) 
C(8)–N(4)  1.3362(19) C(9)–N(5)  1.3425(17) 
C(9)–C(10)  1.384(2) C(10)–C(11)  1.380(2) 
C(11)–C(12)  1.377(2) C(12)–C(13)  1.384(2) 
C(13)–N(5)  1.3366(19) C(14)–N(6)  1.3380(18) 
C(14)–C(15)  1.380(2) C(15)–C(16)  1.385(2) 
C(16)–C(17)  1.370(2) C(17)–C(18)  1.383(2) 
C(18)–N(6)  1.3333(18) N(7)–C(19)  1.319(2) 
C(19)–O(1)  1.2313(17) C(19)–C(20)  1.509(2) 
C(20)–N(8)  1.3380(19) C(20)–C(21)  1.382(2) 
C(21)–C(22)  1.380(2) C(22)–C(23)  1.370(2) 
C(23)–C(24)  1.379(2) C(24)–N(8)  1.331(2) 
 
C(3)–N(1)–C(1) 114.56(12) N(2)–C(1)–N(1) 125.85(12) 
N(2)–C(1)–C(4) 117.90(12) N(1)–C(1)–C(4) 116.25(12) 
C(1)–N(2)–C(2) 114.31(12) N(3)–C(2)–N(2) 125.22(13) 
N(3)–C(2)–C(14) 116.34(12) N(2)–C(2)–C(14) 118.45(12) 
C(2)–N(3)–C(3) 115.04(12) N(1)–C(3)–N(3) 124.99(12) 
N(1)–C(3)–C(9) 119.20(12) N(3)–C(3)–C(9) 115.80(12) 
N(4)–C(4)–C(5) 123.29(13) N(4)–C(4)–C(1) 116.68(12) 
C(5)–C(4)–C(1) 120.03(12) C(6)–C(5)–C(4) 118.72(14) 
C(7)–C(6)–C(5) 118.62(14) C(6)–C(7)–C(8) 118.72(14) 
N(4)–C(8)–C(7) 123.70(14) C(8)–N(4)–C(4) 116.94(13) 
N(5)–C(9)–C(10) 123.29(13) N(5)–C(9)–C(3) 117.18(12) 
C(10)–C(9)–C(3) 119.52(12) C(11)–C(10)–C(9) 118.77(14) 
C(12)–C(11)–C(10) 119.01(14) C(11)–C(12)–C(13) 118.18(14) 
N(5)–C(13)–C(12) 124.15(14) C(13)–N(5)–C(9) 116.55(13) 
N(6)–C(14)–C(15) 122.49(13) N(6)–C(14)–C(2) 116.50(12) 
C(15)–C(14)–C(2) 121.01(12) C(14)–C(15)–C(16) 118.67(14) 
C(17)–C(16)–C(15) 119.50(14) C(16)–C(17)–C(18) 117.96(14) 
N(6)–C(18)–C(17) 123.60(13) C(18)–N(6)–C(14) 117.77(12) 
O(1)–C(19)–N(7) 124.65(15) O(1)–C(19)–C(20) 119.42(13) 
N(7)–C(19)–C(20) 115.93(13) N(8)–C(20)–C(21) 123.04(14) 
N(8)–C(20)–C(19) 117.44(12) C(21)–C(20)–C(19) 119.51(13) 
C(22)–C(21)–C(20) 118.87(15) C(23)–C(22)–C(21) 118.63(15) 
C(22)–C(23)–C(24) 118.75(15) N(8)–C(24)–C(23) 123.76(15) 
C(24)–N(8)–C(20) 116.93(13)  
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Table 4.   Hydrogen coordinates and isotropic displacement parameters (Å2) for gwals1. 
 
      x       y       z       U 
 
H(5) 0.846(2) 0.5207(9) 0.6896(7) 0.042(5) 
H(6) 0.894(2) 0.5763(8) 0.6148(6) 0.030(4) 
H(7) 0.796(2) 0.5244(9) 0.5416(7) 0.039(5) 
H(8) 0.656(2) 0.4174(8) 0.5479(7) 0.038(5) 
H(10) 0.665(2) 0.3558(9) 0.8774(6) 0.042(5) 
H(11) 0.695(3) 0.4112(9) 0.9530(7) 0.049(5) 
H(12) 0.783(3) 0.5274(9) 0.9525(7) 0.046(5) 
H(13) 0.836(2) 0.5795(8) 0.8767(6) 0.030(4) 
H(15) 0.524(3) 0.2317(9) 0.8228(8) 0.046(5) 
H(16) 0.420(3) 0.1201(9) 0.8223(7) 0.046(5) 
H(17) 0.356(2) 0.0690(9) 0.7458(5) 0.033(5) 
H(18) 0.404(2) 0.1316(9) 0.6742(7) 0.036(5) 
H(7B) 0.509(3) 0.3081(11) 0.5996(7) 0.047(5) 
H(7A) 0.490(3) 0.2547(10) 0.6395(8) 0.047(5) 
H(21) 0.410(2) 0.1584(9) 0.4911(6) 0.033(4) 
H(22) 0.383(3) 0.1997(10) 0.4099(7) 0.048(5) 
H(23) 0.406(3) 0.3178(10) 0.3970(8) 0.051(5) 
H(24) 0.456(2) 0.3868(9) 0.4656(6) 0.040(5) 
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Table 5.  Torsion angles [°] for gwals1. 
 
C(3)–N(1)–C(1)–N(2)  1.6(2) C(3)–N(1)–C(1)–C(4) 178.22(11) 
N(1)–C(1)–N(2)–C(2) 0.2(2) C(4)–C(1)–N(2)–C(2)  179.59(12) 
C(1)–N(2)–C(2)–N(3) 1.7(2) C(1)–N(2)–C(2)–C(14)  178.51(12) 
N(2)–C(2)–N(3)–C(3)  1.9(2) C(14)–C(2)–N(3)–C(3) 178.26(12) 
C(1)–N(1)–C(3)–N(3) 1.3(2) C(1)–N(1)–C(3)–C(9)  177.28(12) 
C(2)–N(3)–C(3)–N(1) 0.3(2) C(2)–N(3)–C(3)–C(9) 178.92(12) 
N(2)–C(1)–C(4)–N(4) 5.47(19) N(1)–C(1)–C(4)–N(4)  174.37(12) 
N(2)–C(1)–C(4)–C(5)  174.51(13) N(1)–C(1)–C(4)–C(5) 5.7(2) 
N(4)–C(4)–C(5)–C(6) 0.4(2) C(1)–C(4)–C(5)–C(6)  179.66(13) 
C(4)–C(5)–C(6)–C(7)  0.5(2) C(5)–C(6)–C(7)–C(8) 0.7(2) 
C(6)–C(7)–C(8)–N(4)  1.0(2) C(7)–C(8)–N(4)–C(4) 0.8(2) 
C(5)–C(4)–N(4)–C(8)  0.5(2) C(1)–C(4)–N(4)–C(8) 179.49(13) 
N(1)–C(3)–C(9)–N(5) 3.9(2) N(3)–C(3)–C(9)–N(5)  174.82(12) 
N(1)–C(3)–C(9)–C(10)  177.38(13) N(3)–C(3)–C(9)–C(10) 3.9(2) 
N(5)–C(9)–C(10)–C(11) 1.9(2) C(3)–C(9)–C(10)–C(11)  176.77(14) 
C(9)–C(10)–C(11)–C(12) 0.1(2) C(10)–C(11)–C(12)–C(13)  1.8(2) 
C(11)–C(12)–C(13)–N(5) 1.7(3) C(12)–C(13)–N(5)–C(9) 0.2(2) 
C(10)–C(9)–N(5)–C(13)  2.0(2) C(3)–C(9)–N(5)–C(13) 176.69(13) 
N(3)–C(2)–C(14)–N(6) 178.58(12) N(2)–C(2)–C(14)–N(6)  1.3(2) 
N(3)–C(2)–C(14)–C(15)  1.6(2) N(2)–C(2)–C(14)–C(15) 178.51(14) 
N(6)–C(14)–C(15)–C(16) 0.3(3) C(2)–C(14)–C(15)–C(16)  179.51(14) 
C(14)–C(15)–C(16)–C(17) 0.0(3) C(15)–C(16)–C(17)–C(18)  0.4(3) 
C(16)–C(17)–C(18)–N(6) 0.5(3) C(17)–C(18)–N(6)–C(14)  0.3(2) 
C(15)–C(14)–N(6)–C(18)  0.1(2) C(2)–C(14)–N(6)–C(18) 179.64(13) 
O(1)–C(19)–C(20)–N(8) 175.10(15) N(7)–C(19)–C(20)–N(8)  4.5(2) 
O(1)–C(19)–C(20)–C(21)  4.1(2) N(7)–C(19)–C(20)–C(21) 176.36(15) 
N(8)–C(20)–C(21)–C(22)  1.2(3) C(19)–C(20)–C(21)–C(22) 177.96(15) 
C(20)–C(21)–C(22)–C(23) 0.3(3) C(21)–C(22)–C(23)–C(24) 0.9(3) 
C(22)–C(23)–C(24)–N(8)  1.4(3) C(23)–C(24)–N(8)–C(20) 0.6(3) 
C(21)–C(20)–N(8)–C(24) 0.7(2) C(19)–C(20)–N(8)–C(24)  178.43(14) 
 
 
 
 
Table 6.  Hydrogen bonds for gwals1 [Å and °]. 
 
D–H...A d(D–H) d(H...A) d(D...A) <(DHA) 
 
N(7)–H(7B)...N(4) 0.87(2) 2.38(2) 3.1538(18) 148.9(17) 
N(7)–H(7A)...N(6) 0.92(2) 2.00(2) 2.9060(18) 170.4(18) 
N(7)–H(7A)...N(2) 0.92(2) 2.66(2) 3.2119(18) 119.6(15) 
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5.1.2. Compound 71 X-ray crystal structure data 
 
GW105  (M.M. 194.5) 
Crystal data 
C17H4F8N4S Z = 4 
Mr = 448.30 F(000) = 888 
Triclinic, P¯1 Dx = 1.820 Mg m-3 
a = 9.4800 (9) Å Mo K〈 radiation,  = 0.71073 Å 
b = 11.4612 (11) Å Cell parameters from 10303 reflections 
c = 15.7757 (15) Å  = 2.5–30.4° 
〈 = 75.3725 (14)°  = 0.30 mm-1 
 = 89.9135 (15)° T = 150 K 
 = 80.8998 (15)° Block, colourless 
V = 1636.3 (3)  Å3 0.54 × 0.43 × 0.18 mm 
 
Data collection 
Bruker APEX 2 CCD diffractometer 8270 reflections with I > 2⌠(I) 
Radiation source: fine-focus sealed tube Rint = 0.022 
 rotation with narrow frames scans max = 30.6°, min = 1.9° 
Absorption correction: multi-scan  SADABS v20  
Sheldrick, G.M., (2012) 
h = -13 13 
Tmin = 0.855, Tmax = 0.948 k = -16 16 
26360 measured reflections l = -22 22 
9927 independent reflections  
 
Refinement 
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Refinement on F2 Primary atom site location: structure-invariant di  
methods 
Least-squares matrix: full Hydrogen site location: difference Fourier map 
R[F2 > 2⌠(F2)] = 0.037 All H-atom parameters refined 
wR(F2) = 0.098 w = 1/[⌠2(Fo2) + (0.0461P)2 + 0.6349P]       
(Fo2 + 2Fc2)/3 
S = 1.04 (⊗/⌠)max < 0.001 
9927 reflections ⊗〉max = 0.46 e Å-3 
573 parameters ⊗〉min = -0.45 e Å-3 
0 restraints  
 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
 x y z Uiso*/Ueq 
S1 0.49585 (3) 0.20478 (3) 0.19065 (2) 0.02209 (7) 
C1 0.59489 (13) 0.08824 (11) 0.27336 (8) 0.0185 (2) 
N1 0.71276 (11) 0.01179 (10) 0.25376 (7) 0.0177 (2) 
N2 0.56785 (12) 0.06308 (10) 0.35642 (7) 0.0210 (2) 
C2 0.67149 (13) -0.03703 (11) 0.39583 (8) 0.0187 (2) 
C3 0.69072 (15) -0.10161 (13) 0.48402 (9) 0.0234 (3) 
H3 0.628 (2) -0.0785 (17) 0.5254 (12) 0.031 (5)* 
C4 0.80493 (16) -0.19653 (13) 0.50617 (9) 0.0254 (3) 
H4 0.8253 (19) -0.2415 (17) 0.5675 (12) 0.029 (4)* 
C5 0.89784 (15) -0.22724 (12) 0.44316 (9) 0.0240 (3) 
H5 0.9789 (19) -0.2934 (16) 0.4632 (11) 0.027 (4)* 
C6 0.87936 (14) -0.16516 (12) 0.35504 (8) 0.0210 (2) 
H6 0.9438 (18) -0.1872 (15) 0.3132 (11) 0.023 (4)* 
C7 0.76373 (13) -0.07041 (11) 0.33344 (8) 0.0174 (2) 
C8 0.75508 (13) 0.00565 (11) 0.16956 (8) 0.0171 (2) 
C9 0.75792 (13) -0.10074 (11) 0.14197 (8) 0.0189 (2) 
C10 0.79736 (15) -0.10091 (12) 0.05775 (9) 0.0226 (2) 
N3 0.83426 (13) -0.00733 (11) 0.00126 (7) 0.0247 (2) 
C11 0.83262 (14) 0.09306 (12) 0.02705 (9) 0.0226 (3) 
C12 0.79386 (13) 0.10525 (11) 0.10904 (8) 0.0192 (2) 
F1 0.71840 (9) -0.19965 (7) 0.19479 (5) 0.02516 (17) 
F2 0.79623 (11) -0.20243 (8) 0.03027 (6) 0.0333 (2) 
F3 0.87317 (10) 0.18791 (8) -0.03013 (6) 0.0317 (2) 
F4 0.79370 (9) 0.21141 (7) 0.12975 (5) 0.02467 (17) 
C13 0.32903 (13) 0.15344 (12) 0.20599 (8) 0.0190 (2) 
C14 0.30636 (14) 0.04332 (12) 0.19119 (8) 0.0217 (2) 
C15 0.17270 (16) 0.01004 (12) 0.20405 (8) 0.0239 (3) 
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N4 0.06311 (13) 0.07775 (12) 0.22776 (7) 0.0258 (2) 
C16 0.08399 (15) 0.18156 (13) 0.24219 (9) 0.0256 (3) 
C17 0.21307 (15) 0.22374 (12) 0.23243 (8) 0.0224 (3) 
F5 0.41278 (10) -0.03037 (8) 0.16632 (6) 0.0327 (2) 
F6 0.15093 (11) -0.09700 (8) 0.19276 (6) 0.0350 (2) 
F7 -0.02718 (10) 0.24836 (9) 0.26849 (6) 0.0382 (2) 
F8 0.22586 (10) 0.32999 (8) 0.24943 (6) 0.0346 (2) 
S2 0.60352 (4) 0.39585 (4) 0.34021 (2) 0.02995 (9) 
C18 0.76539 (13) 0.45377 (12) 0.33019 (8) 0.0191 (2) 
N5 0.80609 (11) 0.51147 (10) 0.24726 (6) 0.01684 (19) 
N6 0.85779 (12) 0.44685 (10) 0.39289 (7) 0.0207 (2) 
C19 0.96931 (13) 0.50245 (11) 0.35095 (8) 0.0172 (2) 
C20 1.09716 (14) 0.51960 (12) 0.38672 (9) 0.0209 (2) 
H20 1.1171 (19) 0.4913 (16) 0.4491 (12) 0.027 (4)* 
C21 1.18910 (14) 0.57926 (12) 0.32937 (9) 0.0230 (3) 
H21 1.278 (2) 0.5933 (17) 0.3502 (12) 0.033 (5)* 
C22 1.15594 (14) 0.62184 (12) 0.23938 (9) 0.0218 (2) 
H22 1.221 (2) 0.6642 (17) 0.2030 (12) 0.033 (5)* 
C23 1.02935 (13) 0.60567 (12) 0.20275 (8) 0.0192 (2) 
H23 1.0071 (18) 0.6336 (16) 0.1414 (11) 0.024 (4)* 
C24 0.93948 (12) 0.54395 (11) 0.26057 (8) 0.0160 (2) 
C25 0.73638 (13) 0.53086 (11) 0.16490 (8) 0.0168 (2) 
C26 0.80634 (14) 0.49208 (12) 0.09673 (8) 0.0203 (2) 
C27 0.73832 (16) 0.52315 (14) 0.01498 (9) 0.0258 (3) 
N7 0.60959 (14) 0.58642 (13) -0.00370 (8) 0.0296 (3) 
C28 0.54228 (15) 0.62085 (14) 0.06052 (9) 0.0260 (3) 
C29 0.59838 (14) 0.59610 (12) 0.14529 (8) 0.0198 (2) 
F9 0.93779 (9) 0.42720 (8) 0.10919 (6) 0.02733 (17) 
F10 0.80572 (11) 0.48686 (11) -0.05041 (6) 0.0409 (2) 
F11 0.41119 (10) 0.68572 (10) 0.04148 (6) 0.0403 (2) 
F12 0.52337 (9) 0.63768 (8) 0.20600 (5) 0.02625 (17) 
C30 0.62995 (16) 0.30251 (13) 0.44782 (8) 0.0250 (3) 
C31 0.53099 (17) 0.32041 (15) 0.51020 (9) 0.0303 (3) 
C32 0.5506 (2) 0.24321 (17) 0.59343 (10) 0.0377 (4) 
N8 0.65730 (19) 0.15347 (14) 0.61787 (8) 0.0418 (4) 
C33 0.7506 (2) 0.13563 (15) 0.55911 (10) 0.0366 (4) 
C34 0.74250 (17) 0.20572 (14) 0.47336 (9) 0.0283 (3) 
F13 0.41814 (11) 0.40941 (10) 0.49090 (7) 0.0405 (2) 
F14 0.45641 (15) 0.26015 (13) 0.65348 (7) 0.0589 (4) 
F15 0.85872 (14) 0.04282 (10) 0.58429 (8) 0.0531 (3) 
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F16 0.83880 (10) 0.17974 (9) 0.41726 (6) 0.0379 (2) 
 
 
 
Geometric parameters (Å, º) for (gw105) 
S1—C1 1.7592 (13) S2—C30 1.7574 (13) 
S1—C13 1.7683 (13) S2—C18 1.7575 (13) 
C1—N2 1.3028 (16) C18—N6 1.3010 (16) 
C1—N1 1.3922 (16) C18—N5 1.3929 (15) 
N1—C7 1.4004 (15) N5—C24 1.4038 (15) 
N1—C8 1.4024 (15) N5—C25 1.4088 (15) 
N2—C2 1.3976 (16) N6—C19 1.3998 (16) 
C2—C3 1.3981 (17) C19—C24 1.3984 (16) 
C2—C7 1.4005 (17) C19—C20 1.3998 (17) 
C3—C4 1.384 (2) C20—C21 1.3855 (19) 
C3—H3 0.942 (19) C20—H20 0.964 (18) 
C4—C5 1.401 (2) C21—C22 1.3983 (19) 
C4—H4 0.978 (18) C21—H21 0.959 (19) 
C5—C6 1.3897 (18) C22—C23 1.3910 (18) 
C5—H5 0.981 (18) C22—H22 0.950 (19) 
C6—C7 1.3910 (17) C23—C24 1.3859 (17) 
C6—H6 0.952 (17) C23—H23 0.951 (17) 
C8—C12 1.3896 (17) C25—C26 1.3928 (17) 
C8—C9 1.3910 (17) C25—C29 1.3933 (17) 
C9—F1 1.3326 (14) C26—F9 1.3335 (15) 
C9—C10 1.3801 (17) C26—C27 1.3798 (18) 
C10—N3 1.3045 (18) C27—N7 1.310 (2) 
C10—F2 1.3418 (16) C27—F10 1.3326 (16) 
N3—C11 1.3117 (19) N7—C28 1.3074 (19) 
C11—F3 1.3338 (15) C28—F11 1.3354 (16) 
C11—C12 1.3789 (18) C28—C29 1.3837 (18) 
C12—F4 1.3369 (15) C29—F12 1.3309 (15) 
C13—C17 1.3856 (18) C30—C31 1.389 (2) 
C13—C14 1.3887 (18) C30—C34 1.390 (2) 
C14—F5 1.3349 (15) C31—F13 1.333 (2) 
C14—C15 1.380 (2) C31—C32 1.380 (2) 
C15—N4 1.3084 (19) C32—N8 1.304 (3) 
C15—F6 1.3304 (16) C32—F14 1.330 (2) 
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N4—C16 1.311 (2) N8—C33 1.311 (3) 
C16—F7 1.3314 (16) C33—F15 1.335 (2) 
C16—C17 1.380 (2) C33—C34 1.383 (2) 
C17—F8 1.3346 (16) C34—F16 1.3229 (18) 
    
C1—S1—C13 97.66 (6) C30—S2—C18 99.24 (6) 
N2—C1—N1 113.37 (11) N6—C18—N5 113.81 (11) 
N2—C1—S1 125.47 (10) N6—C18—S2 127.09 (10) 
N1—C1—S1 121.16 (9) N5—C18—S2 119.08 (9) 
C1—N1—C7 106.09 (10) C18—N5—C24 105.55 (10) 
C1—N1—C8 126.07 (10) C18—N5—C25 129.43 (10) 
C7—N1—C8 126.98 (10) C24—N5—C25 124.96 (10) 
C1—N2—C2 105.03 (10) C18—N6—C19 104.93 (10) 
N2—C2—C3 128.95 (12) C24—C19—N6 110.56 (10) 
N2—C2—C7 110.71 (11) C24—C19—C20 119.95 (11) 
C3—C2—C7 120.34 (12) N6—C19—C20 129.49 (11) 
C4—C3—C2 117.24 (12) C21—C20—C19 117.32 (12) 
C4—C3—H3 123.1 (11) C21—C20—H20 122.9 (11) 
C2—C3—H3 119.6 (11) C19—C20—H20 119.7 (11) 
C3—C4—C5 121.68 (12) C20—C21—C22 121.75 (12) 
C3—C4—H4 120.0 (11) C20—C21—H21 120.9 (11) 
C5—C4—H4 118.2 (11) C22—C21—H21 117.4 (11) 
C6—C5—C4 121.91 (13) C23—C22—C21 121.69 (12) 
C6—C5—H5 120.1 (10) C23—C22—H22 119.8 (11) 
C4—C5—H5 117.9 (10) C21—C22—H22 118.5 (11) 
C5—C6—C7 115.91 (12) C24—C23—C22 116.00 (12) 
C5—C6—H6 120.7 (10) C24—C23—H23 122.1 (10) 
C7—C6—H6 123.4 (10) C22—C23—H23 121.8 (10) 
C6—C7—N1 132.31 (12) C23—C24—C19 123.26 (11) 
C6—C7—C2 122.90 (11) C23—C24—N5 131.57 (11) 
N1—C7—C2 104.78 (10) C19—C24—N5 105.15 (10) 
C12—C8—C9 116.56 (11) C26—C25—C29 116.42 (11) 
C12—C8—N1 122.13 (11) C26—C25—N5 121.16 (11) 
C9—C8—N1 121.30 (11) C29—C25—N5 122.29 (11) 
F1—C9—C10 120.40 (11) F9—C26—C27 119.95 (12) 
F1—C9—C8 120.66 (11) F9—C26—C25 121.05 (11) 
C10—C9—C8 118.90 (11) C27—C26—C25 119.00 (12) 
N3—C10—F2 116.73 (12) N7—C27—F10 116.56 (12) 
N3—C10—C9 124.33 (12) N7—C27—C26 124.45 (13) 
F2—C10—C9 118.92 (12) F10—C27—C26 118.99 (13) 
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C10—N3—C11 117.07 (12) C28—N7—C27 116.79 (12) 
N3—C11—F3 117.02 (12) N7—C28—F11 116.83 (12) 
N3—C11—C12 124.16 (12) N7—C28—C29 124.53 (13) 
F3—C11—C12 118.81 (12) F11—C28—C29 118.63 (13) 
F4—C12—C11 120.34 (11) F12—C29—C28 120.37 (12) 
F4—C12—C8 120.68 (11) F12—C29—C25 120.81 (11) 
C11—C12—C8 118.98 (12) C28—C29—C25 118.78 (12) 
C17—C13—C14 116.76 (12) C31—C30—C34 117.33 (13) 
C17—C13—S1 120.73 (10) C31—C30—S2 119.53 (12) 
C14—C13—S1 122.51 (10) C34—C30—S2 123.04 (11) 
F5—C14—C15 120.38 (12) F13—C31—C32 119.94 (15) 
F5—C14—C13 120.57 (12) F13—C31—C30 121.37 (13) 
C15—C14—C13 119.04 (12) C32—C31—C30 118.69 (16) 
N4—C15—F6 116.57 (13) N8—C32—F14 117.00 (15) 
N4—C15—C14 123.85 (13) N8—C32—C31 124.06 (16) 
F6—C15—C14 119.57 (13) F14—C32—C31 118.94 (19) 
C15—N4—C16 117.37 (12) C32—N8—C33 117.53 (14) 
N4—C16—F7 116.94 (13) N8—C33—F15 117.24 (14) 
N4—C16—C17 123.94 (13) N8—C33—C34 124.11 (17) 
F7—C16—C17 119.12 (13) F15—C33—C34 118.65 (17) 
F8—C17—C16 120.21 (12) F16—C34—C33 120.48 (15) 
F8—C17—C13 120.76 (12) F16—C34—C30 121.25 (12) 
C16—C17—C13 119.02 (13) C33—C34—C30 118.26 (15) 
    
C13—S1—C1—N2 -59.26 (12) C30—S2—C18—N6 -12.89 (14) 
C13—S1—C1—N1 120.13 (11) C30—S2—C18—N5 165.31 (11) 
N2—C1—N1—C7 0.48 (14) N6—C18—N5—C24 -0.02 (15) 
S1—C1—N1—C7 -178.98 (9) S2—C18—N5—C24 -178.45 (9) 
N2—C1—N1—C8 170.47 (11) N6—C18—N5—C25 177.29 (12) 
S1—C1—N1—C8 -8.98 (17) S2—C18—N5—C25 -1.14 (19) 
N1—C1—N2—C2 -0.82 (14) N5—C18—N6—C19 -0.29 (15) 
S1—C1—N2—C2 178.61 (9) S2—C18—N6—C19 177.99 (10) 
C1—N2—C2—C3 -179.25 (13) C18—N6—C19—C24 0.50 (14) 
C1—N2—C2—C7 0.86 (14) C18—N6—C19—C20 -179.47 (13) 
N2—C2—C3—C4 -178.61 (13) C24—C19—C20—C21 0.58 (19) 
C7—C2—C3—C4 1.26 (19) N6—C19—C20—C21 -179.46 (13) 
C2—C3—C4—C5 0.0 (2) C19—C20—C21—C22 0.5 (2) 
C3—C4—C5—C6 -0.8 (2) C20—C21—C22—C23 -0.5 (2) 
C4—C5—C6—C7 0.4 (2) C21—C22—C23—C24 -0.66 (19) 
C5—C6—C7—N1 179.22 (13) C22—C23—C24—C19 1.81 (19) 
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C5—C6—C7—C2 0.86 (19) C22—C23—C24—N5 -179.84 (12) 
C1—N1—C7—C6 -178.48 (14) N6—C19—C24—C23 178.21 (12) 
C8—N1—C7—C6 11.6 (2) C20—C19—C24—C23 -1.82 (19) 
C1—N1—C7—C2 0.09 (13) N6—C19—C24—N5 -0.51 (14) 
C8—N1—C7—C2 -169.79 (12) C20—C19—C24—N5 179.46 (11) 
N2—C2—C7—C6 178.16 (12) C18—N5—C24—C23 -178.25 (13) 
C3—C2—C7—C6 -1.7 (2) C25—N5—C24—C23 4.3 (2) 
N2—C2—C7—N1 -0.58 (14) C18—N5—C24—C19 0.32 (13) 
C3—C2—C7—N1 179.52 (11) C25—N5—C24—C19 -177.14 (11) 
C1—N1—C8—C12 61.65 (17) C18—N5—C25—C26 -125.19 (14) 
C7—N1—C8—C12 -130.41 (13) C24—N5—C25—C26 51.65 (17) 
C1—N1—C8—C9 -117.25 (14) C18—N5—C25—C29 59.05 (19) 
C7—N1—C8—C9 50.69 (18) C24—N5—C25—C29 -124.11 (13) 
C12—C8—C9—F1 -178.04 (11) C29—C25—C26—F9 -178.84 (11) 
N1—C8—C9—F1 0.91 (18) N5—C25—C26—F9 5.16 (18) 
C12—C8—C9—C10 -0.40 (18) C29—C25—C26—C27 2.01 (18) 
N1—C8—C9—C10 178.56 (12) N5—C25—C26—C27 -173.99 (12) 
F1—C9—C10—N3 178.38 (13) F9—C26—C27—N7 179.98 (13) 
C8—C9—C10—N3 0.7 (2) C25—C26—C27—N7 -0.9 (2) 
F1—C9—C10—F2 -0.48 (19) F9—C26—C27—F10 0.3 (2) 
C8—C9—C10—F2 -178.14 (12) C25—C26—C27—F10 179.47 (12) 
F2—C10—N3—C11 178.57 (12) F10—C27—N7—C28 179.12 (13) 
C9—C10—N3—C11 -0.3 (2) C26—C27—N7—C28 -0.5 (2) 
C10—N3—C11—F3 178.67 (12) C27—N7—C28—F11 179.78 (13) 
C10—N3—C11—C12 -0.4 (2) C27—N7—C28—C29 0.7 (2) 
N3—C11—C12—F4 -179.29 (12) N7—C28—C29—F12 178.20 (13) 
F3—C11—C12—F4 1.65 (19) F11—C28—C29—F12 -0.8 (2) 
N3—C11—C12—C8 0.7 (2) N7—C28—C29—C25 0.5 (2) 
F3—C11—C12—C8 -178.37 (11) F11—C28—C29—C25 -178.54 (12) 
C9—C8—C12—F4 179.74 (11) C26—C25—C29—F12 -179.55 (11) 
N1—C8—C12—F4 0.80 (18) N5—C25—C29—F12 -3.59 (19) 
C9—C8—C12—C11 -0.25 (18) C26—C25—C29—C28 -1.83 (18) 
N1—C8—C12—C11 -179.19 (11) N5—C25—C29—C28 174.12 (12) 
C1—S1—C13—C17 116.39 (11) C18—S2—C30—C31 123.43 (12) 
C1—S1—C13—C14 -64.64 (11) C18—S2—C30—C34 -60.14 (13) 
C17—C13—C14—F5 -179.40 (11) C34—C30—C31—F13 -178.59 (12) 
S1—C13—C14—F5 1.58 (17) S2—C30—C31—F13 -1.96 (19) 
C17—C13—C14—C15 -0.53 (18) C34—C30—C31—C32 0.9 (2) 
S1—C13—C14—C15 -179.54 (10) S2—C30—C31—C32 177.52 (11) 
F5—C14—C15—N4 -179.49 (12) F13—C31—C32—N8 179.59 (13) 
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C13—C14—C15—N4 1.6 (2) C30—C31—C32—N8 0.1 (2) 
F5—C14—C15—F6 1.00 (19) F13—C31—C32—F14 -0.7 (2) 
C13—C14—C15—F6 -177.88 (11) C30—C31—C32—F14 179.82 (13) 
F6—C15—N4—C16 177.64 (11) F14—C32—N8—C33 179.76 (13) 
C14—C15—N4—C16 -1.9 (2) C31—C32—N8—C33 -0.5 (2) 
C15—N4—C16—F7 -178.31 (12) C32—N8—C33—F15 -179.31 (13) 
C15—N4—C16—C17 1.1 (2) C32—N8—C33—C34 -0.1 (2) 
N4—C16—C17—F8 -179.25 (12) N8—C33—C34—F16 -178.09 (14) 
F7—C16—C17—F8 0.2 (2) F15—C33—C34—F16 1.1 (2) 
N4—C16—C17—C13 -0.1 (2) N8—C33—C34—C30 1.1 (2) 
F7—C16—C17—C13 179.30 (12) F15—C33—C34—C30 -179.70 (13) 
C14—C13—C17—F8 178.95 (11) C31—C30—C34—F16 177.74 (12) 
S1—C13—C17—F8 -2.02 (17) S2—C30—C34—F16 1.2 (2) 
C14—C13—C17—C16 -0.16 (18) C31—C30—C34—C33 -1.4 (2) 
S1—C13—C17—C16 178.87 (10) S2—C30—C34—C33 -177.93 (11) 
 
Computing details 
Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL2013 (Sheldrick, 2013); molecular graphics: Bruker SHELXTL; software used to prepare material 
for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated usin   
full covariance matrix. The cell esds are taken  into account individually in the estimation of esds i  
distances, angles and torsion angles; correlations between esds in cell parameters are only used wh   
are defined by crystal symmetry. An approximate (isotropic)   treatment of cell esds is used for esti  
esds involving l.s. planes. 
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5.1.3. Compound 87 X-ray crystal structure data   
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5.1.4. Compound 95 X-ray crystal structure data 
 
 
 
Crystal data 
C13H12BrNO2S Dx = 1.654 Mg m-3 
Mr = 326.21 Synchrotron radiation,  = 0.7749 Å 
Orthorhombic, Pbca Cell parameters from 9243 reflections 
a = 12.3969 (4) Å  = 2.9–39.9° 
b = 11.4900 (4) Å  = 4.06 mm-1 
c = 18.3914 (6) Å T = 100 K 
V = 2619.68 (15)  Å3 Plate, colourless 
Z = 8 0.15 × 0.10 × 0.02 mm 
F(000) = 1312  
 
Data collection 
Bruker APEX 2 CCD diffractometer 5702 reflections with I > 2⌠(I) 
Radiation source: ALS Station 11.3.1 Rint = 0.035 
 rotation with narrow frames scans max = 40.2°, min = 2.9° 
Absorption correction: multi-scan  SADABS v20  
Sheldrick, G.M., (2009) 
h = -20 20 
Tmin = 0.581, Tmax = 0.923 k = -19 19 
78378 measured reflections l = -30 30 
6306 independent reflections  
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Refinement 
Refinement on F2 Secondary atom site location: all non-H atoms fo   
direct methods 
Least-squares matrix: full Hydrogen site location: difference Fourier map 
R[F2 > 2⌠(F2)] = 0.023 All H-atom parameters refined 
wR(F2) = 0.068 w = 1/[⌠2(Fo2) + (0.0346P)2 + 0.8758P]    P  
(Fo2 + 2Fc2)/3 
S = 1.05 (⊗/⌠)max = 0.002 
6306 reflections ⊗〉max = 0.68 e Å-3 
212 parameters ⊗〉min = -0.65 e Å-3 
1 restraint Extinction correction: SHELXL, 
Fc*=kFc[1+0.001xFc23/sin(2)]-1/4 
Primary atom site location: structure-invariant di  
methods 
Extinction coefficient: 0.0020 (3) 
 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
 x y z Uiso*/Ueq 
Br1 0.53732 (2) 0.70236 (2) 0.39424 (2) 0.02409 (4) 
C1 0.43264 (7) 0.64932 (7) 0.46102 (5) 0.01728 (13) 
C2 0.38746 (8) 0.54020 (8) 0.45004 (5) 0.02176 (15) 
H2 0.4145 (14) 0.4934 (14) 0.4096 (8) 0.027 (4)* 
C3 0.30889 (8) 0.50023 (8) 0.49756 (6) 0.02391 (17) 
H3 0.2741 (15) 0.4253 (15) 0.4911 (10) 0.044 (5)* 
C4 0.27627 (8) 0.56811 (9) 0.55402 (5) 0.02238 (16) 
H4 0.2297 (15) 0.5477 (15) 0.5832 (11) 0.040 (5)* 
C5 0.31984 (8) 0.67916 (9) 0.56504 (5) 0.02169 (15) 
H5 0.2920 (14) 0.7285 (15) 0.6055 (8) 0.029 (4)* 
C6 0.40019 (7) 0.72025 (7) 0.51837 (4) 0.01619 (13) 
N1 0.44470 (7) 0.83216 (6) 0.52778 (4) 0.01859 (12) 
H1 0.4751 (13) 0.8621 (15) 0.4939 (8) 0.035 (4)* 
S1 0.48179 (2) 0.88400 (2) 0.60658 (2) 0.01705 (4) 
O1 0.53878 (6) 0.98913 (6) 0.58867 (4) 0.02464 (14) 
O2 0.39022 (6) 0.89095 (6) 0.65350 (4) 0.02307 (13) 
C7 0.57070 (7) 0.78243 (7) 0.64511 (4) 0.01550 (12) 
C8 0.67406 (8) 0.77075 (8) 0.61691 (5) 0.01988 (14) 
H8 0.6988 (15) 0.8163 (15) 0.5781 (10) 0.036 (4)* 
C9 0.74378 (8) 0.69108 (8) 0.64823 (5) 0.02000 (14) 
H9 0.8137 (14) 0.6823 (14) 0.6292 (10) 0.031 (4)* 
C10 0.71177 (7) 0.62181 (7) 0.70673 (4) 0.01657 (13) 
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C11 0.60753 (7) 0.63533 (8) 0.73389 (5) 0.02007 (14) 
H11 0.5851 (13) 0.5862 (13) 0.7750 (9) 0.025 (4)* 
C12 0.53683 (7) 0.71541 (8) 0.70365 (5) 0.01914 (14) 
H12 0.4640 (12) 0.7324 (16) 0.7217 (10) 0.031 (4)* 
C13 0.78728 (8) 0.53356 (9) 0.73867 (5) 0.02279 (16) 
H13A 0.8541 (16) 0.5310 (17) 0.7125 (11) 0.047 (5)* 
H13B 0.8022 (17) 0.5550 (18) 0.7851 (12) 0.053 (5)* 
H13C 0.7568 (17) 0.4620 (17) 0.7419 (11) 0.052 (6)* 
 
 
 
 
Geometric parameters (Å, º) 
Br1—C1 1.8878 (9) S1—C7 1.7547 (8) 
C1—C2 1.3880 (12) C7—C12 1.3887 (12) 
C1—C6 1.3923 (12) C7—C8 1.3889 (13) 
C2—C3 1.3870 (14) C8—C9 1.3845 (13) 
C2—H2 0.977 (16) C8—H8 0.937 (19) 
C3—C4 1.3602 (15) C9—C10 1.3958 (12) 
C3—H3 0.969 (18) C9—H9 0.940 (18) 
C4—C5 1.4004 (13) C10—C11 1.3942 (12) 
C4—H4 0.822 (19) C10—C13 1.4998 (13) 
C5—C6 1.3971 (12) C11—C12 1.3870 (13) 
C5—H5 0.997 (16) C11—H11 0.984 (16) 
C6—N1 1.4100 (11) C12—H12 0.982 (16) 
N1—S1 1.6329 (8) C13—H13A 0.96 (2) 
N1—H1 0.806 (12) C13—H13B 0.91 (2) 
S1—O2 1.4281 (8) C13—H13C 0.91 (2) 
S1—O1 1.4377 (8)   
    
C2—C1—C6 121.49 (8) N1—S1—C7 107.02 (4) 
C2—C1—Br1 118.32 (7) C12—C7—C8 120.99 (8) 
C6—C1—Br1 120.17 (6) C12—C7—S1 119.48 (7) 
C3—C2—C1 119.40 (9) C8—C7—S1 119.54 (6) 
C3—C2—H2 122.5 (10) C9—C8—C7 118.98 (8) 
C1—C2—H2 118.0 (10) C9—C8—H8 118.8 (11) 
C4—C3—C2 120.00 (8) C7—C8—H8 122.2 (11) 
C4—C3—H3 118.0 (12) C8—C9—C10 121.35 (8) 
C2—C3—H3 121.9 (12) C8—C9—H9 119.4 (11) 
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C3—C4—C5 121.22 (9) C10—C9—H9 119.2 (11) 
C3—C4—H4 122.9 (13) C11—C10—C9 118.43 (8) 
C5—C4—H4 115.9 (13) C11—C10—C13 120.90 (8) 
C6—C5—C4 119.60 (9) C9—C10—C13 120.66 (8) 
C6—C5—H5 120.9 (10) C12—C11—C10 121.06 (8) 
C4—C5—H5 119.5 (10) C12—C11—H11 120.7 (9) 
C1—C6—C5 118.28 (8) C10—C11—H11 118.3 (9) 
C1—C6—N1 120.91 (8) C11—C12—C7 119.19 (8) 
C5—C6—N1 120.78 (8) C11—C12—H12 125.3 (11) 
C6—N1—S1 123.49 (6) C7—C12—H12 115.5 (11) 
C6—N1—H1 118.5 (13) C10—C13—H13A 111.3 (12) 
S1—N1—H1 113.5 (13) C10—C13—H13B 108.2 (13) 
O2—S1—O1 118.82 (5) H13A—C13—H13B 107.7 (18) 
O2—S1—N1 109.45 (4) C10—C13—H13C 112.2 (13) 
O1—S1—N1 103.98 (4) H13A—C13—H13C 111.4 (17) 
O2—S1—C7 107.00 (4) H13B—C13—H13C 105.7 (18) 
O1—S1—C7 110.04 (4)   
    
C6—C1—C2—C3 -0.60 (13) O2—S1—C7—C12 9.28 (8) 
Br1—C1—C2—C3 -178.77 (7) O1—S1—C7—C12 139.68 (7) 
C1—C2—C3—C4 0.43 (14) N1—S1—C7—C12 -107.96 (8) 
C2—C3—C4—C5 0.66 (15) O2—S1—C7—C8 -170.34 (7) 
C3—C4—C5—C6 -1.57 (15) O1—S1—C7—C8 -39.95 (8) 
C2—C1—C6—C5 -0.31 (13) N1—S1—C7—C8 72.42 (8) 
Br1—C1—C6—C5 177.83 (7) C12—C7—C8—C9 -0.22 (14) 
C2—C1—C6—N1 -178.31 (8) S1—C7—C8—C9 179.40 (7) 
Br1—C1—C6—N1 -0.17 (11) C7—C8—C9—C10 0.76 (14) 
C4—C5—C6—C1 1.37 (13) C8—C9—C10—C11 -0.71 (14) 
C4—C5—C6—N1 179.37 (8) C8—C9—C10—C13 178.27 (9) 
C1—C6—N1—S1 -136.73 (8) C9—C10—C11—C12 0.13 (14) 
C5—C6—N1—S1 45.32 (12) C13—C10—C11—C12 -178.85 (9) 
C6—N1—S1—O2 -61.97 (9) C10—C11—C12—C7 0.39 (14) 
C6—N1—S1—O1 170.10 (8) C8—C7—C12—C11 -0.34 (14) 
C6—N1—S1—C7 53.65 (9) S1—C7—C12—C11 -179.96 (7) 
 
Hydrogen-bond geometry (Å, º) 
  D—H···A D—H H···A D···A D—H···A 
N1—H1···Br1 0.81 (1) 2.71 (2) 3.0943 (8) 112 (2) 
N1—H1···O1i 0.81 (1) 2.29 (2) 2.9740 (11) 143 (2) 
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Symmetry code:  (i) -x+1, -y+2, -z+1. 
Computing details 
Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL2012 (Sheldrick, 2012); molecular graphics: Bruker SHELXTL; software used to prepare material 
for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using 
the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in 
distances, angles and torsion angles; correlations between esds in cell parameters are only used when they 
are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating 
esds involving l.s. planes. 
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5.1.5. Compound 100 X-ray crystal structure data 
 
 
Table 1.  Crystal data and structure refinement for gwals2. 
 
Identification code  gwals2 
Chemical formula  C30H16F4N2 
Formula weight  480.45 
Temperature  150(2) K 
Radiation, wavelength  synchrotron, 0.7749 Å 
Crystal system, space group  orthorhombic, Pbca 
Unit cell parameters a = 14.7832(5) Å 〈 = 90° 
 b = 8.2739(3) Å  = 90° 
 c = 17.6768(6) Å  = 90° 
Cell volume 2162.13(13) Å3 
Z 4 
Calculated density  1.476 g/cm3 
Absorption coefficient  0.134 mm1 
F(000) 984 
Crystal colour and size colourless, 0.25  0.03  0.02 mm3 
Reflections for cell refinement 9941 ( range 2.93 to 39.25°) 
Data collection method Bruker APEX 2 CCD diffractometer 
  rotation with narrow frames 
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 range for data collection 2.51 to 40.19° 
Index ranges h 24 to 24, k 13 to 13, l 29 to 28 
Completeness to  = 35.00° 99.9 %  
Intensity decay 0% 
Reflections collected 30700 
Independent reflections 5147 (Rint = 0.0625) 
Reflections with F2>2⌠ 4153 
Absorption correction semi-empirical from equivalents 
Min. and max. transmission 0.967 and 0.997 
Structure solution direct methods 
Refinement method Full-matrix least-squares on F2 
Weighting parameters a, b 0.0839, 0.2174 
Data / restraints / parameters 5147 / 0 / 195 
Final R indices [F2>2⌠] R1 = 0.0506, wR2 = 0.1448 
R indices (all data) R1 = 0.0608, wR2 = 0.1550 
Goodness-of-fit on F2 1.050 
Largest and mean shift/su 0.001 and 0.000 
Largest diff. peak and hole 0.502 and 0.427 e Å3 
 
Acknowledgement: The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy 
Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. 
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Table 2.  Atomic coordinates and equivalent isotropic displacement parameters (Å2) 
for gwals2.  Ueq is defined as one third of the trace of the orthogonalized Uij tensor. 
 
      x      y      z      Ueq 
 
C(1) 0.46278(6) 0.59709(10) 0.44209(4) 0.02303(15) 
C(2) 0.41300(6) 0.55643(11) 0.50607(5) 0.02470(15) 
F(2) 0.32779(4) 0.60636(8) 0.51282(4) 0.03373(15) 
C(3) 0.55066(6) 0.53892(10) 0.43772(5) 0.02420(15) 
F(3) 0.60254(4) 0.58138(8) 0.37924(3) 0.03276(15) 
N(1) 0.42697(5) 0.69386(9) 0.38470(4) 0.02488(14) 
C(4) 0.39698(5) 0.85197(10) 0.39373(5) 0.02277(15) 
C(5) 0.40086(6) 0.94844(11) 0.45749(5) 0.02678(16) 
C(6) 0.36719(7) 1.10398(12) 0.45100(6) 0.03168(19) 
C(7) 0.33155(7) 1.16053(12) 0.38269(7) 0.0338(2) 
C(8) 0.32852(6) 1.06317(12) 0.31937(6) 0.03023(18) 
C(9) 0.36120(5) 0.90572(10) 0.32453(5) 0.02360(15) 
C(10) 0.40922(6) 0.64446(11) 0.31067(5) 0.02467(15) 
C(11) 0.42440(7) 0.49583(13) 0.27725(6) 0.03122(18) 
C(12) 0.39521(8) 0.47640(15) 0.20313(6) 0.0372(2) 
C(13) 0.35259(8) 0.60178(16) 0.16414(5) 0.0371(2) 
C(14) 0.33904(7) 0.75016(13) 0.19771(5) 0.03111(19) 
C(15) 0.36788(5) 0.77349(11) 0.27200(5) 0.02438(15) 
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Table 3.   Bond lengths [Å] and angles [°] for gwals2. 
 
C(1)–C(3)  1.3876(11) C(1)–C(2)  1.3905(12) 
C(1)–N(1)  1.3965(10) C(2)–F(2)  1.3311(10) 
C(2)–C(3')  1.3778(11) C(3)–F(3)  1.3343(10) 
C(3)–C(2')  1.3778(11) N(1)–C(4)  1.3905(11) 
N(1)–C(10)  1.3958(11) C(4)–C(5)  1.3823(13) 
C(4)–C(9)  1.4049(11) C(5)–C(6)  1.3846(13) 
C(6)–C(7)  1.3981(15) C(7)–C(8)  1.3798(16) 
C(8)–C(9)  1.3924(12) C(9)–C(15)  1.4384(13) 
C(10)–C(11)  1.3826(14) C(10)–C(15)  1.4073(12) 
C(11)–C(12)  1.3887(15) C(12)–C(13)  1.3958(18) 
C(13)–C(14)  1.3782(16) C(14)–C(15)  1.3942(12) 
 
C(3)–C(1)–C(2) 117.18(7) C(3)–C(1)–N(1) 120.89(7) 
C(2)–C(1)–N(1) 121.93(7) F(2)–C(2)–C(3') 118.82(7) 
F(2)–C(2)–C(1) 119.91(7) C(3')–C(2)–C(1) 121.25(7) 
F(3)–C(3)–C(2') 119.04(7) F(3)–C(3)–C(1) 119.34(7) 
C(2')–C(3)–C(1) 121.57(8) C(4)–N(1)–C(10) 108.86(7) 
C(4)–N(1)–C(1) 125.23(7) C(10)–N(1)–C(1) 125.76(7) 
C(5)–C(4)–N(1) 128.58(7) C(5)–C(4)–C(9) 122.87(8) 
N(1)–C(4)–C(9) 108.54(7) C(4)–C(5)–C(6) 117.02(8) 
C(5)–C(6)–C(7) 121.20(9) C(8)–C(7)–C(6) 121.17(9) 
C(7)–C(8)–C(9) 118.80(8) C(8)–C(9)–C(4) 118.94(8) 
C(8)–C(9)–C(15) 133.88(8) C(4)–C(9)–C(15) 107.18(7) 
C(11)–C(10)–N(1) 129.09(8) C(11)–C(10)–C(15) 122.52(8) 
N(1)–C(10)–C(15) 108.35(8) C(10)–C(11)–C(12) 117.11(10) 
C(11)–C(12)–C(13) 121.34(10) C(14)–C(13)–C(12) 121.00(9) 
C(13)–C(14)–C(15) 118.97(9) C(14)–C(15)–C(10) 119.03(9) 
C(14)–C(15)–C(9) 133.82(8) C(10)–C(15)–C(9) 107.06(7) 
 
Symmetry operations for equivalent atoms 
'   x+1,y+1,z+1        
 
 
 
 
Table 4.   Hydrogen coordinates and isotropic displacement parameters (Å2) for gwals2. 
 
      x       y       z       U 
 
H(5) 0.4264(10) 0.9101(19) 0.5041(8) 0.034(4) 
H(6) 0.3671(11) 1.174(2) 0.4937(9) 0.041(4) 
H(7) 0.3073(10) 1.271(2) 0.3810(9) 0.039(4) 
H(8) 0.3029(10) 1.100(2) 0.2730(9) 0.039(4) 
H(11) 0.4548(11) 0.4058(19) 0.3037(8) 0.038(4) 
H(12) 0.4056(13) 0.375(3) 0.1765(11) 0.059(5) 
H(13) 0.3316(12) 0.587(2) 0.1111(9) 0.043(4) 
H(14) 0.3066(11) 0.836(2) 0.1714(9) 0.041(4) 
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Table 5.  Torsion angles [°] for gwals2. 
 
C(3)–C(1)–C(2)–F(2)  178.83(8) N(1)–C(1)–C(2)–F(2) 1.91(14) 
C(3)–C(1)–C(2)–C(3')  0.62(15) N(1)–C(1)–C(2)–C(3')  179.88(9) 
C(2)–C(1)–C(3)–F(3)  176.68(8) N(1)–C(1)–C(3)–F(3) 2.59(13) 
C(2)–C(1)–C(3)–C(2') 0.62(15) N(1)–C(1)–C(3)–C(2') 179.89(8) 
C(3)–C(1)–N(1)–C(4)  118.55(10) C(2)–C(1)–N(1)–C(4) 60.68(13) 
C(3)–C(1)–N(1)–C(10) 66.49(12) C(2)–C(1)–N(1)–C(10)  114.27(10) 
C(10)–N(1)–C(4)–C(5) 179.99(9) C(1)–N(1)–C(4)–C(5) 4.32(15) 
C(10)–N(1)–C(4)–C(9)  1.10(10) C(1)–N(1)–C(4)–C(9)  176.78(8) 
N(1)–C(4)–C(5)–C(6) 178.96(9) C(9)–C(4)–C(5)–C(6) 0.20(13) 
C(4)–C(5)–C(6)–C(7)  0.44(14) C(5)–C(6)–C(7)–C(8) 0.13(16) 
C(6)–C(7)–C(8)–C(9) 0.43(15) C(7)–C(8)–C(9)–C(4)  0.66(13) 
C(7)–C(8)–C(9)–C(15) 179.33(9) C(5)–C(4)–C(9)–C(8) 0.35(13) 
N(1)–C(4)–C(9)–C(8)  178.63(8) C(5)–C(4)–C(9)–C(15)  179.64(8) 
N(1)–C(4)–C(9)–C(15) 1.38(9) C(4)–N(1)–C(10)–C(11)  177.51(9) 
C(1)–N(1)–C(10)–C(11)  1.86(15) C(4)–N(1)–C(10)–C(15) 0.37(10) 
C(1)–N(1)–C(10)–C(15) 176.02(8) N(1)–C(10)–C(11)–C(12) 176.30(9) 
C(15)–C(10)–C(11)–C(12)  1.31(14) C(10)–C(11)–C(12)–C(13) 0.13(15) 
C(11)–C(12)–C(13)–C(14) 0.83(17) C(12)–C(13)–C(14)–C(15)  0.60(15) 
C(13)–C(14)–C(15)–C(10)  0.54(13) C(13)–C(14)–C(15)–C(9)  176.54(9) 
C(11)–C(10)–C(15)–C(14) 1.55(13) N(1)–C(10)–C(15)–C(14)  176.50(8) 
C(11)–C(10)–C(15)–C(9) 178.53(8) N(1)–C(10)–C(15)–C(9) 0.48(10) 
C(8)–C(9)–C(15)–C(14)  4.79(17) C(4)–C(9)–C(15)–C(14) 175.20(9) 
C(8)–C(9)–C(15)–C(10) 178.87(9) C(4)–C(9)–C(15)–C(10)  1.14(9) 
 
Symmetry operations for equivalent atoms 
'   x+1,y+1,z+1        
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5.1.6. Compound 101 X-ray crystal structure data 
 
 
 
Table 1.  Crystal data and structure refinement for gwals2a. 
 
Identification code  gwals2a 
Chemical formula  C55H34Cl2F2N4 
Formula weight  859.76 
Temperature  150(2) K 
Radiation, wavelength  synchrotron, 0.7749 Å 
Crystal system, space group  monoclinic, P21/c 
Unit cell parameters a = 17.2455(14) Å 〈 = 90° 
 b = 13.8799(12) Å  = 106.2291(11)° 
 c = 18.1458(15) Å  = 90° 
Cell volume 4170.4(6) Å3 
Z 4 
Calculated density  1.369 g/cm3 
Absorption coefficient  0.260 mm1 
F(000) 1776 
Crystal colour and size colourless, 0.14  0.04  0.03 mm3 
Reflections for cell refinement 9809 ( range 3.01 to 33.55°) 
Data collection method Bruker APEX 2 CCD diffractometer 
  rotation with narrow frames 
 range for data collection 2.99 to 33.62° 
Index ranges h 24 to 24, k 19 to 19, l 25 to 25 
Completeness to  = 33.62° 99.7 %  
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Intensity decay 0% 
Reflections collected 119736 
Independent reflections 12707 (Rint = 0.0735) 
Reflections with F2>2⌠ 10332 
Absorption correction semi-empirical from equivalents 
Min. and max. transmission 0.965 and 0.992 
Structure solution direct methods 
Refinement method Full-matrix least-squares on F2 
Weighting parameters a, b 0.0705, 1.1150 
Data / restraints / parameters 12707 / 132 / 750 
Final R indices [F2>2⌠] R1 = 0.0507, wR2 = 0.1351 
R indices (all data) R1 = 0.0623, wR2 = 0.1460 
Goodness-of-fit on F2 1.029 
Largest and mean shift/su 0.001 and 0.000 
Largest diff. peak and hole 0.475 and 0.484 e Å3 
 
Acknowledgement: The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy 
Sciences, of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. 
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Table 2.  Atomic coordinates and equivalent isotropic displacement parameters (Å2) 
for gwals2a.  Ueq is defined as one third of the trace of the orthogonalized Uij tensor. 
 
      x      y      z      Ueq 
 
C(1) 0.00026(7) 0.42833(8) 0.44472(6) 0.0255(2) 
C(2) 0.00717(7) 0.52561(8) 0.43042(6) 0.0258(2) 
F(2) 0.01985(5) 0.55015(5) 0.36296(4) 0.03078(16) 
C(3) 0.00759(7) 0.59844(7) 0.48289(6) 0.0256(2) 
N(1) 0.00271(6) 0.36120(7) 0.38757(6) 0.02704(19) 
C(4)  0.05476(7) 0.35402(8) 0.31588(6) 0.0265(2) 
C(5)  0.11803(8) 0.41555(9) 0.28169(7) 0.0310(2) 
C(6)  0.16829(8) 0.38931(10) 0.21069(8) 0.0344(3) 
C(7)  0.15570(9) 0.30449(11) 0.17452(8) 0.0384(3) 
C(8)  0.09265(8) 0.24355(10) 0.20916(8) 0.0358(3) 
C(9)  0.04166(7) 0.26789(8) 0.28069(7) 0.0280(2) 
C(10) 0.02641(7) 0.22051(8) 0.33292(7) 0.0273(2) 
C(11) 0.05261(7) 0.27965(8) 0.39796(7) 0.0260(2) 
C(12) 0.11954(8) 0.25726(9) 0.45835(7) 0.0301(2) 
N(2) 0.01735(6) 0.69439(7) 0.46298(6) 0.0271(2) 
C(13) 0.15871(8) 0.17136(10) 0.45376(8) 0.0337(3) 
C(14) 0.13222(8) 0.11033(9) 0.39045(8) 0.0343(3) 
C(15) 0.06680(8) 0.13432(9) 0.32969(8) 0.0319(2) 
C(16)  0.03724(8) 0.74544(8) 0.40410(7) 0.0285(2) 
C(17)  0.10416(9) 0.71257(10) 0.34820(8) 0.0347(3) 
C(18)  0.14865(10) 0.77974(11) 0.29717(9) 0.0429(3) 
C(19)  0.12643(11) 0.87679(12) 0.30218(10) 0.0486(4) 
C(20)  0.06023(10) 0.90902(10) 0.35800(9) 0.0415(3) 
C(21)  0.01502(8) 0.84323(8) 0.41063(7) 0.0313(2) 
C(22) 0.05443(8) 0.85239(8) 0.47637(7) 0.0304(2) 
C(23) 0.07351(7) 0.75955(8) 0.50719(7) 0.0279(2) 
C(24) 0.13980(8) 0.74214(9) 0.56935(8) 0.0325(2) 
C(25) 0.18535(9) 0.82080(11) 0.60346(9) 0.0395(3) 
C(26) 0.16560(9) 0.91385(10) 0.57527(10) 0.0429(3) 
C(27) 0.10094(9) 0.93024(9) 0.51183(9) 0.0391(3) 
C(28) 0.49970(7) 0.40149(8) 0.52054(6) 0.0250(2) 
C(29) 0.50195(7) 0.47565(8) 0.57250(6) 0.0255(2) 
F(29) 0.50932(5) 0.45172(5) 0.64594(4) 0.03052(16) 
C(30) 0.50212(7) 0.57306(8) 0.55510(6) 0.0246(2) 
N(3) 0.50121(6) 0.30563(7) 0.54496(6) 0.0279(2) 
C(31) 0.44312(8) 0.26213(9) 0.57475(7) 0.0303(2) 
C(32) 0.37564(9) 0.30244(11) 0.58978(8) 0.0375(3) 
C(33) 0.32787(11) 0.24234(13) 0.62022(9) 0.0477(4) 
C(34) 0.34688(12) 0.14558(13) 0.63447(10) 0.0547(5) 
C(35) 0.41273(12) 0.10560(12) 0.61739(9) 0.0494(4) 
C(36) 0.46183(9) 0.16388(9) 0.58651(7) 0.0362(3) 
C(37) 0.53325(9) 0.14651(9) 0.56204(7) 0.0361(3) 
C(38) 0.55652(8) 0.23501(9) 0.53713(7) 0.0303(2) 
C(39) 0.62500(8) 0.24470(11) 0.51223(8) 0.0364(3) 
C(40) 0.66933(10) 0.16151(13) 0.51026(9) 0.0473(4) 
C(41) 0.64622(11) 0.07282(12) 0.53325(10) 0.0547(5) 
C(42) 0.57905(11) 0.06450(10) 0.55961(10) 0.0492(4) 
N(4) 0.50482(6) 0.64143(7) 0.61257(6) 0.02599(19) 
C(43) 0.44710(7) 0.65066(8) 0.65324(6) 0.0256(2) 
C(44) 0.38074(8) 0.59266(9) 0.65106(7) 0.0307(2) 
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C(45) 0.33270(8) 0.61884(10) 0.69754(8) 0.0338(3) 
C(46) 0.34957(8) 0.69983(10) 0.74450(8) 0.0355(3) 
C(47) 0.41457(8) 0.75843(10) 0.74490(7) 0.0329(2) 
C(48) 0.46387(7) 0.73402(8) 0.69856(6) 0.0264(2) 
C(49) 0.53479(7) 0.77766(8) 0.68510(6) 0.0270(2) 
C(50) 0.55885(7) 0.71859(8) 0.63254(6) 0.0255(2) 
C(51) 0.62788(8) 0.73705(9) 0.61000(7) 0.0310(2) 
C(52) 0.67175(8) 0.81857(10) 0.63964(8) 0.0358(3) 
C(53) 0.64789(9) 0.87943(10) 0.69045(8) 0.0385(3) 
C(54) 0.57963(9) 0.85960(9) 0.71364(7) 0.0343(3) 
C(55) 0.2110(6) 0.4710(8) 0.3941(5) 0.077(2) 
Cl(1) 0.2164(2) 0.5292(3) 0.48154(15) 0.1015(12) 
Cl(2) 0.28814(15) 0.5144(2) 0.35603(14) 0.0751(5) 
C(55X) 0.2132(11) 0.4733(16) 0.4095(9) 0.136(4) 
Cl(1X) 0.2085(2) 0.5000(3) 0.5042(3) 0.133(2) 
Cl(2X) 0.2835(4) 0.5294(4) 0.3771(5) 0.188(3) 
C(55Y) 0.2307(6) 0.5624(9) 0.3760(6) 0.145(3) 
Cl(1Y) 0.2419(4) 0.4996(6) 0.4608(5) 0.174(2) 
Cl(2Y) 0.3010(3) 0.5347(5) 0.3244(4) 0.188(3) 
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Table 3.   Bond lengths [Å] and angles [°] for gwals2a. 
 
C(1)–C(2)  1.3864(15) C(1)–N(1)  1.4036(14) 
C(1)–C(3')  1.4074(15) C(2)–F(2)  1.3461(12) 
C(2)–C(3)  1.3873(15) C(3)–N(2)  1.4023(14) 
C(3)–C(1')  1.4074(15) N(1)–C(4)  1.4014(15) 
N(1)–C(11)  1.4023(14) C(4)–C(5)  1.3879(17) 
C(4)–C(9)  1.4030(15) C(5)–C(6)  1.3855(19) 
C(6)–C(7)  1.394(2) C(7)–C(8)  1.382(2) 
C(8)–C(9)  1.3907(18) C(9)–C(10)  1.4446(17) 
C(10)–C(15)  1.3938(16) C(10)–C(11)  1.4045(16) 
C(11)–C(12)  1.3866(17) C(12)–C(13)  1.3843(17) 
N(2)–C(23)  1.4019(15) N(2)–C(16)  1.4027(15) 
C(13)–C(14)  1.3974(19) C(14)–C(15)  1.380(2) 
C(16)–C(17)  1.3837(19) C(16)–C(21)  1.4064(16) 
C(17)–C(18)  1.385(2) C(18)–C(19)  1.396(2) 
C(19)–C(20)  1.372(2) C(20)–C(21)  1.3919(18) 
C(21)–C(22)  1.4406(19) C(22)–C(27)  1.3915(18) 
C(22)–C(23)  1.4067(16) C(23)–C(24)  1.3845(18) 
C(24)–C(25)  1.3858(19) C(25)–C(26)  1.396(2) 
C(26)–C(27)  1.379(2) C(28)–C(29)  1.3892(15) 
C(28)–N(3)  1.4003(14) C(28)–C(30")  1.4092(15) 
C(29)–F(29)  1.3444(12) C(29)–C(30)  1.3885(15) 
C(30)–N(4)  1.4011(14) C(30)–C(28")  1.4092(15) 
N(3)–C(31)  1.4011(15) N(3)–C(38)  1.4025(15) 
C(31)–C(32)  1.3853(19) C(31)–C(36)  1.4039(18) 
C(32)–C(33)  1.391(2) C(33)–C(34)  1.390(3) 
C(34)–C(35)  1.375(3) C(35)–C(36)  1.397(2) 
C(36)–C(37)  1.442(2) C(37)–C(42)  1.393(2) 
C(37)–C(38)  1.4056(18) C(38)–C(39)  1.384(2) 
C(39)–C(40)  1.391(2) C(40)–C(41)  1.393(3) 
C(41)–C(42)  1.376(3) N(4)–C(50)  1.3993(14) 
N(4)–C(43)  1.4009(14) C(43)–C(44)  1.3908(17) 
C(43)–C(48)  1.4019(16) C(44)–C(45)  1.3858(17) 
C(45)–C(46)  1.3914(19) C(46)–C(47)  1.3833(19) 
C(47)–C(48)  1.3944(16) C(48)–C(49)  1.4454(17) 
C(49)–C(54)  1.3914(17) C(49)–C(50)  1.4054(16) 
C(50)–C(51)  1.3864(17) C(51)–C(52)  1.3837(18) 
C(52)–C(53)  1.395(2) C(53)–C(54)  1.384(2) 
C(55)–Cl(1)  1.760(6) C(55)–Cl(2)  1.767(6) 
C(55X)–Cl(2X)  1.679(11) C(55X)–Cl(1X)  1.781(10) 
C(55Y)–Cl(1Y)  1.731(10) C(55Y)–Cl(2Y)  1.768(10) 
 
C(2)–C(1)–N(1) 119.10(10) C(2)–C(1)–C(3') 117.88(10) 
N(1)–C(1)–C(3') 123.01(10) F(2)–C(2)–C(1) 117.45(9) 
F(2)–C(2)–C(3) 117.96(9) C(1)–C(2)–C(3) 124.43(10) 
C(2)–C(3)–N(2) 119.54(10) C(2)–C(3)–C(1') 117.69(10) 
N(2)–C(3)–C(1') 122.75(10) C(4)–N(1)–C(11) 108.40(9) 
C(4)–N(1)–C(1) 125.00(10) C(11)–N(1)–C(1) 125.50(10) 
C(5)–C(4)–N(1) 129.41(11) C(5)–C(4)–C(9) 121.82(11) 
N(1)–C(4)–C(9) 108.72(10) C(6)–C(5)–C(4) 117.60(12) 
C(5)–C(6)–C(7) 121.36(13) C(8)–C(7)–C(6) 120.58(13) 
C(7)–C(8)–C(9) 119.19(12) C(8)–C(9)–C(4) 119.44(12) 
C(8)–C(9)–C(10) 133.44(11) C(4)–C(9)–C(10) 107.10(10) 
C(15)–C(10)–C(11) 119.33(12) C(15)–C(10)–C(9) 133.40(11) 
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C(11)–C(10)–C(9) 107.27(10) C(12)–C(11)–N(1) 129.13(11) 
C(12)–C(11)–C(10) 122.30(11) N(1)–C(11)–C(10) 108.52(10) 
C(13)–C(12)–C(11) 117.25(11) C(23)–N(2)–C(3) 125.36(10) 
C(23)–N(2)–C(16) 108.62(9) C(3)–N(2)–C(16) 124.94(10) 
C(12)–C(13)–C(14) 121.24(12) C(15)–C(14)–C(13) 121.13(12) 
C(14)–C(15)–C(10) 118.69(12) C(17)–C(16)–N(2) 129.53(11) 
C(17)–C(16)–C(21) 122.12(12) N(2)–C(16)–C(21) 108.32(11) 
C(16)–C(17)–C(18) 117.44(13) C(17)–C(18)–C(19) 121.01(15) 
C(20)–C(19)–C(18) 121.26(14) C(19)–C(20)–C(21) 118.91(13) 
C(20)–C(21)–C(16) 119.22(13) C(20)–C(21)–C(22) 133.38(12) 
C(16)–C(21)–C(22) 107.39(11) C(27)–C(22)–C(23) 119.14(13) 
C(27)–C(22)–C(21) 133.62(12) C(23)–C(22)–C(21) 107.23(10) 
C(24)–C(23)–N(2) 129.40(11) C(24)–C(23)–C(22) 122.13(11) 
N(2)–C(23)–C(22) 108.43(11) C(23)–C(24)–C(25) 117.54(12) 
C(24)–C(25)–C(26) 121.03(14) C(27)–C(26)–C(25) 121.06(13) 
C(26)–C(27)–C(22) 119.01(13) C(29)–C(28)–N(3) 119.65(10) 
C(29)–C(28)–C(30") 117.66(10) N(3)–C(28)–C(30") 122.67(10) 
F(29)–C(29)–C(30) 117.40(10) F(29)–C(29)–C(28) 117.82(10) 
C(30)–C(29)–C(28) 124.65(10) C(29)–C(30)–N(4) 119.47(10) 
C(29)–C(30)–C(28") 117.69(10) N(4)–C(30)–C(28") 122.83(10) 
C(28)–N(3)–C(31) 125.42(10) C(28)–N(3)–C(38) 125.81(10) 
C(31)–N(3)–C(38) 108.53(10) C(32)–C(31)–N(3) 129.23(12) 
C(32)–C(31)–C(36) 122.17(12) N(3)–C(31)–C(36) 108.57(12) 
C(31)–C(32)–C(33) 117.35(15) C(34)–C(33)–C(32) 121.23(17) 
C(35)–C(34)–C(33) 121.00(14) C(34)–C(35)–C(36) 119.22(15) 
C(35)–C(36)–C(31) 118.96(15) C(35)–C(36)–C(37) 133.85(14) 
C(31)–C(36)–C(37) 107.19(11) C(42)–C(37)–C(38) 119.24(15) 
C(42)–C(37)–C(36) 133.40(14) C(38)–C(37)–C(36) 107.36(11) 
C(39)–C(38)–N(3) 129.19(12) C(39)–C(38)–C(37) 122.44(12) 
N(3)–C(38)–C(37) 108.35(12) C(38)–C(39)–C(40) 116.94(15) 
C(39)–C(40)–C(41) 121.38(16) C(42)–C(41)–C(40) 121.14(14) 
C(41)–C(42)–C(37) 118.83(15) C(50)–N(4)–C(43) 108.26(9) 
C(50)–N(4)–C(30) 126.33(10) C(43)–N(4)–C(30) 124.98(10) 
C(44)–C(43)–N(4) 129.21(10) C(44)–C(43)–C(48) 121.85(11) 
N(4)–C(43)–C(48) 108.91(10) C(45)–C(44)–C(43) 117.26(11) 
C(44)–C(45)–C(46) 121.76(12) C(47)–C(46)–C(45) 120.58(12) 
C(46)–C(47)–C(48) 118.93(12) C(47)–C(48)–C(43) 119.58(11) 
C(47)–C(48)–C(49) 133.42(11) C(43)–C(48)–C(49) 107.00(10) 
C(54)–C(49)–C(50) 119.38(11) C(54)–C(49)–C(48) 133.48(11) 
C(50)–C(49)–C(48) 107.13(10) C(51)–C(50)–N(4) 129.02(11) 
C(51)–C(50)–C(49) 122.22(11) N(4)–C(50)–C(49) 108.70(10) 
C(52)–C(51)–C(50) 117.24(12) C(51)–C(52)–C(53) 121.46(13) 
C(54)–C(53)–C(52) 120.92(12) C(53)–C(54)–C(49) 118.74(12) 
Cl(1)–C(55)–Cl(2) 109.9(4) Cl(2X)–C(55X)–Cl(1X) 118.2(8) 
Cl(1Y)–C(55Y)–Cl(2Y) 116.0(7)  
 
Symmetry operations for equivalent atoms 
'   x,y+1,z+1      "   x+1,y+1,z+1        
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Table 4.   Hydrogen coordinates and isotropic displacement parameters (Å2) for gwals2a. 
 
      x       y       z       U 
 
H(5)  0.1277(10) 0.4752(12) 0.3079(10) 0.039(4) 
H(6)  0.2142(10) 0.4318(12) 0.1856(10) 0.039(4) 
H(7)  0.1939(11) 0.2890(13) 0.1230(11) 0.044(5) 
H(8)  0.0833(11) 0.1829(13) 0.1853(11) 0.046(5) 
H(12) 0.1369(10) 0.3005(12) 0.5033(10) 0.037(4) 
H(13) 0.2061(11) 0.1543(13) 0.4961(10) 0.041(4) 
H(14) 0.1599(11) 0.0476(13) 0.3903(10) 0.043(4) 
H(15) 0.0485(10) 0.0939(12) 0.2853(9) 0.037(4) 
H(17)  0.1187(10) 0.6446(13) 0.3441(10) 0.041(4) 
H(18)  0.1974(12) 0.7581(14) 0.2590(12) 0.053(5) 
H(19)  0.1595(14) 0.9240(17) 0.2651(13) 0.069(6) 
H(20)  0.0426(12) 0.9776(14) 0.3634(11) 0.053(5) 
H(24) 0.1550(11) 0.6765(13) 0.5884(10) 0.042(4) 
H(25) 0.2322(12) 0.8136(14) 0.6489(11) 0.051(5) 
H(26) 0.1974(12) 0.9685(15) 0.5991(12) 0.056(5) 
H(27) 0.0860(11) 0.9954(14) 0.4893(11) 0.047(5) 
H(32) 0.3631(11) 0.3720(14) 0.5813(11) 0.048(5) 
H(33) 0.2800(12) 0.2696(15) 0.6323(12) 0.057(5) 
H(34) 0.3123(13) 0.1058(16) 0.6573(12) 0.067(6) 
H(35) 0.4245(12) 0.0403(15) 0.6273(12) 0.055(5) 
H(39) 0.6414(11) 0.3092(13) 0.4952(10) 0.045(5) 
H(40) 0.7180(12) 0.1671(14) 0.4920(11) 0.053(5) 
H(41) 0.6773(13) 0.0165(16) 0.5293(12) 0.063(6) 
H(42) 0.5632(12) 0.0005(15) 0.5770(11) 0.057(5) 
H(44) 0.3682(10) 0.5345(12) 0.6160(10) 0.041(4) 
H(45) 0.2849(11) 0.5795(14) 0.6970(11) 0.048(5) 
H(46) 0.3144(11) 0.7148(13) 0.7770(11) 0.048(5) 
H(47) 0.4240(11) 0.8146(13) 0.7780(10) 0.044(5) 
H(51) 0.6438(10) 0.6956(12) 0.5738(10) 0.038(4) 
H(52) 0.7212(11) 0.8334(13) 0.6251(10) 0.046(5) 
H(53) 0.6821(11) 0.9380(13) 0.7112(10) 0.046(5) 
H(54) 0.5625(11) 0.9026(14) 0.7489(10) 0.047(5) 
H(55A) 0.1576 0.4831 0.3572 0.093 
H(55B) 0.2172 0.4006 0.4025 0.093 
H(55C) 0.2217 0.4030 0.4065 0.163 
H(55D) 0.1597 0.4881 0.3737 0.163 
H(55E) 0.2346 0.6321 0.3879 0.174 
H(55F) 0.1757 0.5501 0.3422 0.174 
 192 
Table 5.  Torsion angles [°] for gwals2a. 
 
N(1)–C(1)–C(2)–F(2)  3.12(17) C(3')–C(1)–C(2)–F(2) 175.83(10) 
N(1)–C(1)–C(2)–C(3)  178.35(11) C(3')–C(1)–C(2)–C(3) 0.6(2) 
F(2)–C(2)–C(3)–N(2) 2.88(17) C(1)–C(2)–C(3)–N(2) 178.10(11) 
F(2)–C(2)–C(3)–C(1')  175.80(10) C(1)–C(2)–C(3)–C(1')  0.6(2) 
C(2)–C(1)–N(1)–C(4)  64.52(16) C(3')–C(1)–N(1)–C(4) 116.59(13) 
C(2)–C(1)–N(1)–C(11) 128.95(12) C(3')–C(1)–N(1)–C(11)  49.94(17) 
C(11)–N(1)–C(4)–C(5) 177.77(12) C(1)–N(1)–C(4)–C(5) 9.30(19) 
C(11)–N(1)–C(4)–C(9) 0.15(13) C(1)–N(1)–C(4)–C(9)  168.32(10) 
N(1)–C(4)–C(5)–C(6)  177.65(12) C(9)–C(4)–C(5)–C(6)  0.30(18) 
C(4)–C(5)–C(6)–C(7)  0.35(19) C(5)–C(6)–C(7)–C(8) 0.6(2) 
C(6)–C(7)–C(8)–C(9)  0.1(2) C(7)–C(8)–C(9)–C(4)  0.55(19) 
C(7)–C(8)–C(9)–C(10) 177.50(13) C(5)–C(4)–C(9)–C(8) 0.76(18) 
N(1)–C(4)–C(9)–C(8) 178.59(11) C(5)–C(4)–C(9)–C(10)  177.76(11) 
N(1)–C(4)–C(9)–C(10) 0.07(13) C(8)–C(9)–C(10)–C(15) 1.8(2) 
C(4)–C(9)–C(10)–C(15)  179.93(13) C(8)–C(9)–C(10)–C(11)  178.49(14) 
C(4)–C(9)–C(10)–C(11)  0.27(13) C(4)–N(1)–C(11)–C(12) 177.04(12) 
C(1)–N(1)–C(11)–C(12)  14.56(19) C(4)–N(1)–C(11)–C(10)  0.32(13) 
C(1)–N(1)–C(11)–C(10) 168.08(11) C(15)–C(10)–C(11)–C(12) 2.50(18) 
C(9)–C(10)–C(11)–C(12)  177.22(11) C(15)–C(10)–C(11)–N(1)  179.92(10) 
C(9)–C(10)–C(11)–N(1) 0.36(13) N(1)–C(11)–C(12)–C(13)  179.42(12) 
C(10)–C(11)–C(12)–C(13)  2.38(18) C(2)–C(3)–N(2)–C(23)  129.13(13) 
C(1')–C(3)–N(2)–C(23) 49.48(17) C(2)–C(3)–N(2)–C(16) 64.18(16) 
C(1')–C(3)–N(2)–C(16)  117.21(13) C(11)–C(12)–C(13)–C(14) 0.62(19) 
C(12)–C(13)–C(14)–C(15) 1.0(2) C(13)–C(14)–C(15)–C(10)  0.94(19) 
C(11)–C(10)–C(15)–C(14)  0.77(18) C(9)–C(10)–C(15)–C(14) 178.86(13) 
C(23)–N(2)–C(16)–C(17)  177.69(12) C(3)–N(2)–C(16)–C(17)  9.1(2) 
C(23)–N(2)–C(16)–C(21) 0.59(13) C(3)–N(2)–C(16)–C(21) 169.17(10) 
N(2)–C(16)–C(17)–C(18) 179.12(13) C(21)–C(16)–C(17)–C(18) 1.05(19) 
C(16)–C(17)–C(18)–C(19) 0.1(2) C(17)–C(18)–C(19)–C(20)  0.5(3) 
C(18)–C(19)–C(20)–C(21)  0.4(2) C(19)–C(20)–C(21)–C(16) 1.5(2) 
C(19)–C(20)–C(21)–C(22)  177.55(15) C(17)–C(16)–C(21)–C(20)  1.85(19) 
N(2)–C(16)–C(21)–C(20) 179.72(12) C(17)–C(16)–C(21)–C(22) 177.39(11) 
N(2)–C(16)–C(21)–C(22)  1.04(13) C(20)–C(21)–C(22)–C(27) 1.0(3) 
C(16)–C(21)–C(22)–C(27)  178.05(14) C(20)–C(21)–C(22)–C(23)  179.81(14) 
C(16)–C(21)–C(22)–C(23) 1.10(13) C(3)–N(2)–C(23)–C(24) 13.89(19) 
C(16)–N(2)–C(23)–C(24)  177.59(12) C(3)–N(2)–C(23)–C(22)  168.41(11) 
C(16)–N(2)–C(23)–C(22) 0.11(13) C(27)–C(22)–C(23)–C(24)  3.55(19) 
C(21)–C(22)–C(23)–C(24) 177.16(11) C(27)–C(22)–C(23)–N(2) 178.55(11) 
C(21)–C(22)–C(23)–N(2)  0.75(13) N(2)–C(23)–C(24)–C(25)  179.33(12) 
C(22)–C(23)–C(24)–C(25) 3.24(19) C(23)–C(24)–C(25)–C(26)  0.9(2) 
C(24)–C(25)–C(26)–C(27)  1.1(2) C(25)–C(26)–C(27)–C(22) 0.8(2) 
C(23)–C(22)–C(27)–C(26) 1.4(2) C(21)–C(22)–C(27)–C(26)  179.50(14) 
N(3)–C(28)–C(29)–F(29) 3.02(16) C(30")–C(28)–C(29)–F(29)  175.49(10) 
N(3)–C(28)–C(29)–C(30) 178.87(11) C(30")–C(28)–C(29)–C(30) 0.4(2) 
F(29)–C(29)–C(30)–N(4)  3.89(16) C(28)–C(29)–C(30)–N(4)  179.75(11) 
F(29)–C(29)–C(30)–C(28") 175.52(10) C(28)–C(29)–C(30)–C(28")  0.3(2) 
C(29)–C(28)–N(3)–C(31) 61.14(16) C(30")–C(28)–N(3)–C(31)  120.42(13) 
C(29)–C(28)–N(3)–C(38)  125.23(13) C(30")–C(28)–N(3)–C(38) 53.22(17) 
C(28)–N(3)–C(31)–C(32)  3.2(2) C(38)–N(3)–C(31)–C(32)  177.72(13) 
C(28)–N(3)–C(31)–C(36) 175.05(11) C(38)–N(3)–C(31)–C(36) 0.49(13) 
N(3)–C(31)–C(32)–C(33)  179.53(13) C(36)–C(31)–C(32)–C(33) 2.5(2) 
C(31)–C(32)–C(33)–C(34)  0.4(2) C(32)–C(33)–C(34)–C(35)  1.4(2) 
C(33)–C(34)–C(35)–C(36) 1.1(2) C(34)–C(35)–C(36)–C(31) 0.9(2) 
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C(34)–C(35)–C(36)–C(37)  179.54(15) C(32)–C(31)–C(36)–C(35)  2.74(19) 
N(3)–C(31)–C(36)–C(35) 178.89(12) C(32)–C(31)–C(36)–C(37) 177.57(12) 
N(3)–C(31)–C(36)–C(37)  0.80(14) C(35)–C(36)–C(37)–C(42) 0.8(3) 
C(31)–C(36)–C(37)–C(42)  179.60(15) C(35)–C(36)–C(37)–C(38)  178.82(15) 
C(31)–C(36)–C(37)–C(38) 0.81(14) C(28)–N(3)–C(38)–C(39) 7.5(2) 
C(31)–N(3)–C(38)–C(39)  177.98(12) C(28)–N(3)–C(38)–C(37)  174.51(11) 
C(31)–N(3)–C(38)–C(37) 0.03(13) C(42)–C(37)–C(38)–C(39)  2.01(19) 
C(36)–C(37)–C(38)–C(39) 177.65(12) C(42)–C(37)–C(38)–N(3) 179.83(12) 
C(36)–C(37)–C(38)–N(3)  0.51(14) N(3)–C(38)–C(39)–C(40) 179.90(12) 
C(37)–C(38)–C(39)–C(40) 2.14(19) C(38)–C(39)–C(40)–C(41)  0.8(2) 
C(39)–C(40)–C(41)–C(42)  0.7(2) C(40)–C(41)–C(42)–C(37) 0.9(2) 
C(38)–C(37)–C(42)–C(41) 0.4(2) C(36)–C(37)–C(42)–C(41)  179.14(15) 
C(29)–C(30)–N(4)–C(50) 128.70(12) C(28")–C(30)–N(4)–C(50)  50.67(17) 
C(29)–C(30)–N(4)–C(43)  59.72(16) C(28")–C(30)–N(4)–C(43) 120.91(13) 
C(50)–N(4)–C(43)–C(44) 178.50(12) C(30)–N(4)–C(43)–C(44) 5.63(19) 
C(50)–N(4)–C(43)–C(48) 0.51(13) C(30)–N(4)–C(43)–C(48)  172.36(10) 
N(4)–C(43)–C(44)–C(45)  179.72(12) C(48)–C(43)–C(44)–C(45)  1.95(18) 
C(43)–C(44)–C(45)–C(46) 0.2(2) C(44)–C(45)–C(46)–C(47) 1.4(2) 
C(45)–C(46)–C(47)–C(48)  1.2(2) C(46)–C(47)–C(48)–C(43)  0.53(18) 
C(46)–C(47)–C(48)–C(49) 179.91(13) C(44)–C(43)–C(48)–C(47) 2.17(18) 
N(4)–C(43)–C(48)–C(47)  179.66(11) C(44)–C(43)–C(48)–C(49)  178.17(11) 
N(4)–C(43)–C(48)–C(49) 0.00(13) C(47)–C(48)–C(49)–C(54) 0.2(2) 
C(43)–C(48)–C(49)–C(54)  179.39(13) C(47)–C(48)–C(49)–C(50) 179.10(13) 
C(43)–C(48)–C(49)–C(50)  0.50(13) C(43)–N(4)–C(50)–C(51) 176.37(12) 
C(30)–N(4)–C(50)–C(51)  10.89(19) C(43)–N(4)–C(50)–C(49)  0.83(13) 
C(30)–N(4)–C(50)–C(49) 171.92(11) C(54)–C(49)–C(50)–C(51) 2.47(18) 
C(48)–C(49)–C(50)–C(51)  176.61(11) C(54)–C(49)–C(50)–N(4) 179.89(11) 
C(48)–C(49)–C(50)–N(4) 0.82(13) N(4)–C(50)–C(51)–C(52)  178.81(12) 
C(49)–C(50)–C(51)–C(52)  1.95(18) C(50)–C(51)–C(52)–C(53) 0.4(2) 
C(51)–C(52)–C(53)–C(54) 0.7(2) C(52)–C(53)–C(54)–C(49)  0.2(2) 
C(50)–C(49)–C(54)–C(53)  1.33(19) C(48)–C(49)–C(54)–C(53) 177.45(13) 
 
Symmetry operations for equivalent atoms 
'   x,y+1,z+1      "   x+1,y+1,z+1        
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5.1.7. Compound 105 X-ray crystal structure data  
 
Crystal data 
C19H11F4N Dx = 1.491 Mg m-3 
Mr = 329.29 Mo K〈 radiation,  = 0.71073 Å 
Orthorhombic, Pbcn Cell parameters from 6104 reflections 
a = 7.6086 (6) Å  = 2.6–31.3° 
b = 12.4954 (9) Å  = 0.12 mm-1 
c = 15.4335 (11) Å T = 150 K 
V = 1467.30 (19)  Å3 Block, yellow 
Z = 4 0.77 × 0.40 × 0.20 mm 
F(000) = 672  
 
Data collection 
Bruker APEX 2 CCD diffractometer 2365 independent reflections 
Radiation source: fine-focus sealed tube 2014 reflections with I > 2⌠(I) 
graphite Rint = 0.023 
 rotation with narrow frames scans max = 31.5°, min = 2.6° 
Absorption correction: multi-scan  SADABS v20  
Sheldrick, G.M., (2009) 
h = -10 11 
Tmin = 0.911, Tmax = 0.976 k = -17 18 
16055 measured reflections l = -22 22 
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Refinement 
Refinement on F2 Primary atom site location: structure-invariant di  
methods 
Least-squares matrix: full Secondary atom site location: all non-H atoms fo   
direct methods 
R[F2 > 2⌠(F2)] = 0.046 Hydrogen site location: mixed 
wR(F2) = 0.139 H atoms treated by a mixture of independent and 
constrained refinement 
S = 1.04 w = 1/[⌠2(Fo2) + (0.0907P)2 + 0.222P]         
(Fo2 + 2Fc2)/3 
2365 reflections (⊗/⌠)max < 0.001 
127 parameters ⊗〉max = 0.44 e Å-3 
0 restraints ⊗〉min = -0.19 e Å-3 
 
 
 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
 x y z Uiso*/Ueq Occ. (<1) 
N1 0.0000 0.30863 (8) 0.2500 0.0239 (2)  
C1 0.05896 (12) 0.24315 (7) 0.18205 (5) 0.0230 (2)  
C2 0.13210 (15) 0.27195 (8) 0.10282 (6) 0.0290 (2)  
H2 0.1476 (19) 0.3461 (12) 0.0855 (9) 0.037 (4)*  
C3 0.18233 (16) 0.18998 (8) 0.04738 (7) 0.0334 (2)  
H3 0.2374 (19) 0.2069 (10) -0.0071 (9) 0.037 (4)*  
C4 0.15930 (15) 0.08220 (9) 0.07009 (7) 0.0336 (3)  
H4 0.192 (2) 0.0274 (12) 0.0299 (10) 0.043 (4)*  
C5 0.08732 (14) 0.05423 (8) 0.14951 (7) 0.0290 (2)  
H5 0.0751 (19) -0.0222 (11) 0.1654 (9) 0.031 (3)*  
C6 0.03737 (12) 0.13535 (7) 0.20680 (6) 0.0231 (2)  
C7 0.0000 0.42095 (10) 0.2500 0.0230 (3)  
C8 -0.08293 (13) 0.47953 (8) 0.18501 (6) 0.0272 (2)  
F8 -0.16961 (10) 0.42791 (6) 0.12201 (4) 0.0388 (2)  
C9 -0.07794 (14) 0.59024 (9) 0.18442 (8) 0.0345 (3)  
F9 -0.15644 (11) 0.64085 (7) 0.11771 (6) 0.0531 (3)  
C10 0.0000 0.64836 (11) 0.2500 0.0381 (4)  
C11 0.0000 0.76857 (13) 0.2500 0.0609 (7)  
H11A 0.0613 0.7947 0.3017 0.091* 0.5 
H11B -0.1214 0.7947 0.2504 0.091* 0.5 
H11C 0.0601 0.7947 0.1980 0.091* 0.5 
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Geometric parameters (Å, º) 
N1—C7 1.4035 (15) C6—C6i 1.4497 (18) 
N1—C1i 1.4037 (10) C7—C8i 1.3928 (11) 
N1—C1 1.4037 (10) C7—C8 1.3929 (11) 
C1—C2 1.3909 (13) C8—F8 1.3403 (12) 
C1—C6 1.4097 (12) C8—C9 1.3839 (14) 
C2—C3 1.3882 (14) C9—F9 1.3478 (13) 
C2—H2 0.971 (15) C9—C10 1.3796 (14) 
C3—C4 1.4026 (15) C10—C9i 1.3796 (15) 
C3—H3 0.963 (14) C10—C11 1.502 (2) 
C4—C5 1.3872 (14) C11—H11A 0.9800 
C4—H4 0.957 (16) C11—H11B 0.9800 
C5—C6 1.3977 (13) C11—H11C 0.9800 
C5—H5 0.990 (14)   
    
C7—N1—C1i 125.65 (5) C1—C6—C6i 107.15 (5) 
C7—N1—C1 125.65 (5) C8i—C7—C8 116.59 (12) 
C1i—N1—C1 108.69 (10) C8i—C7—N1 121.71 (6) 
C2—C1—N1 129.34 (8) C8—C7—N1 121.70 (6) 
C2—C1—C6 122.14 (8) F8—C8—C9 119.33 (9) 
N1—C1—C6 108.50 (8) F8—C8—C7 119.49 (9) 
C3—C2—C1 117.47 (9) C9—C8—C7 121.17 (10) 
C3—C2—H2 120.0 (8) F9—C9—C10 120.26 (10) 
C1—C2—H2 122.5 (8) F9—C9—C8 117.50 (11) 
C2—C3—C4 121.33 (9) C10—C9—C8 122.22 (10) 
C2—C3—H3 119.7 (8) C9—C10—C9i 116.48 (13) 
C4—C3—H3 118.9 (8) C9—C10—C11 121.76 (6) 
C5—C4—C3 120.80 (9) C9i—C10—C11 121.76 (6) 
C5—C4—H4 119.7 (10) C10—C11—H11A 109.5 
C3—C4—H4 119.5 (9) C10—C11—H11B 109.5 
C4—C5—C6 118.92 (9) H11A—C11—H11B 109.5 
C4—C5—H5 119.9 (8) C10—C11—H11C 109.5 
C6—C5—H5 121.2 (8) H11A—C11—H11C 109.5 
C5—C6—C1 119.33 (8) H11B—C11—H11C 109.5 
C5—C6—C6i 133.51 (6)   
    
C7—N1—C1—C2 1.64 (12) C1—N1—C7—C8i -124.67 (7) 
C1i—N1—C1—C2 -178.36 (12) C1i—N1—C7—C8 -124.67 (7) 
C7—N1—C1—C6 -179.96 (5) C1—N1—C7—C8 55.33 (7) 
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C1i—N1—C1—C6 0.04 (5) C8i—C7—C8—F8 -178.01 (10) 
N1—C1—C2—C3 178.93 (9) N1—C7—C8—F8 1.99 (10) 
C6—C1—C2—C3 0.72 (15) C8i—C7—C8—C9 1.79 (7) 
C1—C2—C3—C4 0.38 (17) N1—C7—C8—C9 -178.21 (7) 
C2—C3—C4—C5 -0.83 (18) F8—C8—C9—F9 -2.38 (14) 
C3—C4—C5—C6 0.17 (17) C7—C8—C9—F9 177.83 (8) 
C4—C5—C6—C1 0.90 (15) F8—C8—C9—C10 176.09 (8) 
C4—C5—C6—C6i -178.87 (13) C7—C8—C9—C10 -3.71 (14) 
C2—C1—C6—C5 -1.38 (15) F9—C9—C10—C9i -179.75 (11) 
N1—C1—C6—C5 -179.91 (8) C8—C9—C10—C9i 1.83 (7) 
C2—C1—C6—C6i 178.45 (10) F9—C9—C10—C11 0.25 (11) 
N1—C1—C6—C6i -0.09 (12) C8—C9—C10—C11 -178.17 (7) 
C1i—N1—C7—C8i 55.33 (7)   
 
Symmetry code:  (i) -x, y, -z+1/2. 
Computing details 
Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL2012 (Sheldrick, 2012); molecular graphics: Bruker SHELXTL; software used to prepare material 
for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using 
the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in 
distances, angles and torsion angles; correlations between esds in cell parameters are only used when they 
are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating 
esds involving l.s. planes. 
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5.1.8. Compound 111 X-ray crystal structure data 
 
 
GW92 
Crystal data 
C19H10F4N2O Dx = 1.542 Mg m-3 
Mr = 358.29 Mo K〈 radiation,  = 0.71073 Å 
Orthorhombic, Pbca Cell parameters from 1594 reflections 
a = 13.571 (4) Å  = 2.9–20.0° 
b = 7.963 (2) Å  = 0.13 mm-1 
c = 28.555 (9) Å T = 150 K 
V = 3085.8 (15) Å3 Plate, colourless 
Z = 8 0.54 × 0.17 × 0.04 mm 
F(000) = 1456  
 
Data collection 
Bruker APEX 2 CCD diffractometer 1736 reflections with I > 2⌠(I) 
Radiation source: fine-focus sealed tube Rint = 0.132 
 rotation with narrow frames scans max = 26.5°, min = 2.1° 
Absorption correction: multi-scan  SADABS v20  h = -16 16 
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Sheldrick, G.M., (2012) 
Tmin = 0.933, Tmax = 0.995 k = -9 9 
25328 measured reflections l = -35 35 
3161 independent reflections  
 
Refinement 
Refinement on F2 Secondary atom site location: all non-H atoms fo   
direct methods 
Least-squares matrix: full Hydrogen site location: difference Fourier map 
R[F2 > 2⌠(F2)] = 0.049 All H-atom parameters refined 
wR(F2) = 0.132 w = 1/[⌠2(Fo2) + (0.0571P)2]     w here P = (Fo2  
2Fc2)/3 
S = 0.99 (⊗/⌠)max < 0.001 
3161 reflections ⊗〉max = 0.25 e Å-3 
276 parameters ⊗〉min = -0.23 e Å-3 
0 restraints Extinction correction: SHELXL, 
Fc*=kFc[1+0.001xFc23/sin(2)]-1/4 
Primary atom site location: structure-invariant di  
methods 
Extinction coefficient: 0.0049 (8) 
 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
 x y z Uiso*/Ueq 
N1 0.04871 (17) 0.1369 (3) 0.35349 (8) 0.0378 (6) 
C1 0.0740 (2) 0.1025 (4) 0.30676 (10) 0.0373 (7) 
C2 0.0590 (2) -0.0423 (4) 0.28075 (11) 0.0426 (8) 
H2 0.026 (2) -0.134 (4) 0.2948 (10) 0.049 (9)* 
C3 0.0935 (2) -0.0441 (5) 0.23534 (12) 0.0483 (8) 
H3 0.083 (2) -0.140 (4) 0.2159 (10) 0.048 (9)* 
C4 0.1424 (2) 0.0930 (4) 0.21631 (13) 0.0487 (8) 
H4 0.166 (2) 0.091 (3) 0.1859 (11) 0.042 (8)* 
C5 0.1591 (2) 0.2355 (4) 0.24234 (11) 0.0449 (8) 
H5 0.193 (2) 0.320 (4) 0.2305 (10) 0.043 (9)* 
C6 0.12468 (19) 0.2421 (3) 0.28843 (10) 0.0383 (7) 
C7 0.1301 (2) 0.3663 (4) 0.32544 (10) 0.0377 (7) 
C8 0.1703 (2) 0.5272 (4) 0.32842 (13) 0.0474 (8) 
H8 0.200 (2) 0.575 (4) 0.3024 (11) 0.046 (9)* 
C9 0.1663 (3) 0.6117 (4) 0.37006 (13) 0.0547 (9) 
H9 0.199 (2) 0.724 (4) 0.3729 (10) 0.060 (9)* 
C10 0.1202 (2) 0.5411 (4) 0.40912 (13) 0.0497 (9) 
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H10 0.122 (2) 0.602 (4) 0.4381 (10) 0.052 (9)* 
C11 0.0771 (2) 0.3840 (4) 0.40700 (12) 0.0440 (8) 
H11 0.0468 (19) 0.341 (3) 0.4337 (10) 0.040 (8)* 
C12 0.0840 (2) 0.2982 (3) 0.36497 (10) 0.0371 (7) 
C13 -0.0088 (2) 0.0320 (3) 0.38198 (10) 0.0334 (7) 
C14 -0.1036 (2) -0.0119 (3) 0.36898 (9) 0.0346 (7) 
F1 -0.14277 (12) 0.05460 (19) 0.32971 (5) 0.0432 (5) 
C15 -0.1600 (2) -0.1206 (3) 0.39521 (10) 0.0351 (7) 
F2 -0.25108 (12) -0.1617 (2) 0.37997 (6) 0.0463 (5) 
C16 -0.1248 (2) -0.1897 (3) 0.43664 (9) 0.0332 (7) 
C17 -0.0316 (2) -0.1421 (3) 0.44970 (10) 0.0363 (7) 
F3 0.00820 (12) -0.2019 (2) 0.49005 (5) 0.0446 (5) 
C18 0.0255 (2) -0.0352 (3) 0.42344 (10) 0.0367 (7) 
F4 0.11782 (11) 0.00170 (19) 0.43845 (6) 0.0468 (5) 
C19 -0.1803 (2) -0.3235 (3) 0.46370 (10) 0.0389 (7) 
O1 -0.14247 (15) -0.4619 (2) 0.46851 (8) 0.0496 (6) 
N2 -0.2671 (2) -0.2802 (3) 0.48027 (10) 0.0487 (8) 
H2A -0.287 (3) -0.171 (5) 0.4789 (13) 0.088 (13)* 
H2B -0.301 (3) -0.351 (4) 0.4983 (12) 0.067 (11)* 
 
Geometric parameters (Å, º) 
N1—C13 1.403 (3) C10—C11 1.382 (4) 
N1—C1 1.405 (4) C10—H10 0.96 (3) 
N1—C12 1.410 (3) C11—C12 1.384 (4) 
C1—C2 1.387 (4) C11—H11 0.93 (3) 
C1—C6 1.408 (4) C13—C18 1.380 (4) 
C2—C3 1.379 (4) C13—C14 1.384 (4) 
C2—H2 0.94 (3) C14—F1 1.349 (3) 
C3—C4 1.388 (5) C14—C15 1.378 (4) 
C3—H3 0.95 (3) C15—F2 1.350 (3) 
C4—C5 1.375 (5) C15—C16 1.389 (4) 
C4—H4 0.93 (3) C16—C17 1.373 (4) 
C5—C6 1.397 (4) C16—C19 1.516 (4) 
C5—H5 0.89 (3) C17—F3 1.358 (3) 
C6—C7 1.449 (4) C17—C18 1.373 (4) 
C7—C8 1.395 (4) C18—F4 1.357 (3) 
C7—C12 1.400 (4) C19—O1 1.224 (3) 
C8—C9 1.367 (5) C19—N2 1.316 (4) 
C8—H8 0.93 (3) N2—H2A 0.92 (4) 
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C9—C10 1.397 (5) N2—H2B 0.89 (4) 
C9—H9 1.00 (3)   
    
C13—N1—C1 124.8 (2) C9—C10—H10 118.0 (18) 
C13—N1—C12 126.6 (2) C10—C11—C12 117.1 (3) 
C1—N1—C12 108.4 (2) C10—C11—H11 118.8 (17) 
C2—C1—N1 129.4 (3) C12—C11—H11 124.0 (17) 
C2—C1—C6 122.0 (3) C11—C12—C7 122.6 (3) 
N1—C1—C6 108.6 (2) C11—C12—N1 128.9 (3) 
C3—C2—C1 117.5 (3) C7—C12—N1 108.5 (2) 
C3—C2—H2 123.6 (17) C18—C13—C14 116.4 (2) 
C1—C2—H2 118.9 (17) C18—C13—N1 122.8 (2) 
C2—C3—C4 121.5 (4) C14—C13—N1 120.8 (2) 
C2—C3—H3 120.1 (17) F1—C14—C15 118.6 (3) 
C4—C3—H3 118.3 (17) F1—C14—C13 119.4 (2) 
C5—C4—C3 121.1 (3) C15—C14—C13 122.0 (3) 
C5—C4—H4 117.6 (17) F2—C15—C14 119.1 (2) 
C3—C4—H4 121.3 (17) F2—C15—C16 119.5 (2) 
C4—C5—C6 119.0 (3) C14—C15—C16 121.4 (3) 
C4—C5—H5 120.6 (18) C17—C16—C15 116.0 (2) 
C6—C5—H5 120.3 (19) C17—C16—C19 120.9 (2) 
C5—C6—C1 118.9 (3) C15—C16—C19 122.8 (3) 
C5—C6—C7 134.1 (3) F3—C17—C16 120.0 (2) 
C1—C6—C7 107.0 (2) F3—C17—C18 117.2 (2) 
C8—C7—C12 118.8 (3) C16—C17—C18 122.8 (3) 
C8—C7—C6 133.7 (3) F4—C18—C17 118.8 (2) 
C12—C7—C6 107.5 (2) F4—C18—C13 119.9 (2) 
C9—C8—C7 119.3 (3) C17—C18—C13 121.3 (3) 
C9—C8—H8 120.6 (18) O1—C19—N2 124.8 (3) 
C7—C8—H8 120.1 (18) O1—C19—C16 118.8 (3) 
C8—C9—C10 120.9 (3) N2—C19—C16 116.4 (3) 
C8—C9—H9 119.5 (18) C19—N2—H2A 120 (2) 
C10—C9—H9 119.6 (18) C19—N2—H2B 120 (2) 
C11—C10—C9 121.2 (3) H2A—N2—H2B 118 (3) 
C11—C10—H10 120.6 (18)   
    
C13—N1—C1—C2 -7.7 (5) C1—N1—C12—C7 0.9 (3) 
C12—N1—C1—C2 176.9 (3) C1—N1—C13—C18 120.3 (3) 
C13—N1—C1—C6 175.0 (2) C12—N1—C13—C18 -65.1 (4) 
C12—N1—C1—C6 -0.4 (3) C1—N1—C13—C14 -58.5 (4) 
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N1—C1—C2—C3 -178.5 (3) C12—N1—C13—C14 116.1 (3) 
C6—C1—C2—C3 -1.5 (4) C18—C13—C14—F1 177.5 (2) 
C1—C2—C3—C4 0.6 (5) N1—C13—C14—F1 -3.6 (4) 
C2—C3—C4—C5 0.6 (5) C18—C13—C14—C15 -1.8 (4) 
C3—C4—C5—C6 -0.9 (5) N1—C13—C14—C15 177.0 (2) 
C4—C5—C6—C1 0.0 (4) F1—C14—C15—F2 2.4 (4) 
C4—C5—C6—C7 178.6 (3) C13—C14—C15—F2 -178.3 (2) 
C2—C1—C6—C5 1.3 (4) F1—C14—C15—C16 -178.3 (2) 
N1—C1—C6—C5 178.8 (2) C13—C14—C15—C16 1.1 (4) 
C2—C1—C6—C7 -177.7 (3) F2—C15—C16—C17 179.8 (2) 
N1—C1—C6—C7 -0.1 (3) C14—C15—C16—C17 0.4 (4) 
C5—C6—C7—C8 1.5 (6) F2—C15—C16—C19 6.0 (4) 
C1—C6—C7—C8 -179.8 (3) C14—C15—C16—C19 -173.4 (3) 
C5—C6—C7—C12 -178.1 (3) C15—C16—C17—F3 179.1 (2) 
C1—C6—C7—C12 0.7 (3) C19—C16—C17—F3 -6.9 (4) 
C12—C7—C8—C9 2.0 (4) C15—C16—C17—C18 -1.2 (4) 
C6—C7—C8—C9 -177.5 (3) C19—C16—C17—C18 172.8 (3) 
C7—C8—C9—C10 -1.8 (5) F3—C17—C18—F4 1.4 (4) 
C8—C9—C10—C11 -0.1 (5) C16—C17—C18—F4 -178.3 (2) 
C9—C10—C11—C12 1.8 (5) F3—C17—C18—C13 -179.9 (2) 
C10—C11—C12—C7 -1.6 (4) C16—C17—C18—C13 0.4 (4) 
C10—C11—C12—N1 178.8 (3) C14—C13—C18—F4 179.8 (2) 
C8—C7—C12—C11 -0.3 (4) N1—C13—C18—F4 1.0 (4) 
C6—C7—C12—C11 179.3 (3) C14—C13—C18—C17 1.1 (4) 
C8—C7—C12—N1 179.4 (3) N1—C13—C18—C17 -177.7 (3) 
C6—C7—C12—N1 -1.0 (3) C17—C16—C19—O1 -56.4 (4) 
C13—N1—C12—C11 5.3 (5) C15—C16—C19—O1 117.1 (3) 
C1—N1—C12—C11 -179.4 (3) C17—C16—C19—N2 123.8 (3) 
C13—N1—C12—C7 -174.4 (3) C15—C16—C19—N2 -62.7 (4) 
 
Hydrogen-bond geometry (Å, º) 
  D—H···A D—H H···A D···A D—H···A 
N2—H2A···O1i 0.92 (4) 1.94 (4) 2.835 (3) 166 (3) 
N2—H2B···F3ii 0.89 (4) 2.65 (3) 3.168 (3) 118 (3) 
N2—H2B···F4ii 0.89 (4) 2.43 (4) 3.307 (3) 167 (3) 
 
Symmetry codes:  (i) -x-1/2, y+1/2, z; (ii) x-1/2, -y-1/2, -z+1. 
Computing details 
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Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL2013 (Sheldrick, 2013); molecular graphics: Bruker SHELXTL; software used to prepare material 
for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using 
the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in 
distances, angles and torsion angles; correlations between esds in cell parameters are only used when they 
are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating 
esds involving l.s. planes. 
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5.1.9. Compound 116 X-ray crystal structure data 
 
 
GW89 
Crystal data 
C20H11F4NO2 F(000) = 760 
Mr = 373.30 Dx = 1.529 Mg m-3 
Monoclinic, P21/n Mo K〈 radiation,  = 0.71073 Å 
a = 10.738 (5) Å Cell parameters from 1630 reflections 
b = 8.060 (4) Å  = 2.8–20.9° 
c = 18.743 (9) Å  = 0.13 mm-1 
 = 91.914 (9)° T = 150 K 
V = 1621.3 (14)  Å3 Tablet, colourless 
Z = 4 0.38 × 0.18 × 0.06 mm 
 
Data collection 
Bruker APEX 2 CCD diffractometer 3171 independent reflections 
Radiation source: fine-focus sealed X-ray tube 2156 reflections with I > 2⌠(I) 
graphite Rint = 0.075 
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 rotation with narrow frames scans max = 26.0°, min = 2.2° 
Absorption correction: multi-scan  SADABS v20  
Sheldrick, G.M., (2009) 
h = -13 13 
Tmin = 0.952, Tmax = 0.992 k = 0 9 
24001 measured reflections l = 0 22 
 
Refinement 
Refinement on F2 Primary atom site location: structure-invariant di  
methods 
Least-squares matrix: full Secondary atom site location: all non-H atoms fo   
direct methods 
R[F2 > 2⌠(F2)] = 0.041 Hydrogen site location: difference Fourier map 
wR(F2) = 0.094 Only H-atom coordinates refined 
S = 1.01 w = 1/[⌠2(Fo2) + (0.0382P)2 + 0.1557P]         
(Fo2 + 2Fc2)/3 
3171 reflections (⊗/⌠)max < 0.001 
278 parameters ⊗〉max = 0.18 e Å-3 
0 restraints ⊗〉min = -0.19 e Å-3 
 
 
 
 
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) 
 x y z Uiso*/Ueq 
N1 0.85756 (17) 0.5249 (2) 0.26300 (11) 0.0318 (5) 
C1 0.7748 (2) 0.4961 (3) 0.31861 (14) 0.0334 (6) 
C2 0.6555 (2) 0.4269 (3) 0.31502 (16) 0.0402 (7) 
H2 0.621 (2) 0.396 (3) 0.2730 (14) 0.048* 
C3 0.5963 (3) 0.4034 (3) 0.37881 (17) 0.0486 (7) 
H3 0.509 (3) 0.352 (4) 0.3755 (15) 0.058* 
C4 0.6536 (3) 0.4453 (4) 0.44403 (17) 0.0503 (8) 
H4 0.612 (3) 0.428 (4) 0.4864 (15) 0.060* 
C5 0.7709 (3) 0.5158 (3) 0.44726 (16) 0.0437 (7) 
H5 0.808 (2) 0.550 (4) 0.4956 (14) 0.052* 
C6 0.8324 (2) 0.5426 (3) 0.38356 (14) 0.0349 (6) 
C7 0.9543 (2) 0.6072 (3) 0.36804 (13) 0.0344 (6) 
C8 1.0512 (3) 0.6758 (4) 0.41013 (16) 0.0455 (7) 
H8 1.042 (3) 0.681 (4) 0.4610 (16) 0.055* 
C9 1.1583 (3) 0.7246 (4) 0.37752 (18) 0.0493 (8) 
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H9 1.219 (3) 0.771 (3) 0.4068 (18) 0.059* 
C10 1.1705 (3) 0.7101 (4) 0.30427 (17) 0.0453 (7) 
H10 1.250 (3) 0.746 (3) 0.2848 (16) 0.054* 
C11 1.0754 (2) 0.6437 (3) 0.26069 (15) 0.0374 (7) 
H11 1.084 (2) 0.636 (3) 0.2125 (15) 0.045* 
C12 0.9689 (2) 0.5919 (3) 0.29373 (13) 0.0313 (6) 
C13 0.8371 (2) 0.4866 (3) 0.19060 (13) 0.0303 (6) 
C14 0.7317 (2) 0.5410 (3) 0.15204 (13) 0.0301 (6) 
F14 0.64686 (12) 0.63473 (16) 0.18547 (7) 0.0366 (4) 
C15 0.7140 (2) 0.5072 (3) 0.08089 (14) 0.0310 (6) 
F15 0.60909 (12) 0.56754 (18) 0.04800 (7) 0.0406 (4) 
C16 0.8010 (2) 0.4220 (3) 0.04221 (13) 0.0320 (6) 
C17 0.9075 (2) 0.3701 (3) 0.08051 (14) 0.0340 (6) 
F17 0.99628 (13) 0.28389 (19) 0.04747 (9) 0.0450 (4) 
C18 0.9227 (2) 0.3951 (3) 0.15271 (14) 0.0333 (6) 
F18 1.02318 (12) 0.32964 (18) 0.18693 (8) 0.0426 (4) 
C19 0.7856 (2) 0.3830 (3) -0.03600 (14) 0.0350 (6) 
O1 0.86958 (17) 0.3861 (2) -0.07698 (10) 0.0486 (5) 
O2 0.66870 (15) 0.3407 (2) -0.05347 (9) 0.0398 (5) 
C20 0.6456 (3) 0.2960 (4) -0.12776 (17) 0.0476 (7) 
H20A 0.559 (3) 0.266 (4) -0.1294 (18) 0.071* 
H20B 0.662 (3) 0.387 (4) -0.1567 (17) 0.071* 
H20C 0.703 (3) 0.204 (4) -0.1400 (16) 0.071* 
Geometric parameters (Å, º) 
N1—C13 1.402 (3) C10—H10 0.98 (3) 
N1—C1 1.411 (3) C11—C12 1.384 (4) 
N1—C12 1.416 (3) C11—H11 0.91 (3) 
C1—C2 1.397 (3) C13—C18 1.392 (3) 
C1—C6 1.398 (3) C13—C14 1.393 (3) 
C2—C3 1.385 (4) C14—F14 1.354 (3) 
C2—H2 0.89 (3) C14—C15 1.368 (3) 
C3—C4 1.392 (4) C15—F15 1.356 (3) 
C3—H3 1.02 (3) C15—C16 1.384 (3) 
C4—C5 1.381 (4) C16—C17 1.394 (3) 
C4—H4 0.94 (3) C16—C19 1.503 (4) 
C5—C6 1.400 (4) C17—F17 1.347 (3) 
C5—H5 1.02 (3) C17—C18 1.372 (4) 
C6—C7 1.447 (3) C18—F18 1.344 (3) 
C7—C8 1.398 (4) C19—O1 1.204 (3) 
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C7—C12 1.412 (3) C19—O2 1.330 (3) 
C8—C9 1.378 (4) O2—C20 1.452 (3) 
C8—H8 0.96 (3) C20—H20A 0.96 (4) 
C9—C10 1.388 (5) C20—H20B 0.94 (3) 
C9—H9 0.92 (3) C20—H20C 1.00 (3) 
C10—C11 1.393 (4)   
    
C13—N1—C1 126.62 (19) C12—C11—H11 122.5 (16) 
C13—N1—C12 125.5 (2) C10—C11—H11 120.4 (17) 
C1—N1—C12 107.81 (19) C11—C12—C7 122.4 (2) 
C2—C1—C6 121.8 (2) C11—C12—N1 129.2 (2) 
C2—C1—N1 129.0 (2) C7—C12—N1 108.4 (2) 
C6—C1—N1 109.1 (2) C18—C13—C14 116.2 (2) 
C3—C2—C1 117.3 (3) C18—C13—N1 121.7 (2) 
C3—C2—H2 122.3 (18) C14—C13—N1 122.1 (2) 
C1—C2—H2 120.4 (18) F14—C14—C15 119.2 (2) 
C2—C3—C4 121.5 (3) F14—C14—C13 118.9 (2) 
C2—C3—H3 116.6 (16) C15—C14—C13 121.8 (2) 
C4—C3—H3 121.9 (16) F15—C15—C14 117.3 (2) 
C5—C4—C3 120.9 (3) F15—C15—C16 120.3 (2) 
C5—C4—H4 119.2 (18) C14—C15—C16 122.3 (2) 
C3—C4—H4 119.8 (17) C15—C16—C17 115.8 (2) 
C4—C5—C6 118.8 (3) C15—C16—C19 124.1 (2) 
C4—C5—H5 118.8 (15) C17—C16—C19 120.1 (2) 
C6—C5—H5 122.4 (15) F17—C17—C18 117.8 (2) 
C1—C6—C5 119.6 (2) F17—C17—C16 119.9 (2) 
C1—C6—C7 107.4 (2) C18—C17—C16 122.2 (2) 
C5—C6—C7 133.0 (2) F18—C18—C17 118.7 (2) 
C8—C7—C12 119.1 (2) F18—C18—C13 119.8 (2) 
C8—C7—C6 133.6 (3) C17—C18—C13 121.4 (2) 
C12—C7—C6 107.3 (2) O1—C19—O2 124.7 (2) 
C9—C8—C7 118.6 (3) O1—C19—C16 123.8 (2) 
C9—C8—H8 123.0 (17) O2—C19—C16 111.5 (2) 
C7—C8—H8 118.3 (18) C19—O2—C20 115.4 (2) 
C8—C9—C10 121.5 (3) O2—C20—H20A 103 (2) 
C8—C9—H9 116 (2) O2—C20—H20B 109.3 (19) 
C10—C9—H9 123 (2) H20A—C20—H20B 112 (3) 
C9—C10—C11 121.4 (3) O2—C20—H20C 108.6 (18) 
C9—C10—H10 117.0 (18) H20A—C20—H20C 114 (3) 
C11—C10—H10 121.6 (18) H20B—C20—H20C 109 (3) 
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C12—C11—C10 117.0 (3)   
    
C13—N1—C1—C2 -1.0 (4) C1—N1—C13—C18 -127.8 (3) 
C12—N1—C1—C2 -177.9 (2) C12—N1—C13—C18 48.5 (3) 
C13—N1—C1—C6 176.5 (2) C1—N1—C13—C14 53.7 (3) 
C12—N1—C1—C6 -0.4 (3) C12—N1—C13—C14 -129.9 (3) 
C6—C1—C2—C3 -0.9 (4) C18—C13—C14—F14 -178.1 (2) 
N1—C1—C2—C3 176.3 (2) N1—C13—C14—F14 0.4 (3) 
C1—C2—C3—C4 -0.7 (4) C18—C13—C14—C15 -0.4 (3) 
C2—C3—C4—C5 1.6 (4) N1—C13—C14—C15 178.1 (2) 
C3—C4—C5—C6 -0.9 (4) F14—C14—C15—F15 -1.5 (3) 
C2—C1—C6—C5 1.6 (4) C13—C14—C15—F15 -179.2 (2) 
N1—C1—C6—C5 -176.1 (2) F14—C14—C15—C16 175.5 (2) 
C2—C1—C6—C7 179.3 (2) C13—C14—C15—C16 -2.2 (4) 
N1—C1—C6—C7 1.6 (3) F15—C15—C16—C17 177.9 (2) 
C4—C5—C6—C1 -0.6 (4) C14—C15—C16—C17 1.0 (4) 
C4—C5—C6—C7 -177.7 (3) F15—C15—C16—C19 -2.8 (4) 
C1—C6—C7—C8 177.8 (3) C14—C15—C16—C19 -179.7 (2) 
C5—C6—C7—C8 -4.9 (5) C15—C16—C17—F17 178.9 (2) 
C1—C6—C7—C12 -2.2 (3) C19—C16—C17—F17 -0.4 (4) 
C5—C6—C7—C12 175.1 (3) C15—C16—C17—C18 2.9 (4) 
C12—C7—C8—C9 -0.7 (4) C19—C16—C17—C18 -176.5 (2) 
C6—C7—C8—C9 179.3 (3) F17—C17—C18—F18 -1.5 (3) 
C7—C8—C9—C10 1.3 (4) C16—C17—C18—F18 174.6 (2) 
C8—C9—C10—C11 -0.8 (5) F17—C17—C18—C13 178.2 (2) 
C9—C10—C11—C12 -0.4 (4) C16—C17—C18—C13 -5.6 (4) 
C10—C11—C12—C7 1.1 (4) C14—C13—C18—F18 -176.0 (2) 
C10—C11—C12—N1 178.0 (2) N1—C13—C18—F18 5.4 (3) 
C8—C7—C12—C11 -0.6 (4) C14—C13—C18—C17 4.2 (3) 
C6—C7—C12—C11 179.5 (2) N1—C13—C18—C17 -174.3 (2) 
C8—C7—C12—N1 -178.0 (2) C15—C16—C19—O1 142.3 (3) 
C6—C7—C12—N1 2.0 (3) C17—C16—C19—O1 -38.4 (4) 
C13—N1—C12—C11 4.8 (4) C15—C16—C19—O2 -39.3 (3) 
C1—N1—C12—C11 -178.3 (2) C17—C16—C19—O2 140.0 (2) 
C13—N1—C12—C7 -177.9 (2) O1—C19—O2—C20 0.1 (4) 
C1—N1—C12—C7 -1.0 (3) C16—C19—O2—C20 -178.2 (2) 
 
Hydrogen-bond geometry (Å, º) 
  D—H···A D—H H···A D···A D—H···A 
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C20—H20A···F14i 0.96 (4) 2.54 (3) 3.335 (4) 140 (2) 
 
Symmetry code:  (i) -x+1, -y+1, -z. 
 
Computing details 
Data collection: Bruker APEX 2; cell refinement: Bruker SAINT; data reduction: Bruker SAINT; 
program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: 
SHELXL2012 (Sheldrick, 2012); molecular graphics: Bruker SHELXTL; software used to prepare material 
for publication: Bruker SHELXTL. 
Special details 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using 
the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in 
distances, angles and torsion angles; correlations between esds in cell parameters are only used when they 
are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating 
esds involving l.s. planes. 
Refinement. Refined as a 2-component twin with 180 degree rotation about reciprocal axis 1 0 1. 
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5.2. DNA thermal denaturation assay data  
5.2.1. DNA thermal denaturation study of compound 41-DNA complex 
Compound 14-DNA complex Mean value 
DNA 
 
ACTD-
DNA Tm 
Compound 41 
 
 
 
 
 
Tm °C  
 (1) 
 
Tm °C 
(2) 
Tm °C 
 (3) Tm °C  Tm °C Tm °C Tm °C  
69 70 70 70 67 84 3  
5.2.2. DNA thermal denaturation study of compound 42-DNA complex 
Compound 15-DNA complex Mean value 
DNA 
 
ACTD-
DNA Tm 
Compound 42 
 
 
Tm °C   
 (1) 
 
Tm °C 
 (2) 
Tm °C   
(3) Tm °C Tm °C Tm °C  Tm °C 
69 72 71 71 67 84 4  
5.2.3. DNA thermal denaturation study of compound 46-DNA complex 
Compound 19-DNA complex Mean value 
DNA 
 
ACTD-
DNA Tm 
Compound 46 
 
 
Tm °C   
 (1) 
 
Tm °C 
 (2) 
Tm  °C  
(3) Tm °C Tm °C Tm °C Tm °C 
70 72 69 70 67 84 3  
5.2.4. DNA thermal denaturation study of compound 48-DNA complex 
Compound 21-DNA complex Mean value 
DNA 
 
ACTD-
DNA Tm 
Compound 48 
 
 
Tm °C   
 (1) 
 
Tm °C 
 (2) 
Tm °C  
(3) Tm °C Tm °C Tm °C Tm °C  
71 72 70 71 67 84 4     
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5.2.5. DNA thermal denaturation study of compound 82-DNA complex 
Compound 53-DNA complex Mean value 
DNA 
 
ACTD-
DNA Tm 
Compound 82 
 
 
Tm °C   
 (1) 
 
Tm °C 
 (2) 
Tm  °C 
(3) Tm °C Tm °C Tm °C Tm °C 
69 71 64 69 67 84 2  
5.2.6. DNA thermal denaturation study of compound 83-DNA complex 
Compound 54-DNA complex Mean value 
DNA 
 
ACTD-
DNA Tm 
Compound 83 
 
 
Tm °C   
 (1) 
 
Tm °C  
 (2) 
Tm °C   
(3) Tm °C Tm °C  Tm °C Tm °C 
68 79 73 73 67 84 6  
5.2.7. DNA thermal denaturation study of compound 87-DNA complex 
Compound 58-DNA complex Mean value 
DNA 
 
ACTD-
DNA Tm 
Compound 87 
 
 
Tm °C  
 (1) 
 
Tm °C  
 (2) 
Tm °C  
(3) Tm °C  Tm °C Tm °C Tm °C 
83 62 78 78 67 84 11  
5.2.8. DNA thermal denaturation study of compound 100-DNA complex 
Compound 71-DNA complex Mean value 
DNA 
 
ACTD-
DNA Tm 
Compound 100 
 
 
Tm °C   
 (1) 
 
Tm °C 
 (2) 
Tm °C   
(3) Tm °C  Tm °C Tm °C Tm °C 
77 72 78 77 67 84 10 
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5.2.9. DNA thermal denaturation study of compound 105-DNA complex 
Compound 76-DNA complex Mean value 
DNA 
 
ACTD-
DNA Tm 
Compound 105 
 
 
Tm °C    
 (1) 
 
Tm °C 
 (2) 
Tm °C   
(3) Tm °C Tm °C  Tm °C Tm °C  
83 80 69 80 67 84 13  
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5.3. UV-visible spectroscopy data 
5.3.1. UV-visible spectra of compound 42  
The a spectra showed the absorbance of the compound in absence (a), and in the presence 
of 5.6 µM (b), 10 µM (c), 15 µM (d), 20 µM (e), 24 µM (f), and 28 µM (g) DNA. The 
arrow shows increasing DNA concentration. Inside graph is the plot of A0 / (A-A0) vs.     
1/ [DNA] for determination of K and G values. 
 
nm.
290.00 350.00 400.00
A
b
s.
0.600
0.400
0.200
0.000
-0.100
 
Absorption spectra of 1  10-3 M of compound 42, R2= 0.95048 for six points. 
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5.3.2. UV-visible spectra of compound 46 
nm.
280.00 300.00 350.00 400.00
Abs
.
0.600
0.400
0.200
0.000
-0.100
 
Absorption spectra of 1  10-2 M of compound 46, R2= 0.97533 for six points. 
 
5.3.3. UV-visible spectra of compound 48 
nm.
290.00 350.00 400.00
Abs
.
1.200
1.000
0.500
0.000
-0.100
 
Absorption spectra of 1  10-2 M of compound 48, R2= 0.96026 for six points. 
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5.3.4. UV-visible spectra of compound 59 
nm.
280.00 300.00 320.00 340.00 350.00
Abs
.
2.000
1.500
1.000
0.500
0.000
-0.400
 
Absorption spectra of 1  10-3 M of compound 59, R2= 0.96103 for six points. 
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5.3.5. UV-visible spectra of compound 68 
nm.
290.00 350.00 400.00
A
bs
.
1.000
0.500
0.000
-0.400
 
Absorption spectra of 1  10-3 M of compound 68, R2= 0.99238 for six points. 
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5.3.6. UV-visible spectra of compound 71 
nm.
300.00 310.00 320.00 330.00 340.00 350.00
Abs
.
0.150
0.100
0.000
-0.100
-0.110
 
Absorption spectra of 1  10-3 M of compound 71, R2= 0.95796 for six points. 
 
5.3.7. UV-visible spectra of compound 76 
nm.
290.00 350.00 400.00
Abs
.
0.800
0.500
0.000
-0.400
 
Absorption spectra of 1  10-3 M of compound 76, R2= 0.93289 for six points. 
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5.3.8. UV-visible spectra of compound 83 
nm.
285.00 300.00 350.00 400.00
Abs
.
0.400
0.200
0.000
-0.200
 
Absorption spectra of 1  10-3 M of compound 83, R2= 0.92403 for six points. 
 
5.3.9. UV- visible spectra of compound 84 
nm.
285.00 300.00 350.00 400.00
Abs
.
1.000
0.500
0.000
-0.123
 
Absorption spectra of 1  10-2 M of compound 84, R2= 0.98136 for six points. 
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5.3.10. UV-visible spectra of compound 87 
nm.
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Absorption spectra of 1  10-3 M of compound 87, R2= 0.98613for six points. 
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5.3.11. UV-visible spectra of compound 90 
nm.
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Absorption spectra of 1  10-3 M of compound 90, R2= 0.98438for six points. 
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5.3.12. UV-visible spectra of compound 96 
nm.
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Absorption spectra of 1  10-2 M of compound 96, R2= 0.99816 for six points. 
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5.3.13. UV-visible spectra of compound 100  
nm.
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Absorption spectra of 1  10-3 M of compound 100, R2= 0.99967 for six points. 
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5.3.14. UV-visible spectra of compound 102 
nm.
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Absorption spectra of 1  10-3 M of compound 102, R2= 0.98702 for six points. 
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5.3.15. UV-visible spectra of compound 103 
nm.
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Absorption spectra of 1  10-3 M of compound 103, R2= 0.81914 for six points. 
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5.3.16. UV-visible spectra of compound 105 
nm.
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Absorption spectra of 1  10-3 M of compound 105, R2= 0.99806 for six points. 
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5.3.17. UV-visible spectra of compound 109 
nm.
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Absorption spectra of 1  10-3 M of compound 109, R2= 0.99961 for six points. 
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5.3.18. UV-visible spectra of compound 111 
nm.
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Absorption spectra of 1  10-3 M of compound 111, R2= 0.99732 for six points). 
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5.3.19. UV-visible spectra of compound 114 
nm.
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Absorption spectra of 1  10-3 M of compound 114, R2= 0.99603 for six points. 
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5.3.20. UV-visible spectra of compound 116 
nm.
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Absorption spectra of 1  10-3 M of compound 116, R2= 0.98178 for six points. 
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5.3.21. UV-visible spectra of compound 117 
nm.
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Absorption spectra of 1  10-3 M of compound 117, R2= 0.99227 for six points. 
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5.3.22. UV-visible spectra of compound 120 
nm.
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Absorption spectra of 1  10-3 M of compound 120, R2= 0.98451 for six points. 
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5.3.23. UV-visible spectra of compound 133 
nm.
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Absorption spectra of 1  10-3 M of compound 133, R2= 0.9629 for six points. 
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5.3.24. UV-visible spectra of compound 135 
nm.
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Absorption spectra of 1  10-3 M of compound 135, R2= 0.99983 for six points. 
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5.4. Fluorescence spectroscopy data for the ethidium bromide displacement 
assay  
Emission spectra of SS-DNA-EB in trisma base buffer on titration of the synthesised 
compounds. Kex = 480 nm; [EB] = 1  10-6 M; [DNA] = 1.5  10-4 M. The arrow shows 
the increase of the complex concentration (a) 0.0, (b) 1  10-6, (c) 2  10-6, (d) 4  10-6, 
(e) 6  10-6, (f) 8  10-6, (g) 1  10-5 M. Inside graph is the plot of I0 / I vs. complex 
concentration for determination of K and G values.   
5.4.1. Fluorescence spectra of compound 42          
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Compound 42  
R2= 0.96334 for six points. 
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5.4.2. Fluorescence spectra of compound 46         
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Compound 46   
R2= 0.89321 for six points. 
 
5.4.3. Fluorescence spectra of compound 48         
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Compound 48 
R2= 0.99657 for six points. 
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5.4.4. Fluorescence spectra of Compound 59         
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Compound 59   
R2= 0.94588 for six points.  
5.4.5. Fluorescence spectra of Compound 68        
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Compound 68   
R2= 0.96175 for six points.  
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5.4.6. Fluorescence spectra of Compound 71  
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Compound 71 
R2= 0.9718 for six points. 
5.4.7. Fluorescence spectra of Compound 76  
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Compound 76 
R2= 0.98563 for six points. 
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5.4.8. Fluorescence spectra of compound 82         
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Compound 82 
R2= 0.96344 for six points. 
5.4.9. Fluorescence spectra of compound 83         
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Compound 83 
R2= 0.97382 for six points. 
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5.4.10. Fluorescence spectra of compound 84         
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Compound 84   
R2= 0.89946 for six points. 
5.4.11. Fluorescence spectra of compound 87 
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Compound 87 
R2= 0.94354 for six points.  
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5.4.12. Fluorescence spectra of compound 90         
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Compound 90   
R2= 0.90266 for six points. 
5.4.13. Fluorescence spectra of compound 91          
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Compound 91 
R2= 0.9672 for six points.   
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5.4.14. Fluorescence spectra of compound 96        
540.0 560 580 600 620 640 660 680 700.5
0.0
50
100
150
200
250
300
350.0
nm
INT 
 
Compound 96 
R2= 0.99667 for six points. 
5.4.15. Fluorescence spectra of compound 100         
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Compound 100 
R2= 0.99024 for six points.   
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5.4.16. Fluorescence spectra of compound 102          
540.0 560 580 600 620 640 660 680 700.5
22.2
50
100
150
200
250
300
346.3
nm
INT 
 
Compound 102 
R2= 0.96626 for six points. 
5.4.17. Fluorescence spectra of compound 103         
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Compound 103  
R2= 0.94012 for six points. 
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5.4.18. Fluorescence spectra of compound 105  
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Compound 105 
R2= 0.82974 for six points. 
5.4.19. Fluorescence spectra of compound 109         
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Compound 109 
R2= 0.9499 for six points.  
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5.4.20. Fluorescence spectra of compound 111 
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Compound 111 
R2= 0.90178 for six points. 
5.4.21. Fluorescence spectra of compound 114 
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Compound 114 
R2= 0.91145 for six points.  
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5.4.22. Fluorescence spectra of compound 116         
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Compound 116 
R2= 0.96138 for six points. 
5.4.23. Fluorescence spectra of compound 117 
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Compound 117   
R2= 0.95205 for six points.   
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5.4.24. Fluorescence spectra of compound 119 
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Compound 119   
R2= 0.8854 for six points. 
5.4.25. Fluorescence spectra of compound 120          
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Compound 120   
R2= 0.74776 for six points. 
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5.4.26. Fluorescence spectra of compound 127         
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Compound 127   
R2= 0.9763 for six points. 
5.4.27. Fluorescence spectra of compound 133           
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Compound 133 
R2= 0.9634 for six points. 
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5.4.28. Fluorescence spectra of compound 135          
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Compound 135 
R2= 0.96518 for six points.     
